id	sid	tid	token	lemma	pos
can-11500	1	1	characterization	characterization	NOUN
can-11500	1	2	and	and	CCONJ
can-11500	1	3	application	application	NOUN
can-11500	1	4	of	of	ADP
can-11500	1	5	nanomaterials	nanomaterial	NOUN
can-11500	1	6	2025	2025	NUM
can-11500	1	7	,	,	PUNCT
can-11500	1	8	8(3	8(3	NUM
can-11500	1	9	)	)	PUNCT
can-11500	1	10	,	,	PUNCT
can-11500	1	11	11500	11500	NUM
can-11500	1	12	.	.	PUNCT
can-11500	2	1	https://doi.org/10.24294/can11500	https://doi.org/10.24294/can11500	PROPN
can-11500	2	2	1	1	NUM
can-11500	2	3	article	article	NOUN
can-11500	2	4	investigation	investigation	NOUN
can-11500	2	5	of	of	ADP
can-11500	2	6	the	the	DET
can-11500	2	7	effect	effect	NOUN
can-11500	2	8	of	of	ADP
can-11500	2	9	dexamethasone	dexamethasone	NOUN
can-11500	2	10	-	-	PUNCT
can-11500	2	11	loaded	load	VERB
can-11500	2	12	magnetic	magnetic	ADJ
can-11500	2	13	nanoparticles	nanoparticle	NOUN
can-11500	2	14	on	on	ADP
can-11500	2	15	mda	mda	PROPN
can-11500	2	16	-	-	PUNCT
can-11500	2	17	mb-231	mb-231	PROPN
can-11500	2	18	cell	cell	NOUN
can-11500	2	19	lines	line	NOUN
can-11500	2	20	deniz	deniz	PROPN
can-11500	2	21	sude	sude	PROPN
can-11500	2	22	polat1	polat1	PROPN
can-11500	2	23	,	,	PUNCT
can-11500	2	24	dorukhan	dorukhan	PROPN
can-11500	2	25	atar1	atar1	PROPN
can-11500	2	26	,	,	PUNCT
can-11500	2	27	duygu	duygu	PROPN
can-11500	2	28	ayça	ayça	PROPN
can-11500	2	29	doğan1	doğan1	PROPN
can-11500	2	30	,	,	PUNCT
can-11500	2	31	ecem	ecem	PROPN
can-11500	2	32	akdereli1	akdereli1	PROPN
can-11500	2	33	,	,	PUNCT
can-11500	2	34	fırat	fırat	PROPN
can-11500	2	35	botan1	botan1	NOUN
can-11500	2	36	,	,	PUNCT
can-11500	2	37	gülhat	gülhat	PROPN
can-11500	2	38	yıldız1	yıldız1	PROPN
can-11500	2	39	,	,	PUNCT
can-11500	2	40	hatice	hatice	NOUN
can-11500	2	41	elve	elve	PROPN
can-11500	2	42	bozkaya1	bozkaya1	PROPN
can-11500	2	43	,	,	PUNCT
can-11500	2	44	mehmet	mehmet	PROPN
can-11500	2	45	ali	ali	PROPN
can-11500	2	46	özdemir1	özdemir1	PROPN
can-11500	2	47	,	,	PUNCT
can-11500	2	48	melisa	melisa	PROPN
can-11500	2	49	bulut1	bulut1	PROPN
can-11500	2	50	,	,	PUNCT
can-11500	2	51	muhammed	muhammed	PROPN
can-11500	2	52	furkan	furkan	PROPN
can-11500	2	53	yaşar1	yaşar1	PROPN
can-11500	2	54	,	,	PUNCT
can-11500	2	55	samet	samet	PROPN
can-11500	2	56	bozkurt1	bozkurt1	PROPN
can-11500	2	57	,	,	PUNCT
can-11500	2	58	sude	sude	PROPN
can-11500	2	59	naz	naz	PROPN
can-11500	2	60	bahar1	bahar1	PROPN
can-11500	2	61	,	,	PUNCT
can-11500	2	62	furkan	furkan	PROPN
can-11500	2	63	bayram	bayram	PROPN
can-11500	2	64	çoşkun2	çoşkun2	PROPN
can-11500	2	65	,	,	PUNCT
can-11500	2	66	serap	serap	VERB
can-11500	2	67	yalcin	yalcin	PROPN
can-11500	2	68	azarkan3	azarkan3	PROPN
can-11500	2	69	*	*	SYM
can-11500	2	70	1	1	NUM
can-11500	2	71	department	department	NOUN
can-11500	2	72	of	of	ADP
can-11500	2	73	medicine	medicine	NOUN
can-11500	2	74	,	,	PUNCT
can-11500	2	75	faculty	faculty	NOUN
can-11500	2	76	of	of	ADP
can-11500	2	77	medicine	medicine	NOUN
can-11500	2	78	,	,	PUNCT
can-11500	2	79	kırsehir	kırsehir	ADJ
can-11500	2	80	ahi	ahi	NOUN
can-11500	2	81	evran	evran	PROPN
can-11500	2	82	university	university	PROPN
can-11500	2	83	,	,	PUNCT
can-11500	2	84	kırsehir	kırsehir	PROPN
can-11500	2	85	40100	40100	NUM
can-11500	2	86	,	,	PUNCT
can-11500	2	87	turkey	turkey	PROPN
can-11500	2	88	2	2	NUM
can-11500	2	89	department	department	NOUN
can-11500	2	90	of	of	ADP
can-11500	2	91	medical	medical	ADJ
can-11500	2	92	biology	biology	NOUN
can-11500	2	93	,	,	PUNCT
can-11500	2	94	graduate	graduate	NOUN
can-11500	2	95	school	school	NOUN
can-11500	2	96	of	of	ADP
can-11500	2	97	health	health	NOUN
can-11500	2	98	sciences	sciences	PROPN
can-11500	2	99	,	,	PUNCT
can-11500	2	100	kırsehir	kırsehir	ADJ
can-11500	2	101	ahi	ahi	NOUN
can-11500	2	102	evran	evran	PROPN
can-11500	2	103	university	university	PROPN
can-11500	2	104	,	,	PUNCT
can-11500	2	105	kırsehir	kırsehir	PROPN
can-11500	2	106	40100	40100	NUM
can-11500	2	107	,	,	PUNCT
can-11500	2	108	turkey	turkey	PROPN
can-11500	2	109	3	3	NUM
can-11500	2	110	department	department	PROPN
can-11500	2	111	of	of	ADP
can-11500	2	112	pharmacology	pharmacology	NOUN
can-11500	2	113	,	,	PUNCT
can-11500	2	114	faculty	faculty	NOUN
can-11500	2	115	of	of	ADP
can-11500	2	116	medicine	medicine	NOUN
can-11500	2	117	,	,	PUNCT
can-11500	2	118	kırsehir	kırsehir	ADJ
can-11500	2	119	ahi	ahi	NOUN
can-11500	2	120	evran	evran	PROPN
can-11500	2	121	university	university	PROPN
can-11500	2	122	,	,	PUNCT
can-11500	2	123	kırsehir	kırsehir	PROPN
can-11500	2	124	40100	40100	NUM
can-11500	2	125	,	,	PUNCT
can-11500	2	126	turkey	turkey	NOUN
can-11500	2	127	*	*	PUNCT
can-11500	2	128	corresponding	correspond	VERB
can-11500	2	129	author	author	NOUN
can-11500	2	130	:	:	PUNCT
can-11500	2	131	serap	serap	VERB
can-11500	2	132	yalcin	yalcin	PROPN
can-11500	2	133	azarkan	azarkan	PROPN
can-11500	2	134	,	,	PUNCT
can-11500	2	135	syalcin	syalcin	PROPN
can-11500	2	136	@ahievran.edu.tr	@ahievran.edu.tr	PROPN
can-11500	2	137	abstract	abstract	NOUN
can-11500	2	138	:	:	PUNCT
can-11500	2	139	the	the	DET
can-11500	2	140	mda	mda	PROPN
can-11500	2	141	-	-	PUNCT
can-11500	2	142	mb-231	mb-231	PROPN
can-11500	2	143	cell	cell	NOUN
can-11500	2	144	line	line	NOUN
can-11500	2	145	is	be	AUX
can-11500	2	146	derived	derive	VERB
can-11500	2	147	from	from	ADP
can-11500	2	148	triple	triple	ADJ
can-11500	2	149	-	-	PUNCT
can-11500	2	150	negative	negative	ADJ
can-11500	2	151	breast	breast	NOUN
can-11500	2	152	cancer	cancer	NOUN
can-11500	2	153	(	(	PUNCT
can-11500	2	154	tnbc	tnbc	PROPN
can-11500	2	155	)	)	PUNCT
can-11500	2	156	,	,	PUNCT
can-11500	2	157	representing	represent	VERB
can-11500	2	158	one	one	NUM
can-11500	2	159	of	of	ADP
can-11500	2	160	the	the	DET
can-11500	2	161	most	most	ADV
can-11500	2	162	aggressive	aggressive	ADJ
can-11500	2	163	forms	form	NOUN
can-11500	2	164	of	of	ADP
can-11500	2	165	breast	breast	NOUN
can-11500	2	166	cancer	cancer	NOUN
can-11500	2	167	.	.	PUNCT
can-11500	3	1	innovative	innovative	ADJ
can-11500	3	2	therapeutic	therapeutic	ADJ
can-11500	3	3	strategies	strategy	NOUN
can-11500	3	4	,	,	PUNCT
can-11500	3	5	including	include	VERB
can-11500	3	6	s	s	PRON
can-11500	3	7	targeted	target	VERB
can-11500	3	8	therapies	therapy	NOUN
can-11500	3	9	using	use	VERB
can-11500	3	10	nanocarriers	nanocarrier	NOUN
can-11500	3	11	,	,	PUNCT
can-11500	3	12	hold	hold	VERB
can-11500	3	13	significant	significant	ADJ
can-11500	3	14	promise	promise	NOUN
can-11500	3	15	,	,	PUNCT
can-11500	3	16	particularly	particularly	ADV
can-11500	3	17	for	for	ADP
can-11500	3	18	difficult	difficult	ADJ
can-11500	3	19	-	-	PUNCT
can-11500	3	20	to	to	ADP
can-11500	3	21	-	-	PUNCT
can-11500	3	22	treat	treat	VERB
can-11500	3	23	cancers	cancer	NOUN
can-11500	3	24	such	such	ADJ
can-11500	3	25	as	as	ADP
can-11500	3	26	tnbc	tnbc	ADJ
can-11500	3	27	.	.	PUNCT
can-11500	4	1	nanoparticles	nanoparticle	NOUN
can-11500	4	2	have	have	AUX
can-11500	4	3	transformed	transform	VERB
can-11500	4	4	the	the	DET
can-11500	4	5	medical	medical	ADJ
can-11500	4	6	field	field	NOUN
can-11500	4	7	by	by	ADP
can-11500	4	8	serving	serve	VERB
can-11500	4	9	as	as	ADP
can-11500	4	10	advanced	advanced	ADJ
can-11500	4	11	drug	drug	NOUN
can-11500	4	12	delivery	delivery	NOUN
can-11500	4	13	systems	system	NOUN
can-11500	4	14	for	for	ADP
can-11500	4	15	cancer	cancer	NOUN
can-11500	4	16	treatment	treatment	NOUN
can-11500	4	17	.	.	PUNCT
can-11500	5	1	they	they	PRON
can-11500	5	2	play	play	VERB
can-11500	5	3	a	a	DET
can-11500	5	4	critical	critical	ADJ
can-11500	5	5	role	role	NOUN
can-11500	5	6	in	in	ADP
can-11500	5	7	overcoming	overcome	VERB
can-11500	5	8	the	the	DET
can-11500	5	9	drug	drug	NOUN
can-11500	5	10	resistance	resistance	NOUN
can-11500	5	11	often	often	ADV
can-11500	5	12	associated	associate	VERB
can-11500	5	13	with	with	ADP
can-11500	5	14	cancer	cancer	NOUN
can-11500	5	15	therapies	therapy	NOUN
can-11500	5	16	.	.	PUNCT
can-11500	6	1	when	when	SCONJ
can-11500	6	2	utilized	utilize	VERB
can-11500	6	3	as	as	ADP
can-11500	6	4	drug	drug	NOUN
can-11500	6	5	delivery	delivery	NOUN
can-11500	6	6	vehicles	vehicle	NOUN
can-11500	6	7	,	,	PUNCT
can-11500	6	8	nanoparticles	nanoparticle	NOUN
can-11500	6	9	can	can	AUX
can-11500	6	10	specifically	specifically	ADV
can-11500	6	11	target	target	VERB
can-11500	6	12	cancer	cancer	NOUN
can-11500	6	13	cells	cell	NOUN
can-11500	6	14	and	and	CCONJ
can-11500	6	15	effectively	effectively	ADV
can-11500	6	16	reduce	reduce	VERB
can-11500	6	17	or	or	CCONJ
can-11500	6	18	eliminate	eliminate	VERB
can-11500	6	19	multidrug	multidrug	NOUN
can-11500	6	20	resistance	resistance	NOUN
can-11500	6	21	.	.	PUNCT
can-11500	7	1	among	among	ADP
can-11500	7	2	them	they	PRON
can-11500	7	3	,	,	PUNCT
can-11500	7	4	chitosan	chitosan	NOUN
can-11500	7	5	-	-	PUNCT
can-11500	7	6	coated	coat	VERB
can-11500	7	7	magnetic	magnetic	ADJ
can-11500	7	8	nanoparticles	nanoparticle	NOUN
can-11500	7	9	(	(	PUNCT
can-11500	7	10	mnps	mnps	PROPN
can-11500	7	11	)	)	PUNCT
can-11500	7	12	have	have	AUX
can-11500	7	13	been	be	AUX
can-11500	7	14	widely	widely	ADV
can-11500	7	15	explored	explore	VERB
can-11500	7	16	for	for	ADP
can-11500	7	17	the	the	DET
can-11500	7	18	loading	loading	NOUN
can-11500	7	19	and	and	CCONJ
can-11500	7	20	controlled	control	VERB
can-11500	7	21	release	release	NOUN
can-11500	7	22	of	of	ADP
can-11500	7	23	various	various	ADJ
can-11500	7	24	anticancer	anticancer	NOUN
can-11500	7	25	agents	agent	NOUN
can-11500	7	26	.	.	PUNCT
can-11500	8	1	in	in	ADP
can-11500	8	2	this	this	DET
can-11500	8	3	study	study	NOUN
can-11500	8	4	,	,	PUNCT
can-11500	8	5	we	we	PRON
can-11500	8	6	evaluated	evaluate	VERB
can-11500	8	7	the	the	DET
can-11500	8	8	effects	effect	NOUN
can-11500	8	9	of	of	ADP
can-11500	8	10	dexamethasone	dexamethasone	NOUN
can-11500	8	11	-	-	PUNCT
can-11500	8	12	loaded	load	VERB
can-11500	8	13	chitosan	chitosan	NOUN
can-11500	8	14	-	-	PUNCT
can-11500	8	15	coated	coat	VERB
can-11500	8	16	mnps	mnps	NOUN
can-11500	8	17	on	on	ADP
can-11500	8	18	mda	mda	PROPN
can-11500	8	19	-	-	PUNCT
can-11500	8	20	mb-231	mb-231	PROPN
can-11500	8	21	cell	cell	NOUN
can-11500	8	22	lines	line	NOUN
can-11500	8	23	.	.	PUNCT
can-11500	9	1	fourier	fourier	NOUN
can-11500	9	2	transform	transform	VERB
can-11500	9	3	infrared	infrared	ADJ
can-11500	9	4	spectroscopy	spectroscopy	NOUN
can-11500	9	5	and	and	CCONJ
can-11500	9	6	scanning	scan	VERB
can-11500	9	7	electron	electron	NOUN
can-11500	9	8	microscopy	microscopy	NOUN
can-11500	9	9	were	be	AUX
can-11500	9	10	employed	employ	VERB
can-11500	9	11	to	to	PART
can-11500	9	12	verify	verify	VERB
can-11500	9	13	the	the	DET
can-11500	9	14	successful	successful	ADJ
can-11500	9	15	loading	loading	NOUN
can-11500	9	16	of	of	ADP
can-11500	9	17	dexamethasone	dexamethasone	NOUN
can-11500	9	18	onto	onto	ADP
can-11500	9	19	the	the	DET
can-11500	9	20	nanoparticles	nanoparticle	NOUN
can-11500	9	21	.	.	PUNCT
can-11500	10	1	to	to	PART
can-11500	10	2	assess	assess	VERB
can-11500	10	3	cytotoxicity	cytotoxicity	NOUN
can-11500	10	4	,	,	PUNCT
can-11500	10	5	empty	empty	ADJ
can-11500	10	6	nanoparticles	nanoparticle	NOUN
can-11500	10	7	,	,	PUNCT
can-11500	10	8	free	free	ADJ
can-11500	10	9	drug	drug	NOUN
can-11500	10	10	,	,	PUNCT
can-11500	10	11	and	and	CCONJ
can-11500	10	12	drug	drug	NOUN
can-11500	10	13	-	-	PUNCT
can-11500	10	14	loaded	load	VERB
can-11500	10	15	nanoparticles	nanoparticle	NOUN
can-11500	10	16	were	be	AUX
can-11500	10	17	tested	test	VERB
can-11500	10	18	on	on	ADP
can-11500	10	19	the	the	DET
can-11500	10	20	cells	cell	NOUN
can-11500	10	21	.	.	PUNCT
can-11500	11	1	the	the	DET
can-11500	11	2	results	result	NOUN
can-11500	11	3	indicated	indicate	VERB
can-11500	11	4	that	that	SCONJ
can-11500	11	5	empty	empty	ADJ
can-11500	11	6	nanoparticles	nanoparticle	NOUN
can-11500	11	7	exhibited	exhibit	VERB
can-11500	11	8	no	no	DET
can-11500	11	9	toxic	toxic	ADJ
can-11500	11	10	effects	effect	NOUN
can-11500	11	11	.	.	PUNCT
can-11500	12	1	the	the	DET
can-11500	12	2	ic50	ic50	PROPN
can-11500	12	3	value	value	NOUN
can-11500	12	4	of	of	ADP
can-11500	12	5	the	the	DET
can-11500	12	6	free	free	ADJ
can-11500	12	7	drug	drug	NOUN
can-11500	12	8	was	be	AUX
can-11500	12	9	123	123	NUM
can-11500	12	10	µg	µg	NOUN
can-11500	12	11	/	/	SYM
can-11500	12	12	ml	ml	NOUN
can-11500	12	13	,	,	PUNCT
can-11500	12	14	while	while	SCONJ
can-11500	12	15	the	the	DET
can-11500	12	16	ic50	ic50	PROPN
can-11500	12	17	value	value	NOUN
can-11500	12	18	of	of	ADP
can-11500	12	19	the	the	DET
can-11500	12	20	drug	drug	NOUN
can-11500	12	21	-	-	PUNCT
can-11500	12	22	loaded	load	VERB
can-11500	12	23	nanoparticles	nanoparticle	NOUN
can-11500	12	24	was	be	AUX
can-11500	12	25	significantly	significantly	ADV
can-11500	12	26	lower	low	ADJ
can-11500	12	27	,	,	PUNCT
can-11500	12	28	at	at	ADP
can-11500	12	29	63	63	NUM
can-11500	12	30	µg	µg	NOUN
can-11500	12	31	/	/	SYM
can-11500	12	32	ml	ml	NOUN
can-11500	12	33	.	.	PUNCT
can-11500	13	1	these	these	DET
can-11500	13	2	findings	finding	NOUN
can-11500	13	3	confirmed	confirm	VERB
can-11500	13	4	the	the	DET
can-11500	13	5	successful	successful	ADJ
can-11500	13	6	conjugation	conjugation	NOUN
can-11500	13	7	of	of	ADP
can-11500	13	8	dexamethasone	dexamethasone	NOUN
can-11500	13	9	to	to	ADP
can-11500	13	10	the	the	DET
can-11500	13	11	chitosan	chitosan	NOUN
can-11500	13	12	-	-	PUNCT
can-11500	13	13	coated	coat	VERB
can-11500	13	14	mnps	mnps	NOUN
can-11500	13	15	,	,	PUNCT
can-11500	13	16	demonstrating	demonstrate	VERB
can-11500	13	17	substantial	substantial	ADJ
can-11500	13	18	cytotoxic	cytotoxic	ADJ
can-11500	13	19	effects	effect	NOUN
can-11500	13	20	on	on	ADP
can-11500	13	21	breast	breast	NOUN
can-11500	13	22	cancer	cancer	NOUN
can-11500	13	23	cells	cell	NOUN
can-11500	13	24	.	.	PUNCT
can-11500	14	1	although	although	SCONJ
can-11500	14	2	dexamethasone	dexamethasone	NOUN
can-11500	14	3	has	have	AUX
can-11500	14	4	been	be	AUX
can-11500	14	5	reported	report	VERB
can-11500	14	6	to	to	PART
can-11500	14	7	exhibit	exhibit	VERB
can-11500	14	8	both	both	PRON
can-11500	14	9	tumor	tumor	NOUN
can-11500	14	10	-	-	PUNCT
can-11500	14	11	suppressive	suppressive	ADJ
can-11500	14	12	and	and	CCONJ
can-11500	14	13	pro	pro	ADJ
can-11500	14	14	-	-	ADJ
can-11500	14	15	metastatic	metastatic	ADJ
can-11500	14	16	effects	effect	NOUN
can-11500	14	17	,	,	PUNCT
can-11500	14	18	its	its	PRON
can-11500	14	19	specific	specific	ADJ
can-11500	14	20	impact	impact	NOUN
can-11500	14	21	on	on	ADP
can-11500	14	22	tnbc	tnbc	ADJ
can-11500	14	23	warrants	warrant	NOUN
can-11500	14	24	further	further	ADJ
can-11500	14	25	investigation	investigation	NOUN
can-11500	14	26	in	in	ADP
can-11500	14	27	future	future	ADJ
can-11500	14	28	studies	study	NOUN
can-11500	14	29	.	.	PUNCT
can-11500	15	1	keywords	keyword	NOUN
can-11500	15	2	:	:	PUNCT
can-11500	15	3	nanoparticles	nanoparticle	NOUN
can-11500	15	4	;	;	PUNCT
can-11500	15	5	dexamethasone	dexamethasone	NOUN
can-11500	15	6	;	;	PUNCT
can-11500	15	7	breast	breast	NOUN
can-11500	15	8	cancer	cancer	NOUN
can-11500	15	9	;	;	PUNCT
can-11500	15	10	cytotoxicity	cytotoxicity	NOUN
can-11500	15	11	1	1	NUM
can-11500	15	12	.	.	PUNCT
can-11500	15	13	introduction	introduction	NOUN
can-11500	15	14	breast	breast	NOUN
can-11500	15	15	cancer	cancer	NOUN
can-11500	15	16	is	be	AUX
can-11500	15	17	the	the	DET
can-11500	15	18	most	most	ADV
can-11500	15	19	commonly	commonly	ADV
can-11500	15	20	diagnosed	diagnose	VERB
can-11500	15	21	cancer	cancer	NOUN
can-11500	15	22	among	among	ADP
can-11500	15	23	women	woman	NOUN
can-11500	15	24	worldwide	worldwide	ADV
can-11500	15	25	and	and	CCONJ
can-11500	15	26	is	be	AUX
can-11500	15	27	treatable	treatable	ADJ
can-11500	15	28	when	when	SCONJ
can-11500	15	29	detected	detect	VERB
can-11500	15	30	at	at	ADP
can-11500	15	31	an	an	DET
can-11500	15	32	early	early	ADJ
can-11500	15	33	stage	stage	NOUN
can-11500	15	34	.	.	PUNCT
can-11500	16	1	however	however	ADV
can-11500	16	2	,	,	PUNCT
can-11500	16	3	advanced	advanced	ADJ
can-11500	16	4	-	-	PUNCT
can-11500	16	5	stage	stage	NOUN
can-11500	16	6	breast	breast	NOUN
can-11500	16	7	cancer	cancer	NOUN
can-11500	16	8	is	be	AUX
can-11500	16	9	considered	consider	VERB
can-11500	16	10	incurable	incurable	ADJ
can-11500	16	11	by	by	ADP
can-11500	16	12	current	current	ADJ
can-11500	16	13	treatment	treatment	NOUN
can-11500	16	14	methods	method	NOUN
can-11500	16	15	[	[	X
can-11500	16	16	1,2,3	1,2,3	NUM
can-11500	16	17	]	]	X
can-11500	16	18	.	.	PUNCT
can-11500	17	1	breast	breast	NOUN
can-11500	17	2	cancer	cancer	NOUN
can-11500	17	3	is	be	AUX
can-11500	17	4	known	know	VERB
can-11500	17	5	to	to	PART
can-11500	17	6	be	be	AUX
can-11500	17	7	a	a	DET
can-11500	17	8	molecularly	molecularly	ADV
can-11500	17	9	heterogeneous	heterogeneous	ADJ
can-11500	17	10	disease	disease	NOUN
can-11500	17	11	.	.	PUNCT
can-11500	18	1	the	the	DET
can-11500	18	2	key	key	ADJ
can-11500	18	3	molecular	molecular	ADJ
can-11500	18	4	characteristics	characteristic	NOUN
can-11500	18	5	include	include	VERB
can-11500	18	6	the	the	DET
can-11500	18	7	human	human	ADJ
can-11500	18	8	epidermal	epidermal	ADJ
can-11500	18	9	growth	growth	NOUN
can-11500	18	10	factor	factor	NOUN
can-11500	18	11	receptor	receptor	NOUN
can-11500	18	12	2	2	NUM
can-11500	18	13	(	(	PUNCT
can-11500	18	14	her2	her2	PROPN
can-11500	18	15	)	)	PUNCT
can-11500	18	16	,	,	PUNCT
can-11500	18	17	hormone	hormone	NOUN
can-11500	18	18	receptors	receptor	NOUN
can-11500	18	19	(	(	PUNCT
can-11500	18	20	estrogen	estrogen	NOUN
can-11500	18	21	and	and	CCONJ
can-11500	18	22	progesterone	progesterone	NOUN
can-11500	18	23	receptors	receptor	NOUN
can-11500	18	24	)	)	PUNCT
can-11500	18	25	,	,	PUNCT
can-11500	18	26	and	and	CCONJ
can-11500	18	27	brca	brca	PROPN
can-11500	18	28	mutations	mutation	NOUN
can-11500	18	29	[	[	X
can-11500	18	30	1,3,4	1,3,4	NUM
can-11500	18	31	]	]	PUNCT
can-11500	18	32	.	.	PUNCT
can-11500	19	1	these	these	DET
can-11500	19	2	molecular	molecular	ADJ
can-11500	19	3	subtypes	subtype	NOUN
can-11500	19	4	determine	determine	VERB
can-11500	19	5	treatment	treatment	NOUN
can-11500	19	6	strategies	strategy	NOUN
can-11500	19	7	and	and	CCONJ
can-11500	19	8	significantly	significantly	ADV
can-11500	19	9	impact	impact	NOUN
can-11500	19	10	disease	disease	NOUN
can-11500	19	11	management	management	NOUN
can-11500	20	1	[	[	X
can-11500	20	2	2	2	NUM
can-11500	20	3	]	]	PUNCT
can-11500	20	4	.	.	PUNCT
can-11500	21	1	treatments	treatment	NOUN
can-11500	21	2	of	of	ADP
can-11500	21	3	breast	breast	NOUN
can-11500	21	4	cancer	cancer	NOUN
can-11500	21	5	encompass	encompass	NOUN
can-11500	21	6	local	local	ADJ
can-11500	21	7	(	(	PUNCT
can-11500	21	8	surgery	surgery	NOUN
can-11500	21	9	and	and	CCONJ
can-11500	21	10	radiotherapy	radiotherapy	NOUN
can-11500	21	11	)	)	PUNCT
can-11500	21	12	and	and	CCONJ
can-11500	21	13	systemic	systemic	ADJ
can-11500	21	14	(	(	PUNCT
can-11500	21	15	endocrine	endocrine	NOUN
can-11500	21	16	therapy	therapy	NOUN
can-11500	21	17	,	,	PUNCT
can-11500	21	18	chemotherapy	chemotherapy	NOUN
can-11500	21	19	,	,	PUNCT
can-11500	21	20	anti	anti	ADJ
can-11500	21	21	-	-	ADJ
can-11500	21	22	her2	her2	ADJ
can-11500	21	23	therapy	therapy	NOUN
can-11500	21	24	,	,	PUNCT
can-11500	21	25	and	and	CCONJ
can-11500	21	26	immunotherapy	immunotherapy	NOUN
can-11500	21	27	)	)	PUNCT
can-11500	21	28	citation	citation	NOUN
can-11500	21	29	polat	polat	NOUN
can-11500	21	30	ds	ds	PROPN
can-11500	21	31	,	,	PUNCT
can-11500	21	32	atar	atar	NOUN
can-11500	21	33	d	d	PROPN
can-11500	21	34	,	,	PUNCT
can-11500	21	35	doğan	doğan	X
can-11500	21	36	da	da	PROPN
can-11500	21	37	et	et	PROPN
can-11500	21	38	al	al	PROPN
can-11500	21	39	.	.	PROPN
can-11500	21	40	(	(	PUNCT
can-11500	21	41	2025	2025	NUM
can-11500	21	42	)	)	PUNCT
can-11500	21	43	.	.	PUNCT
can-11500	22	1	investigation	investigation	NOUN
can-11500	22	2	of	of	ADP
can-11500	22	3	the	the	DET
can-11500	22	4	effect	effect	NOUN
can-11500	22	5	of	of	ADP
can-11500	22	6	dexamethasone	dexamethasone	NOUN
can-11500	22	7	-	-	PUNCT
can-11500	22	8	loaded	load	VERB
can-11500	22	9	magnetic	magnetic	ADJ
can-11500	22	10	nanoparticles	nanoparticle	NOUN
can-11500	22	11	on	on	ADP
can-11500	22	12	mda	mda	PROPN
can-11500	22	13	-	-	PUNCT
can-11500	22	14	mb-231	mb-231	PROPN
can-11500	22	15	cell	cell	NOUN
can-11500	22	16	lines	line	NOUN
can-11500	22	17	.	.	PUNCT
can-11500	23	1	characterization	characterization	NOUN
can-11500	23	2	and	and	CCONJ
can-11500	23	3	application	application	NOUN
can-11500	23	4	of	of	ADP
can-11500	23	5	nanomaterials	nanomaterial	NOUN
can-11500	23	6	.	.	PUNCT
can-11500	24	1	8(3	8(3	NUM
can-11500	24	2	):	):	PUNCT
can-11500	24	3	11500	11500	NUM
can-11500	24	4	.	.	PUNCT
can-11500	25	1	https://doi.org/10.24294/can11500	https://doi.org/10.24294/can11500	PROPN
can-11500	25	2	article	article	NOUN
can-11500	25	3	info	info	NOUN
can-11500	25	4	received	receive	VERB
can-11500	25	5	:	:	PUNCT
can-11500	25	6	11	11	NUM
can-11500	25	7	february	february	NOUN
can-11500	25	8	2025	2025	NUM
can-11500	25	9	accepted	accept	VERB
can-11500	25	10	:	:	PUNCT
can-11500	25	11	3	3	NUM
can-11500	25	12	march	march	PROPN
can-11500	25	13	2025	2025	NUM
can-11500	25	14	available	available	ADJ
can-11500	25	15	online	online	NOUN
can-11500	25	16	:	:	PUNCT
can-11500	25	17	20	20	NUM
can-11500	25	18	november	november	NOUN
can-11500	25	19	2025	2025	NUM
can-11500	25	20	copyright	copyright	NOUN
can-11500	25	21	copyright	copyright	NOUN
can-11500	25	22	©	©	PROPN
can-11500	25	23	2025	2025	NUM
can-11500	25	24	by	by	ADP
can-11500	25	25	author(s	author(s	NOUN
can-11500	25	26	)	)	PUNCT
can-11500	25	27	.	.	PUNCT
can-11500	26	1	characterization	characterization	NOUN
can-11500	26	2	and	and	CCONJ
can-11500	26	3	application	application	NOUN
can-11500	26	4	of	of	ADP
can-11500	26	5	nanomaterials	nanomaterial	NOUN
can-11500	26	6	is	be	AUX
can-11500	26	7	published	publish	VERB
can-11500	26	8	by	by	ADP
can-11500	26	9	enpress	enpress	NOUN
can-11500	26	10	publisher	publisher	NOUN
can-11500	26	11	,	,	PUNCT
can-11500	26	12	llc	llc	PROPN
can-11500	26	13	.	.	PUNCT
can-11500	27	1	this	this	DET
can-11500	27	2	work	work	NOUN
can-11500	27	3	is	be	AUX
can-11500	27	4	licensed	license	VERB
can-11500	27	5	under	under	ADP
can-11500	27	6	the	the	DET
can-11500	27	7	creative	creative	ADJ
can-11500	27	8	commons	common	NOUN
can-11500	27	9	attribution	attribution	NOUN
can-11500	27	10	(	(	PUNCT
can-11500	27	11	cc	cc	NOUN
can-11500	27	12	by	by	ADP
can-11500	27	13	)	)	PUNCT
can-11500	27	14	license	license	NOUN
can-11500	27	15	.	.	PUNCT
can-11500	28	1	https://creativecommons.org/licenses/	https://creativecommons.org/licenses/	INTJ
can-11500	28	2	by/4.0/	by/4.0/	NOUN
can-11500	28	3	characterization	characterization	NOUN
can-11500	28	4	and	and	CCONJ
can-11500	28	5	application	application	NOUN
can-11500	28	6	of	of	ADP
can-11500	28	7	nanomaterials	nanomaterial	NOUN
can-11500	28	8	2025	2025	NUM
can-11500	28	9	,	,	PUNCT
can-11500	28	10	8(3	8(3	NUM
can-11500	28	11	)	)	PUNCT
can-11500	28	12	,	,	PUNCT
can-11500	28	13	11500	11500	NUM
can-11500	28	14	.	.	PUNCT
can-11500	29	1	2	2	NUM
can-11500	29	2	approaches	approach	NOUN
can-11500	29	3	.	.	PUNCT
can-11500	30	1	neo	neo	X
can-11500	30	2	-	-	PUNCT
can-11500	30	3	adjuvant	adjuvant	ADJ
can-11500	30	4	therapy	therapy	NOUN
can-11500	30	5	is	be	AUX
can-11500	30	6	a	a	DET
can-11500	30	7	widely	widely	ADV
can-11500	30	8	used	use	VERB
can-11500	30	9	practice	practice	NOUN
can-11500	30	10	in	in	ADP
can-11500	30	11	her2	her2	PROPN
can-11500	30	12	-	-	PUNCT
can-11500	30	13	positive	positive	ADJ
can-11500	30	14	breast	breast	NOUN
can-11500	30	15	cancer	cancer	NOUN
can-11500	30	16	and	and	CCONJ
can-11500	30	17	triple	triple	ADJ
can-11500	30	18	-	-	PUNCT
can-11500	30	19	negative	negative	ADJ
can-11500	30	20	breast	breast	NOUN
can-11500	30	21	cancer	cancer	NOUN
can-11500	30	22	(	(	PUNCT
can-11500	30	23	tnbc	tnbc	ADV
can-11500	30	24	)	)	PUNCT
can-11500	31	1	[	[	X
can-11500	31	2	1,3,5	1,3,5	NUM
can-11500	31	3	]	]	X
can-11500	31	4	.	.	PUNCT
can-11500	32	1	in	in	ADP
can-11500	32	2	metastatic	metastatic	ADJ
can-11500	32	3	breast	breast	NOUN
can-11500	32	4	cancer	cancer	NOUN
can-11500	32	5	,	,	PUNCT
can-11500	32	6	the	the	DET
can-11500	32	7	treatment	treatment	NOUN
can-11500	32	8	goals	goal	NOUN
can-11500	32	9	are	be	AUX
can-11500	32	10	to	to	PART
can-11500	32	11	prolong	prolong	VERB
can-11500	32	12	survival	survival	NOUN
can-11500	32	13	and	and	CCONJ
can-11500	32	14	maintain	maintain	VERB
can-11500	32	15	quality	quality	NOUN
can-11500	32	16	of	of	ADP
can-11500	32	17	life	life	NOUN
can-11500	32	18	[	[	X
can-11500	32	19	2,3	2,3	NUM
can-11500	32	20	]	]	PUNCT
can-11500	32	21	.	.	PUNCT
can-11500	33	1	genetic	genetic	ADJ
can-11500	33	2	predisposition	predisposition	NOUN
can-11500	33	3	,	,	PUNCT
can-11500	33	4	particularly	particularly	ADV
can-11500	33	5	brca1	brca1	PROPN
can-11500	33	6	and	and	CCONJ
can-11500	33	7	brca2	brca2	PROPN
can-11500	33	8	gene	gene	NOUN
can-11500	33	9	mutations	mutation	NOUN
can-11500	33	10	,	,	PUNCT
can-11500	33	11	has	have	AUX
can-11500	33	12	been	be	AUX
can-11500	33	13	reported	report	VERB
can-11500	33	14	to	to	PART
can-11500	33	15	play	play	VERB
can-11500	33	16	a	a	DET
can-11500	33	17	significant	significant	ADJ
can-11500	33	18	role	role	NOUN
can-11500	33	19	in	in	ADP
can-11500	33	20	the	the	DET
can-11500	33	21	development	development	NOUN
can-11500	33	22	of	of	ADP
can-11500	33	23	breast	breast	NOUN
can-11500	33	24	cancer	cancer	NOUN
can-11500	33	25	.	.	PUNCT
can-11500	34	1	additionally	additionally	ADV
can-11500	34	2	,	,	PUNCT
can-11500	34	3	environmental	environmental	ADJ
can-11500	34	4	and	and	CCONJ
can-11500	34	5	lifestyle	lifestyle	NOUN
can-11500	34	6	factors	factor	NOUN
can-11500	34	7	may	may	AUX
can-11500	34	8	also	also	ADV
can-11500	34	9	influence	influence	VERB
can-11500	34	10	the	the	DET
can-11500	34	11	risk	risk	NOUN
can-11500	34	12	[	[	X
can-11500	34	13	4,6,7	4,6,7	NOUN
can-11500	34	14	]	]	PUNCT
can-11500	34	15	.	.	PUNCT
can-11500	35	1	mda	mda	PROPN
can-11500	35	2	-	-	PUNCT
can-11500	35	3	mb-231	mb-231	PROPN
can-11500	35	4	is	be	AUX
can-11500	35	5	recognized	recognize	VERB
can-11500	35	6	as	as	ADP
can-11500	35	7	a	a	DET
can-11500	35	8	tnbc	tnbc	ADJ
can-11500	35	9	cell	cell	NOUN
can-11500	35	10	line	line	NOUN
can-11500	35	11	,	,	PUNCT
can-11500	35	12	and	and	CCONJ
can-11500	35	13	these	these	DET
can-11500	35	14	cells	cell	NOUN
can-11500	35	15	are	be	AUX
can-11500	35	16	reported	report	VERB
can-11500	35	17	to	to	PART
can-11500	35	18	represent	represent	VERB
can-11500	35	19	one	one	NUM
can-11500	35	20	of	of	ADP
can-11500	35	21	the	the	DET
can-11500	35	22	most	most	ADV
can-11500	35	23	aggressive	aggressive	ADJ
can-11500	35	24	forms	form	NOUN
can-11500	35	25	of	of	ADP
can-11500	35	26	breast	breast	NOUN
can-11500	35	27	cancer	cancer	NOUN
can-11500	35	28	.	.	PUNCT
can-11500	36	1	they	they	PRON
can-11500	36	2	exhibit	exhibit	VERB
can-11500	36	3	increased	increase	VERB
can-11500	36	4	resistance	resistance	NOUN
can-11500	36	5	to	to	ADP
can-11500	36	6	antitumor	antitumor	PROPN
can-11500	36	7	compounds	compound	NOUN
can-11500	36	8	,	,	PUNCT
can-11500	36	9	and	and	CCONJ
can-11500	36	10	this	this	DET
can-11500	36	11	resistance	resistance	NOUN
can-11500	36	12	has	have	AUX
can-11500	36	13	been	be	AUX
can-11500	36	14	reported	report	VERB
can-11500	36	15	to	to	PART
can-11500	36	16	become	become	VERB
can-11500	36	17	more	more	ADV
can-11500	36	18	pronounced	pronounce	VERB
can-11500	36	19	in	in	ADP
can-11500	36	20	3d	3d	NUM
can-11500	36	21	spheroid	spheroid	NOUN
can-11500	36	22	models	model	NOUN
can-11500	36	23	[	[	X
can-11500	36	24	8	8	NUM
can-11500	36	25	]	]	PUNCT
can-11500	36	26	.	.	PUNCT
can-11500	37	1	novel	novel	ADJ
can-11500	37	2	treatment	treatment	NOUN
can-11500	37	3	methods	method	NOUN
can-11500	37	4	,	,	PUNCT
can-11500	37	5	such	such	ADJ
can-11500	37	6	as	as	ADP
can-11500	37	7	immunotherapy	immunotherapy	NOUN
can-11500	37	8	and	and	CCONJ
can-11500	37	9	targeted	target	VERB
can-11500	37	10	therapies	therapy	NOUN
can-11500	37	11	(	(	PUNCT
can-11500	37	12	nanocarriers	nanocarrier	NOUN
can-11500	37	13	)	)	PUNCT
can-11500	37	14	,	,	PUNCT
can-11500	37	15	hold	hold	VERB
can-11500	37	16	significant	significant	ADJ
can-11500	37	17	promise	promise	NOUN
can-11500	37	18	,	,	PUNCT
can-11500	37	19	particularly	particularly	ADV
can-11500	37	20	for	for	ADP
can-11500	37	21	challenging	challenge	VERB
can-11500	37	22	cancers	cancer	NOUN
can-11500	37	23	such	such	ADJ
can-11500	37	24	as	as	ADP
can-11500	37	25	tnbc	tnbc	NOUN
can-11500	37	26	[	[	X
can-11500	37	27	4,9	4,9	NUM
can-11500	37	28	]	]	PUNCT
can-11500	37	29	.	.	PUNCT
can-11500	38	1	nanoparticles	nanoparticle	NOUN
can-11500	38	2	have	have	AUX
can-11500	38	3	revolutionized	revolutionize	VERB
can-11500	38	4	the	the	DET
can-11500	38	5	field	field	NOUN
can-11500	38	6	of	of	ADP
can-11500	38	7	medicine	medicine	NOUN
can-11500	38	8	by	by	ADP
can-11500	38	9	being	be	AUX
can-11500	38	10	utilized	utilize	VERB
can-11500	38	11	in	in	ADP
can-11500	38	12	next	next	ADJ
can-11500	38	13	-	-	PUNCT
can-11500	38	14	generation	generation	NOUN
can-11500	38	15	drug	drug	NOUN
can-11500	38	16	delivery	delivery	NOUN
can-11500	38	17	systems	system	NOUN
can-11500	38	18	for	for	ADP
can-11500	38	19	cancer	cancer	NOUN
can-11500	38	20	treatment	treatment	NOUN
can-11500	38	21	.	.	PUNCT
can-11500	39	1	they	they	PRON
can-11500	39	2	have	have	AUX
can-11500	39	3	demonstrated	demonstrate	VERB
can-11500	39	4	experimental	experimental	ADJ
can-11500	39	5	success	success	NOUN
can-11500	39	6	as	as	ADP
can-11500	39	7	drug	drug	NOUN
can-11500	39	8	delivery	delivery	NOUN
can-11500	39	9	agents	agent	NOUN
can-11500	39	10	,	,	PUNCT
can-11500	39	11	fundamentally	fundamentally	ADV
can-11500	39	12	transforming	transform	VERB
can-11500	39	13	the	the	DET
can-11500	39	14	cancer	cancer	NOUN
can-11500	39	15	treatment	treatment	NOUN
can-11500	39	16	landscape	landscape	NOUN
can-11500	39	17	by	by	ADP
can-11500	39	18	enabling	enable	VERB
can-11500	39	19	more	more	ADV
can-11500	39	20	accurate	accurate	ADJ
can-11500	39	21	detection	detection	NOUN
can-11500	39	22	methods	method	NOUN
can-11500	39	23	,	,	PUNCT
can-11500	39	24	diagnosis	diagnosis	NOUN
can-11500	39	25	,	,	PUNCT
can-11500	39	26	and	and	CCONJ
can-11500	39	27	targeted	target	VERB
can-11500	39	28	drug	drug	NOUN
can-11500	39	29	delivery	delivery	NOUN
can-11500	39	30	to	to	PART
can-11500	39	31	eradicate	eradicate	VERB
can-11500	39	32	tumors	tumor	NOUN
can-11500	39	33	[	[	X
can-11500	39	34	10	10	NUM
can-11500	39	35	]	]	PUNCT
can-11500	39	36	.	.	PUNCT
can-11500	40	1	nanocarriers	nanocarrier	NOUN
can-11500	40	2	accumulate	accumulate	VERB
can-11500	40	3	in	in	ADP
can-11500	40	4	tumors	tumor	NOUN
can-11500	40	5	through	through	ADP
can-11500	40	6	the	the	DET
can-11500	40	7	enhanced	enhanced	ADJ
can-11500	40	8	permeability	permeability	NOUN
can-11500	40	9	and	and	CCONJ
can-11500	40	10	retention	retention	NOUN
can-11500	40	11	effect	effect	NOUN
can-11500	40	12	,	,	PUNCT
can-11500	40	13	along	along	ADP
can-11500	40	14	with	with	ADP
can-11500	40	15	other	other	ADJ
can-11500	40	16	complementary	complementary	ADJ
can-11500	40	17	mechanisms	mechanism	NOUN
can-11500	40	18	,	,	PUNCT
can-11500	40	19	such	such	ADJ
can-11500	40	20	as	as	ADP
can-11500	40	21	vascular	vascular	ADJ
can-11500	40	22	transcytosis	transcytosis	NOUN
can-11500	40	23	.	.	PUNCT
can-11500	41	1	because	because	SCONJ
can-11500	41	2	cell	cell	NOUN
can-11500	41	3	membrane	membrane	NOUN
can-11500	41	4	transporters	transporter	NOUN
can-11500	41	5	can	can	AUX
can-11500	41	6	not	not	PART
can-11500	41	7	remove	remove	VERB
can-11500	41	8	nanoparticles	nanoparticle	NOUN
can-11500	41	9	that	that	PRON
can-11500	41	10	accumulate	accumulate	VERB
can-11500	41	11	in	in	ADP
can-11500	41	12	tumors	tumor	NOUN
can-11500	41	13	,	,	PUNCT
can-11500	41	14	lower	low	ADJ
can-11500	41	15	doses	dose	NOUN
can-11500	41	16	achieve	achieve	VERB
can-11500	41	17	effective	effective	ADJ
can-11500	41	18	results	result	NOUN
can-11500	41	19	[	[	X
can-11500	41	20	11	11	NUM
can-11500	41	21	]	]	PUNCT
can-11500	41	22	.	.	PUNCT
can-11500	42	1	nanoparticles	nanoparticle	NOUN
can-11500	42	2	play	play	VERB
can-11500	42	3	a	a	DET
can-11500	42	4	crucial	crucial	ADJ
can-11500	42	5	role	role	NOUN
can-11500	42	6	in	in	ADP
can-11500	42	7	overcoming	overcome	VERB
can-11500	42	8	drug	drug	NOUN
can-11500	42	9	resistance	resistance	NOUN
can-11500	42	10	associated	associate	VERB
can-11500	42	11	with	with	ADP
can-11500	42	12	cancer	cancer	NOUN
can-11500	42	13	.	.	PUNCT
can-11500	43	1	when	when	SCONJ
can-11500	43	2	used	use	VERB
can-11500	43	3	as	as	ADP
can-11500	43	4	drug	drug	NOUN
can-11500	43	5	delivery	delivery	NOUN
can-11500	43	6	systems	system	NOUN
can-11500	43	7	,	,	PUNCT
can-11500	43	8	these	these	DET
can-11500	43	9	particles	particle	NOUN
can-11500	43	10	can	can	AUX
can-11500	43	11	target	target	VERB
can-11500	43	12	and	and	CCONJ
can-11500	43	13	reduce	reduce	VERB
can-11500	43	14	or	or	CCONJ
can-11500	43	15	eliminate	eliminate	VERB
can-11500	43	16	multidrug	multidrug	NOUN
can-11500	43	17	resistance	resistance	NOUN
can-11500	43	18	[	[	X
can-11500	43	19	12,13	12,13	NUM
can-11500	43	20	]	]	PUNCT
can-11500	43	21	.	.	PUNCT
can-11500	44	1	by	by	ADP
can-11500	44	2	leveraging	leverage	VERB
can-11500	44	3	the	the	DET
can-11500	44	4	unique	unique	ADJ
can-11500	44	5	pathophysiology	pathophysiology	NOUN
can-11500	44	6	of	of	ADP
can-11500	44	7	tumors	tumor	NOUN
can-11500	44	8	,	,	PUNCT
can-11500	44	9	nanoparticles	nanoparticle	NOUN
can-11500	44	10	can	can	AUX
can-11500	44	11	actively	actively	ADV
can-11500	44	12	deliver	deliver	VERB
can-11500	44	13	drugs	drug	NOUN
can-11500	44	14	to	to	ADP
can-11500	44	15	cancer	cancer	NOUN
can-11500	44	16	cells	cell	NOUN
can-11500	44	17	through	through	ADP
can-11500	44	18	increased	increase	VERB
can-11500	44	19	permeability	permeability	NOUN
can-11500	44	20	and	and	CCONJ
can-11500	44	21	retention	retention	NOUN
can-11500	44	22	effects	effect	NOUN
can-11500	44	23	,	,	PUNCT
can-11500	44	24	providing	provide	VERB
can-11500	44	25	a	a	DET
can-11500	44	26	more	more	ADV
can-11500	44	27	effective	effective	ADJ
can-11500	44	28	treatment	treatment	NOUN
can-11500	44	29	in	in	ADP
can-11500	44	30	cases	case	NOUN
can-11500	44	31	where	where	SCONJ
can-11500	44	32	traditional	traditional	ADJ
can-11500	44	33	therapies	therapy	NOUN
can-11500	44	34	are	be	AUX
can-11500	44	35	ineffective	ineffective	ADJ
can-11500	45	1	[	[	X
can-11500	45	2	12	12	NUM
can-11500	45	3	]	]	PUNCT
can-11500	45	4	.	.	PUNCT
can-11500	46	1	chitosan	chitosan	NOUN
can-11500	46	2	-	-	PUNCT
can-11500	46	3	coated	coat	VERB
can-11500	46	4	magnetic	magnetic	ADJ
can-11500	46	5	nanoparticles	nanoparticle	NOUN
can-11500	46	6	(	(	PUNCT
can-11500	46	7	mnps	mnps	PROPN
can-11500	46	8	)	)	PUNCT
can-11500	46	9	have	have	AUX
can-11500	46	10	been	be	AUX
can-11500	46	11	utilized	utilize	VERB
can-11500	46	12	for	for	ADP
can-11500	46	13	the	the	DET
can-11500	46	14	loading	loading	NOUN
can-11500	46	15	and	and	CCONJ
can-11500	46	16	controlled	control	VERB
can-11500	46	17	release	release	NOUN
can-11500	46	18	of	of	ADP
can-11500	46	19	various	various	ADJ
can-11500	46	20	anticancer	anticancer	NOUN
can-11500	46	21	drugs	drug	NOUN
can-11500	46	22	.	.	PUNCT
can-11500	47	1	researchers	researcher	NOUN
can-11500	47	2	have	have	AUX
can-11500	47	3	successfully	successfully	ADV
can-11500	47	4	incorporated	incorporate	VERB
can-11500	47	5	drugs	drug	NOUN
can-11500	47	6	such	such	ADJ
can-11500	47	7	as	as	ADP
can-11500	47	8	5	5	NUM
can-11500	47	9	-	-	PUNCT
can-11500	47	10	fluorouracil	fluorouracil	NOUN
can-11500	47	11	and	and	CCONJ
can-11500	47	12	gemcitabine	gemcitabine	VERB
can-11500	47	13	into	into	ADP
can-11500	47	14	these	these	DET
can-11500	47	15	nanoparticles	nanoparticle	NOUN
can-11500	47	16	,	,	PUNCT
can-11500	47	17	demonstrating	demonstrate	VERB
can-11500	47	18	improved	improved	ADJ
can-11500	47	19	efficacy	efficacy	NOUN
can-11500	47	20	in	in	ADP
can-11500	47	21	target	target	NOUN
can-11500	47	22	cells	cell	NOUN
can-11500	47	23	[	[	X
can-11500	47	24	14	14	NUM
can-11500	47	25	]	]	PUNCT
can-11500	47	26	.	.	PUNCT
can-11500	48	1	chitosan	chitosan	NOUN
can-11500	48	2	-	-	PUNCT
can-11500	48	3	coated	coat	VERB
can-11500	48	4	mnps	mnps	NOUN
can-11500	48	5	can	can	AUX
can-11500	48	6	be	be	AUX
can-11500	48	7	directed	direct	VERB
can-11500	48	8	to	to	ADP
can-11500	48	9	the	the	DET
can-11500	48	10	target	target	NOUN
can-11500	48	11	site	site	NOUN
can-11500	48	12	using	use	VERB
can-11500	48	13	a	a	DET
can-11500	48	14	magnetic	magnetic	ADJ
can-11500	48	15	field	field	NOUN
can-11500	48	16	,	,	PUNCT
can-11500	48	17	allowing	allow	VERB
can-11500	48	18	for	for	ADP
can-11500	48	19	the	the	DET
can-11500	48	20	specific	specific	ADJ
can-11500	48	21	delivery	delivery	NOUN
can-11500	48	22	of	of	ADP
can-11500	48	23	drugs	drug	NOUN
can-11500	48	24	to	to	ADP
can-11500	48	25	cancer	cancer	NOUN
can-11500	48	26	cells	cell	NOUN
can-11500	48	27	.	.	PUNCT
can-11500	49	1	this	this	DET
can-11500	49	2	approach	approach	NOUN
can-11500	49	3	shows	show	VERB
can-11500	49	4	that	that	SCONJ
can-11500	49	5	cancer	cancer	NOUN
can-11500	49	6	cells	cell	NOUN
can-11500	49	7	can	can	AUX
can-11500	49	8	be	be	AUX
can-11500	49	9	targeted	target	VERB
can-11500	49	10	while	while	SCONJ
can-11500	49	11	minimizing	minimize	VERB
can-11500	49	12	damage	damage	NOUN
can-11500	49	13	to	to	ADP
can-11500	49	14	healthy	healthy	ADJ
can-11500	49	15	tissues	tissue	NOUN
can-11500	49	16	[	[	X
can-11500	49	17	15	15	NUM
can-11500	49	18	]	]	PUNCT
can-11500	49	19	.	.	PUNCT
can-11500	50	1	chitosan	chitosan	NOUN
can-11500	50	2	-	-	PUNCT
can-11500	50	3	coated	coat	VERB
can-11500	50	4	mnps	mnps	NOUN
can-11500	50	5	exhibit	exhibit	VERB
can-11500	50	6	high	high	ADJ
can-11500	50	7	biocompatibility	biocompatibility	NOUN
can-11500	50	8	and	and	CCONJ
can-11500	50	9	a	a	DET
can-11500	50	10	low	low	ADJ
can-11500	50	11	toxicity	toxicity	NOUN
can-11500	50	12	profile	profile	NOUN
can-11500	50	13	,	,	PUNCT
can-11500	50	14	suggesting	suggest	VERB
can-11500	50	15	that	that	SCONJ
can-11500	50	16	these	these	DET
can-11500	50	17	nanoparticles	nanoparticle	NOUN
can-11500	50	18	can	can	AUX
can-11500	50	19	be	be	AUX
can-11500	50	20	safely	safely	ADV
can-11500	50	21	used	use	VERB
can-11500	50	22	in	in	ADP
can-11500	50	23	cancer	cancer	NOUN
can-11500	50	24	treatment	treatment	NOUN
can-11500	50	25	[	[	X
can-11500	50	26	16,17	16,17	NUM
can-11500	50	27	]	]	PUNCT
can-11500	50	28	.	.	PUNCT
can-11500	51	1	dexamethasone	dexamethasone	NOUN
can-11500	51	2	is	be	AUX
can-11500	51	3	a	a	DET
can-11500	51	4	synthetic	synthetic	ADJ
can-11500	51	5	glucocorticoid	glucocorticoid	NOUN
can-11500	51	6	that	that	PRON
can-11500	51	7	presents	present	VERB
can-11500	51	8	as	as	ADP
can-11500	51	9	an	an	DET
can-11500	51	10	odorless	odorless	ADJ
can-11500	51	11	,	,	PUNCT
can-11500	51	12	white	white	ADJ
can-11500	51	13	crystalline	crystalline	NOUN
can-11500	51	14	powder	powder	NOUN
can-11500	51	15	with	with	ADP
can-11500	51	16	a	a	DET
can-11500	51	17	mildly	mildly	ADV
can-11500	51	18	bitter	bitter	ADJ
can-11500	51	19	taste	taste	NOUN
can-11500	51	20	(	(	PUNCT
can-11500	51	21	figure	figure	NOUN
can-11500	51	22	1	1	NUM
can-11500	51	23	)	)	PUNCT
can-11500	51	24	.	.	PUNCT
can-11500	52	1	it	it	PRON
can-11500	52	2	is	be	AUX
can-11500	52	3	a	a	DET
can-11500	52	4	fluorinated	fluorinated	ADJ
can-11500	52	5	steroid	steroid	NOUN
can-11500	52	6	,	,	PUNCT
can-11500	52	7	specifically	specifically	ADV
can-11500	52	8	a	a	DET
can-11500	52	9	9	9	NUM
can-11500	52	10	-	-	PUNCT
can-11500	52	11	fluoro	fluoro	NOUN
can-11500	52	12	-	-	PUNCT
can-11500	52	13	pregna-1,4	pregna-1,4	NOUN
can-11500	52	14	-	-	PUNCT
can-11500	52	15	diene	diene	NOUN
can-11500	52	16	,	,	PUNCT
can-11500	52	17	characterized	characterize	VERB
can-11500	52	18	by	by	ADP
can-11500	52	19	hydroxyl	hydroxyl	NOUN
can-11500	52	20	groups	group	NOUN
can-11500	52	21	at	at	ADP
can-11500	52	22	the	the	DET
can-11500	52	23	11	11	NUM
can-11500	52	24	,	,	PUNCT
can-11500	52	25	17	17	NUM
can-11500	52	26	,	,	PUNCT
can-11500	52	27	and	and	CCONJ
can-11500	52	28	21	21	NUM
can-11500	52	29	positions	position	NOUN
can-11500	52	30	,	,	PUNCT
can-11500	52	31	a	a	DET
can-11500	52	32	methyl	methyl	NOUN
can-11500	52	33	group	group	NOUN
can-11500	52	34	at	at	ADP
can-11500	52	35	the	the	DET
can-11500	52	36	16	16	NUM
can-11500	52	37	position	position	NOUN
can-11500	52	38	,	,	PUNCT
can-11500	52	39	and	and	CCONJ
can-11500	52	40	oxo	oxo	NOUN
can-11500	52	41	groups	group	NOUN
can-11500	52	42	at	at	ADP
can-11500	52	43	the	the	DET
can-11500	52	44	3	3	NUM
can-11500	52	45	and	and	CCONJ
can-11500	52	46	20	20	NUM
can-11500	52	47	positions	position	NOUN
can-11500	52	48	.	.	PUNCT
can-11500	53	1	renowned	renowned	ADJ
can-11500	53	2	for	for	ADP
can-11500	53	3	its	its	PRON
can-11500	53	4	anti	anti	ADJ
can-11500	53	5	-	-	ADJ
can-11500	53	6	inflammatory	inflammatory	ADJ
can-11500	53	7	,	,	PUNCT
can-11500	53	8	immunosuppressive	immunosuppressive	ADJ
can-11500	53	9	,	,	PUNCT
can-11500	53	10	and	and	CCONJ
can-11500	53	11	painrelieving	painrelieve	VERB
can-11500	53	12	properties	property	NOUN
can-11500	53	13	,	,	PUNCT
can-11500	53	14	dexamethasone	dexamethasone	NOUN
can-11500	53	15	is	be	AUX
can-11500	53	16	widely	widely	ADV
can-11500	53	17	used	use	VERB
can-11500	53	18	to	to	PART
can-11500	53	19	manage	manage	VERB
can-11500	53	20	conditions	condition	NOUN
can-11500	53	21	such	such	ADJ
can-11500	53	22	as	as	ADP
can-11500	53	23	postoperative	postoperative	ADJ
can-11500	53	24	nausea	nausea	NOUN
can-11500	53	25	and	and	CCONJ
can-11500	53	26	vomiting	vomiting	NOUN
can-11500	53	27	,	,	PUNCT
can-11500	53	28	autoimmune	autoimmune	ADJ
can-11500	53	29	disorders	disorder	NOUN
can-11500	53	30	,	,	PUNCT
can-11500	53	31	and	and	CCONJ
can-11500	53	32	allergic	allergic	ADJ
can-11500	53	33	reactions	reaction	NOUN
can-11500	53	34	[	[	X
can-11500	53	35	19	19	NUM
can-11500	53	36	]	]	PUNCT
can-11500	53	37	.	.	PUNCT
can-11500	54	1	characterization	characterization	NOUN
can-11500	54	2	and	and	CCONJ
can-11500	54	3	application	application	NOUN
can-11500	54	4	of	of	ADP
can-11500	54	5	nanomaterials	nanomaterial	NOUN
can-11500	54	6	2025	2025	NUM
can-11500	54	7	,	,	PUNCT
can-11500	54	8	8(3	8(3	NUM
can-11500	54	9	)	)	PUNCT
can-11500	54	10	,	,	PUNCT
can-11500	54	11	11500	11500	NUM
can-11500	54	12	.	.	PUNCT
can-11500	55	1	3	3	NUM
can-11500	55	2	figure	figure	NOUN
can-11500	55	3	1	1	NUM
can-11500	55	4	.	.	PUNCT
can-11500	55	5	chemical	chemical	ADJ
can-11500	55	6	structure	structure	NOUN
can-11500	55	7	of	of	ADP
can-11500	55	8	dexamethasone	dexamethasone	NOUN
can-11500	55	9	.	.	PUNCT
can-11500	56	1	reprinted	reprint	VERB
can-11500	56	2	from	from	ADP
can-11500	56	3	national	national	ADJ
can-11500	56	4	center	center	NOUN
can-11500	56	5	for	for	ADP
can-11500	56	6	biotechnology	biotechnology	NOUN
can-11500	56	7	information	information	NOUN
can-11500	56	8	[	[	X
can-11500	56	9	18	18	NUM
can-11500	56	10	]	]	PUNCT
can-11500	56	11	.	.	PUNCT
can-11500	57	1	this	this	DET
can-11500	57	2	study	study	NOUN
can-11500	57	3	investigates	investigate	VERB
can-11500	57	4	the	the	DET
can-11500	57	5	impact	impact	NOUN
can-11500	57	6	of	of	ADP
can-11500	57	7	dexamethasone	dexamethasone	NOUN
can-11500	57	8	-	-	PUNCT
can-11500	57	9	loaded	load	VERB
can-11500	57	10	chitosan	chitosan	NOUN
can-11500	57	11	-	-	PUNCT
can-11500	57	12	coated	coat	VERB
can-11500	57	13	mnps	mnps	NOUN
can-11500	57	14	on	on	ADP
can-11500	57	15	tnbc	tnbc	PROPN
can-11500	57	16	(	(	PUNCT
can-11500	57	17	mda	mda	PROPN
can-11500	57	18	-	-	PUNCT
can-11500	57	19	mb-231	mb-231	PROPN
can-11500	57	20	)	)	PUNCT
can-11500	57	21	cell	cell	NOUN
can-11500	57	22	lines	line	NOUN
can-11500	57	23	.	.	PUNCT
can-11500	58	1	2	2	X
can-11500	58	2	.	.	X
can-11500	58	3	materials	material	NOUN
can-11500	58	4	and	and	CCONJ
can-11500	58	5	methods	method	NOUN
can-11500	58	6	2.1	2.1	NUM
can-11500	58	7	.	.	PUNCT
can-11500	59	1	synthesis	synthesis	NOUN
can-11500	59	2	and	and	CCONJ
can-11500	59	3	characterization	characterization	NOUN
can-11500	59	4	of	of	ADP
can-11500	59	5	magnetic	magnetic	ADJ
can-11500	59	6	nanoparticles	nanoparticle	NOUN
can-11500	59	7	and	and	CCONJ
can-11500	59	8	drug	drug	NOUN
can-11500	59	9	loading	loading	NOUN
can-11500	59	10	analyses	analyse	VERB
can-11500	59	11	the	the	DET
can-11500	59	12	mnps	mnps	PROPN
can-11500	59	13	(	(	PUNCT
can-11500	59	14	fe3o4	fe3o4	PROPN
can-11500	59	15	)	)	PUNCT
can-11500	59	16	were	be	AUX
can-11500	59	17	synthesized	synthesize	VERB
can-11500	59	18	using	use	VERB
can-11500	59	19	the	the	DET
can-11500	59	20	co	co	NOUN
can-11500	59	21	-	-	ADJ
can-11500	59	22	precipitation	precipitation	ADJ
can-11500	59	23	method	method	NOUN
can-11500	59	24	.	.	PUNCT
can-11500	60	1	the	the	DET
can-11500	60	2	surface	surface	NOUN
can-11500	60	3	of	of	ADP
can-11500	60	4	the	the	DET
can-11500	60	5	synthesized	synthesize	VERB
can-11500	60	6	mnps	mnps	NOUN
can-11500	60	7	was	be	AUX
can-11500	60	8	designed	design	VERB
can-11500	60	9	according	accord	VERB
can-11500	60	10	to	to	ADP
can-11500	60	11	the	the	DET
can-11500	60	12	properties	property	NOUN
can-11500	60	13	of	of	ADP
can-11500	60	14	the	the	DET
can-11500	60	15	drug	drug	NOUN
can-11500	60	16	and	and	CCONJ
can-11500	60	17	polymer	polymer	NOUN
can-11500	60	18	to	to	PART
can-11500	60	19	be	be	AUX
can-11500	60	20	loaded	load	VERB
can-11500	60	21	onto	onto	ADP
can-11500	60	22	them	they	PRON
can-11500	60	23	.	.	PUNCT
can-11500	61	1	to	to	PART
can-11500	61	2	optimize	optimize	VERB
can-11500	61	3	the	the	DET
can-11500	61	4	synthesis	synthesis	NOUN
can-11500	61	5	of	of	ADP
can-11500	61	6	mnps	mnps	NOUN
can-11500	61	7	,	,	PUNCT
can-11500	61	8	parameters	parameter	NOUN
can-11500	61	9	such	such	ADJ
can-11500	61	10	as	as	ADP
can-11500	61	11	mixing	mix	VERB
can-11500	61	12	speed	speed	NOUN
can-11500	61	13	,	,	PUNCT
can-11500	61	14	reagent	reagent	ADJ
can-11500	61	15	ratios	ratio	NOUN
can-11500	61	16	,	,	PUNCT
can-11500	61	17	and	and	CCONJ
can-11500	61	18	temperature	temperature	NOUN
can-11500	61	19	were	be	AUX
can-11500	61	20	studied	study	VERB
can-11500	61	21	to	to	PART
can-11500	61	22	determine	determine	VERB
can-11500	61	23	the	the	DET
can-11500	61	24	optimal	optimal	ADJ
can-11500	61	25	conditions	condition	NOUN
can-11500	61	26	.	.	PUNCT
can-11500	62	1	the	the	DET
can-11500	62	2	crystal	crystal	NOUN
can-11500	62	3	structures	structure	NOUN
can-11500	62	4	of	of	ADP
can-11500	62	5	the	the	DET
can-11500	62	6	mnps	mnps	NOUN
can-11500	62	7	were	be	AUX
can-11500	62	8	determined	determine	VERB
can-11500	62	9	using	use	VERB
can-11500	62	10	x	x	PROPN
can-11500	62	11	-	-	NOUN
can-11500	62	12	ray	ray	NOUN
can-11500	62	13	diffraction	diffraction	NOUN
can-11500	62	14	(	(	PUNCT
can-11500	62	15	xrd	xrd	PROPN
can-11500	62	16	)	)	PUNCT
can-11500	62	17	.	.	PUNCT
can-11500	63	1	the	the	DET
can-11500	63	2	shape	shape	NOUN
can-11500	63	3	and	and	CCONJ
can-11500	63	4	size	size	NOUN
can-11500	63	5	of	of	ADP
can-11500	63	6	the	the	DET
can-11500	63	7	mnps	mnps	PROPN
can-11500	63	8	were	be	AUX
can-11500	63	9	examined	examine	VERB
can-11500	63	10	at	at	ADP
can-11500	63	11	each	each	DET
can-11500	63	12	stage	stage	NOUN
can-11500	63	13	of	of	ADP
can-11500	63	14	synthesis	synthesis	NOUN
can-11500	63	15	using	use	VERB
can-11500	63	16	transmission	transmission	NOUN
can-11500	63	17	electron	electron	NOUN
can-11500	63	18	microscopy	microscopy	NOUN
can-11500	63	19	(	(	PUNCT
can-11500	63	20	tem	tem	PROPN
can-11500	63	21	)	)	PUNCT
can-11500	63	22	.	.	PUNCT
can-11500	64	1	changes	change	NOUN
can-11500	64	2	in	in	ADP
can-11500	64	3	the	the	DET
can-11500	64	4	functional	functional	ADJ
can-11500	64	5	groups	group	NOUN
can-11500	64	6	of	of	ADP
can-11500	64	7	the	the	DET
can-11500	64	8	mnps	mnps	PROPN
can-11500	64	9	after	after	SCONJ
can-11500	64	10	synthesis	synthesis	NOUN
can-11500	64	11	were	be	AUX
can-11500	64	12	identified	identify	VERB
can-11500	64	13	using	use	VERB
can-11500	64	14	fourier	fourier	NOUN
can-11500	64	15	transform	transform	NOUN
can-11500	64	16	infrared	infrared	ADJ
can-11500	64	17	spectroscopy	spectroscopy	NOUN
can-11500	64	18	(	(	PUNCT
can-11500	64	19	ftir	ftir	PROPN
can-11500	64	20	)	)	PUNCT
can-11500	64	21	.	.	PUNCT
can-11500	65	1	at	at	ADP
can-11500	65	2	each	each	DET
can-11500	65	3	stage	stage	NOUN
can-11500	65	4	of	of	ADP
can-11500	65	5	synthesis	synthesis	NOUN
can-11500	65	6	,	,	PUNCT
can-11500	65	7	properties	property	NOUN
can-11500	65	8	such	such	ADJ
can-11500	65	9	as	as	ADP
can-11500	65	10	size	size	NOUN
can-11500	65	11	distribution	distribution	NOUN
can-11500	65	12	(	(	PUNCT
can-11500	65	13	dls	dls	PROPN
can-11500	65	14	)	)	PUNCT
can-11500	65	15	,	,	PUNCT
can-11500	65	16	zeta	zeta	NOUN
can-11500	65	17	potential	potential	NOUN
can-11500	65	18	,	,	PUNCT
can-11500	65	19	vibrating	vibrate	VERB
can-11500	65	20	sample	sample	NOUN
can-11500	65	21	magnetometry	magnetometry	NOUN
can-11500	65	22	(	(	PUNCT
can-11500	65	23	vsm	vsm	PROPN
can-11500	65	24	)	)	PUNCT
can-11500	65	25	,	,	PUNCT
can-11500	65	26	thermogravimetric	thermogravimetric	ADJ
can-11500	65	27	analysis	analysis	NOUN
can-11500	65	28	(	(	PUNCT
can-11500	65	29	tga	tga	NOUN
can-11500	65	30	)	)	PUNCT
can-11500	65	31	,	,	PUNCT
can-11500	65	32	x	x	X
can-11500	65	33	-	-	NOUN
can-11500	65	34	ray	ray	NOUN
can-11500	65	35	photoelectron	photoelectron	NOUN
can-11500	65	36	spectroscopy	spectroscopy	NOUN
can-11500	65	37	(	(	PUNCT
can-11500	65	38	xps	xps	PROPN
can-11500	65	39	)	)	PUNCT
can-11500	65	40	,	,	PUNCT
can-11500	65	41	and	and	CCONJ
can-11500	65	42	electrical	electrical	ADJ
can-11500	65	43	and	and	CCONJ
can-11500	65	44	magnetic	magnetic	ADJ
can-11500	65	45	characteristics	characteristic	NOUN
can-11500	65	46	were	be	AUX
can-11500	65	47	determined	determine	VERB
can-11500	65	48	[	[	X
can-11500	65	49	19	19	NUM
can-11500	65	50	]	]	PUNCT
can-11500	65	51	.	.	PUNCT
can-11500	66	1	specifically	specifically	ADV
can-11500	66	2	,	,	PUNCT
can-11500	66	3	chitosan	chitosan	NOUN
can-11500	66	4	-	-	PUNCT
can-11500	66	5	coated	coat	VERB
can-11500	66	6	magnetic	magnetic	ADJ
can-11500	66	7	iron	iron	NOUN
can-11500	66	8	oxide	oxide	NOUN
can-11500	66	9	nanoparticles	nanoparticle	NOUN
can-11500	66	10	were	be	AUX
can-11500	66	11	prepared	prepare	VERB
can-11500	66	12	by	by	ADP
can-11500	66	13	co	co	VERB
can-11500	66	14	-	-	ADJ
can-11500	66	15	precipitating	precipitating	ADJ
can-11500	66	16	fe(ii	fe(ii	PROPN
can-11500	66	17	)	)	PUNCT
can-11500	66	18	and	and	CCONJ
can-11500	66	19	fe(iii	fe(iii	NOUN
can-11500	66	20	)	)	PUNCT
can-11500	66	21	salts	salt	NOUN
can-11500	66	22	in	in	ADP
can-11500	66	23	a	a	DET
can-11500	66	24	1:2	1:2	NUM
can-11500	66	25	molar	molar	ADJ
can-11500	66	26	ratio	ratio	NOUN
can-11500	66	27	in	in	ADP
can-11500	66	28	the	the	DET
can-11500	66	29	presence	presence	NOUN
can-11500	66	30	of	of	ADP
can-11500	66	31	chitosan	chitosan	NOUN
can-11500	66	32	and	and	CCONJ
can-11500	66	33	tripolyphosphate	tripolyphosphate	NOUN
can-11500	66	34	(	(	PUNCT
can-11500	66	35	tpp	tpp	PROPN
can-11500	66	36	)	)	PUNCT
can-11500	66	37	using	use	VERB
can-11500	66	38	a	a	DET
can-11500	66	39	five	five	NUM
can-11500	66	40	-	-	PUNCT
can-11500	66	41	neck	neck	NOUN
can-11500	66	42	glass	glass	NOUN
can-11500	66	43	flask	flask	NOUN
can-11500	67	1	[	[	X
can-11500	67	2	20	20	NUM
can-11500	67	3	]	]	PUNCT
can-11500	67	4	.	.	PUNCT
can-11500	68	1	during	during	ADP
can-11500	68	2	the	the	DET
can-11500	68	3	formation	formation	NOUN
can-11500	68	4	of	of	ADP
can-11500	68	5	fe3o4	fe3o4	PROPN
can-11500	68	6	nuclei	nucleus	NOUN
can-11500	68	7	,	,	PUNCT
can-11500	68	8	chitosan	chitosan	ADJ
can-11500	68	9	molecules	molecule	NOUN
can-11500	68	10	surround	surround	VERB
can-11500	68	11	these	these	DET
can-11500	68	12	anionic	anionic	ADJ
can-11500	68	13	nuclei	nucleus	NOUN
can-11500	68	14	,	,	PUNCT
can-11500	68	15	and	and	CCONJ
can-11500	68	16	tpp	tpp	PROPN
can-11500	68	17	acts	act	VERB
can-11500	68	18	as	as	ADP
can-11500	68	19	a	a	DET
can-11500	68	20	cross	cross	NOUN
can-11500	68	21	-	-	NOUN
can-11500	68	22	linker	linker	ADJ
can-11500	68	23	,	,	PUNCT
can-11500	68	24	binding	bind	VERB
can-11500	68	25	the	the	DET
can-11500	68	26	chitosan	chitosan	ADJ
can-11500	68	27	molecules	molecule	NOUN
can-11500	68	28	around	around	ADP
can-11500	68	29	the	the	DET
can-11500	68	30	fe3o4	fe3o4	PROPN
can-11500	68	31	core	core	NOUN
can-11500	68	32	.	.	PUNCT
can-11500	69	1	the	the	DET
can-11500	69	2	synthesized	synthesize	VERB
can-11500	69	3	chitosan	chitosan	NOUN
can-11500	69	4	-	-	PUNCT
can-11500	69	5	coated	coat	VERB
can-11500	69	6	mnps	mnps	NOUN
can-11500	69	7	were	be	AUX
can-11500	69	8	characterized	characterize	VERB
can-11500	69	9	using	use	VERB
can-11500	69	10	techniques	technique	NOUN
can-11500	69	11	including	include	VERB
can-11500	69	12	xrd	xrd	PROPN
can-11500	69	13	,	,	PUNCT
can-11500	69	14	xps	xps	PROPN
can-11500	69	15	,	,	PUNCT
can-11500	69	16	ftir	ftir	PROPN
can-11500	69	17	,	,	PUNCT
can-11500	69	18	tem	tem	PROPN
can-11500	69	19	,	,	PUNCT
can-11500	69	20	dls	dls	PROPN
can-11500	69	21	,	,	PUNCT
can-11500	69	22	tga	tga	PROPN
can-11500	69	23	,	,	PUNCT
can-11500	69	24	vsm	vsm	PROPN
can-11500	69	25	,	,	PUNCT
can-11500	69	26	and	and	CCONJ
can-11500	69	27	zeta	zeta	VERB
can-11500	69	28	potential	potential	ADJ
can-11500	69	29	analysis	analysis	NOUN
can-11500	69	30	[	[	X
can-11500	69	31	20	20	NUM
can-11500	69	32	]	]	PUNCT
can-11500	69	33	.	.	PUNCT
can-11500	70	1	dexamethasone	dexamethasone	NOUN
can-11500	70	2	was	be	AUX
can-11500	70	3	then	then	ADV
can-11500	70	4	loaded	load	VERB
can-11500	70	5	onto	onto	ADP
can-11500	70	6	the	the	DET
can-11500	70	7	nanoparticles	nanoparticle	NOUN
can-11500	70	8	,	,	PUNCT
can-11500	70	9	followed	follow	VERB
can-11500	70	10	by	by	ADP
can-11500	70	11	stability	stability	NOUN
can-11500	70	12	and	and	CCONJ
can-11500	70	13	release	release	VERB
can-11500	70	14	studies	study	NOUN
can-11500	70	15	[	[	X
can-11500	70	16	20	20	NUM
can-11500	70	17	]	]	PUNCT
can-11500	70	18	.	.	PUNCT
can-11500	71	1	the	the	DET
can-11500	71	2	synthesis	synthesis	NOUN
can-11500	71	3	and	and	CCONJ
can-11500	71	4	characterization	characterization	NOUN
can-11500	71	5	of	of	ADP
can-11500	71	6	chitosan	chitosan	NOUN
can-11500	71	7	-	-	PUNCT
can-11500	71	8	coated	coat	VERB
can-11500	71	9	mnps	mnps	NOUN
can-11500	71	10	loaded	load	VERB
can-11500	71	11	with	with	ADP
can-11500	71	12	various	various	ADJ
can-11500	71	13	anticancer	anticancer	NOUN
can-11500	71	14	agents	agent	NOUN
can-11500	71	15	are	be	AUX
can-11500	71	16	standard	standard	ADJ
can-11500	71	17	procedures	procedure	NOUN
can-11500	71	18	in	in	ADP
can-11500	71	19	our	our	PRON
can-11500	71	20	laboratory	laboratory	NOUN
can-11500	71	21	,	,	PUNCT
can-11500	71	22	and	and	CCONJ
can-11500	71	23	the	the	DET
can-11500	71	24	results	result	NOUN
can-11500	71	25	have	have	AUX
can-11500	71	26	been	be	AUX
can-11500	71	27	and	and	CCONJ
can-11500	71	28	continue	continue	VERB
can-11500	71	29	to	to	PART
can-11500	71	30	be	be	AUX
can-11500	71	31	published	publish	VERB
can-11500	71	32	in	in	ADP
can-11500	71	33	scientific	scientific	ADJ
can-11500	71	34	journals	journal	NOUN
can-11500	71	35	.	.	PUNCT
can-11500	72	1	the	the	DET
can-11500	72	2	drugs	drug	NOUN
can-11500	72	3	and	and	CCONJ
can-11500	72	4	characterization	characterization	NOUN
can-11500	72	5	and	and	CCONJ
can-11500	72	6	application	application	NOUN
can-11500	72	7	of	of	ADP
can-11500	72	8	nanomaterials	nanomaterial	NOUN
can-11500	72	9	2025	2025	NUM
can-11500	72	10	,	,	PUNCT
can-11500	72	11	8(3	8(3	NUM
can-11500	72	12	)	)	PUNCT
can-11500	72	13	,	,	PUNCT
can-11500	72	14	11500	11500	NUM
can-11500	72	15	.	.	PUNCT
can-11500	73	1	4	4	NUM
can-11500	73	2	mnps	mnps	NOUN
can-11500	73	3	were	be	AUX
can-11500	73	4	mixed	mix	VERB
can-11500	73	5	in	in	ADP
can-11500	73	6	a	a	DET
can-11500	73	7	potassium	potassium	NOUN
can-11500	73	8	buffer	buffer	NOUN
can-11500	73	9	and	and	CCONJ
can-11500	73	10	rotated	rotate	VERB
can-11500	73	11	at	at	ADP
can-11500	73	12	500	500	NUM
can-11500	73	13	rpm	rpm	NOUN
can-11500	73	14	for	for	ADP
can-11500	73	15	24	24	NUM
can-11500	73	16	h	h	NOUN
can-11500	73	17	at	at	ADP
can-11500	73	18	room	room	NOUN
can-11500	73	19	temperature	temperature	NOUN
can-11500	73	20	(	(	PUNCT
can-11500	73	21	figure	figure	NOUN
can-11500	73	22	2	2	NUM
can-11500	73	23	)	)	PUNCT
can-11500	73	24	.	.	PUNCT
can-11500	74	1	drug	drug	NOUN
can-11500	74	2	-	-	PUNCT
can-11500	74	3	loaded	load	VERB
can-11500	74	4	mnps	mnps	NOUN
can-11500	74	5	were	be	AUX
can-11500	74	6	isolated	isolate	VERB
can-11500	74	7	from	from	ADP
can-11500	74	8	unbound	unbound	NOUN
can-11500	74	9	drug	drug	NOUN
can-11500	74	10	using	use	VERB
can-11500	74	11	neodymium	neodymium	NOUN
can-11500	74	12	magnets	magnet	NOUN
can-11500	74	13	.	.	PUNCT
can-11500	75	1	the	the	DET
can-11500	75	2	drug	drug	NOUN
can-11500	75	3	loading	loading	NOUN
can-11500	75	4	efficiency	efficiency	NOUN
can-11500	75	5	was	be	AUX
can-11500	75	6	determined	determine	VERB
can-11500	75	7	by	by	ADP
can-11500	75	8	measuring	measure	VERB
can-11500	75	9	absorbance	absorbance	NOUN
can-11500	75	10	at	at	ADP
can-11500	75	11	240	240	NUM
can-11500	75	12	nm	nm	NOUN
can-11500	75	13	using	use	VERB
can-11500	75	14	a	a	DET
can-11500	75	15	uv	uv	NOUN
can-11500	75	16	spectrophotometer	spectrophotometer	NOUN
can-11500	75	17	(	(	PUNCT
can-11500	75	18	multiskan	multiskan	VERB
can-11500	75	19	go	go	VERB
can-11500	75	20	,	,	PUNCT
can-11500	75	21	thermo	thermo	NOUN
can-11500	75	22	scientific	scientific	NOUN
can-11500	75	23	,	,	PUNCT
can-11500	75	24	united	united	PROPN
can-11500	75	25	states	states	PROPN
can-11500	76	1	[	[	X
can-11500	76	2	us	we	PRON
can-11500	76	3	]	]	X
can-11500	76	4	)	)	PUNCT
can-11500	76	5	.	.	PUNCT
can-11500	77	1	ftir	ftir	PROPN
can-11500	77	2	and	and	CCONJ
can-11500	77	3	scanning	scan	VERB
can-11500	77	4	electron	electron	NOUN
can-11500	77	5	microscopy	microscopy	NOUN
can-11500	77	6	(	(	PUNCT
can-11500	77	7	sem	sem	NOUN
can-11500	77	8	)	)	PUNCT
can-11500	77	9	,	,	PUNCT
can-11500	77	10	conducted	conduct	VERB
can-11500	77	11	at	at	ADP
can-11500	77	12	kırşehir	kırşehir	PROPN
can-11500	77	13	ahi	ahi	NOUN
can-11500	77	14	evran	evran	PROPN
can-11500	77	15	university	university	PROPN
can-11500	77	16	,	,	PUNCT
can-11500	77	17	were	be	AUX
can-11500	77	18	employed	employ	VERB
can-11500	77	19	to	to	PART
can-11500	77	20	confirm	confirm	VERB
can-11500	77	21	the	the	DET
can-11500	77	22	successful	successful	ADJ
can-11500	77	23	loading	loading	NOUN
can-11500	77	24	of	of	ADP
can-11500	77	25	dexamethasone	dexamethasone	NOUN
can-11500	77	26	onto	onto	ADP
can-11500	77	27	the	the	DET
can-11500	77	28	mnps	mnps	PROPN
can-11500	77	29	.	.	PUNCT
can-11500	78	1	figure	figure	NOUN
can-11500	78	2	2	2	NUM
can-11500	78	3	.	.	PUNCT
can-11500	78	4	drug	drug	NOUN
can-11500	78	5	loading	loading	NOUN
can-11500	78	6	analyses	analysis	NOUN
can-11500	78	7	.	.	PUNCT
can-11500	79	1	the	the	DET
can-11500	79	2	drug	drug	NOUN
can-11500	79	3	was	be	AUX
can-11500	79	4	loaded	load	VERB
can-11500	79	5	onto	onto	ADP
can-11500	79	6	free	free	ADJ
can-11500	79	7	magnetic	magnetic	ADJ
can-11500	79	8	nanoparticles	nanoparticle	NOUN
can-11500	79	9	by	by	ADP
can-11500	79	10	stirring	stir	VERB
can-11500	79	11	at	at	ADP
can-11500	79	12	room	room	NOUN
can-11500	79	13	temperature	temperature	NOUN
can-11500	79	14	for	for	ADP
can-11500	79	15	24	24	NUM
can-11500	79	16	h	h	NOUN
can-11500	79	17	using	use	VERB
can-11500	79	18	a	a	DET
can-11500	79	19	rotator	rotator	NOUN
can-11500	79	20	machine	machine	NOUN
can-11500	79	21	.	.	PUNCT
can-11500	80	1	2.2	2.2	NUM
can-11500	80	2	.	.	PUNCT
can-11500	80	3	drug	drug	NOUN
can-11500	80	4	release	release	NOUN
can-11500	80	5	analyses	analyse	VERB
can-11500	80	6	the	the	DET
can-11500	80	7	in	in	X
can-11500	80	8	vitro	vitro	X
can-11500	80	9	drug	drug	NOUN
can-11500	80	10	release	release	NOUN
can-11500	80	11	study	study	NOUN
can-11500	80	12	of	of	ADP
can-11500	80	13	mnps	mnps	PROPN
can-11500	80	14	,	,	PUNCT
can-11500	80	15	free	free	ADJ
can-11500	80	16	nanoparticles	nanoparticle	NOUN
can-11500	80	17	,	,	PUNCT
can-11500	80	18	and	and	CCONJ
can-11500	80	19	dexamethasone	dexamethasone	NOUN
can-11500	80	20	-	-	PUNCT
can-11500	80	21	loaded	load	VERB
can-11500	80	22	mnps	mnps	NOUN
can-11500	80	23	was	be	AUX
can-11500	80	24	conducted	conduct	VERB
can-11500	80	25	in	in	ADP
can-11500	80	26	a	a	DET
can-11500	80	27	sodium	sodium	NOUN
can-11500	80	28	phosphate	phosphate	NOUN
can-11500	80	29	buffer	buffer	NOUN
can-11500	80	30	solution	solution	NOUN
can-11500	80	31	(	(	PUNCT
can-11500	80	32	pbs	pbs	PROPN
can-11500	80	33	,	,	PUNCT
can-11500	80	34	ph	ph	VERB
can-11500	80	35	7.4	7.4	NUM
can-11500	80	36	)	)	PUNCT
can-11500	80	37	.	.	PUNCT
can-11500	81	1	at	at	ADP
can-11500	81	2	predetermined	predetermine	VERB
can-11500	81	3	time	time	NOUN
can-11500	81	4	intervals	interval	NOUN
can-11500	81	5	,	,	PUNCT
can-11500	81	6	a	a	DET
can-11500	81	7	10	10	NUM
can-11500	81	8	μl	μl	PRON
can-11500	81	9	aliquot	aliquot	NOUN
can-11500	81	10	was	be	AUX
can-11500	81	11	withdrawn	withdraw	VERB
can-11500	81	12	from	from	ADP
can-11500	81	13	the	the	DET
can-11500	81	14	pbs	pbs	PROPN
can-11500	81	15	stock	stock	NOUN
can-11500	81	16	solution	solution	NOUN
can-11500	81	17	containing	contain	VERB
can-11500	81	18	dexamethasone	dexamethasone	NOUN
can-11500	81	19	-	-	PUNCT
can-11500	81	20	loaded	load	VERB
can-11500	81	21	mnps	mnps	NOUN
can-11500	81	22	.	.	PUNCT
can-11500	82	1	the	the	DET
can-11500	82	2	samples	sample	NOUN
can-11500	82	3	were	be	AUX
can-11500	82	4	analyzed	analyze	VERB
can-11500	82	5	at	at	ADP
can-11500	82	6	242	242	NUM
can-11500	82	7	nm	nm	NOUN
can-11500	82	8	using	use	VERB
can-11500	82	9	a	a	DET
can-11500	82	10	uv	uv	NOUN
can-11500	82	11	spectrophotometer	spectrophotometer	NOUN
can-11500	82	12	(	(	PUNCT
can-11500	82	13	shimadzu	shimadzu	ADJ
can-11500	82	14	uv-1800	uv-1800	NOUN
can-11500	82	15	,	,	PUNCT
can-11500	82	16	shimadzu	shimadzu	PROPN
can-11500	82	17	corporation	corporation	NOUN
can-11500	82	18	,	,	PUNCT
can-11500	82	19	japan	japan	PROPN
can-11500	82	20	)	)	PUNCT
can-11500	82	21	.	.	PUNCT
can-11500	83	1	2.3	2.3	NUM
can-11500	83	2	.	.	PUNCT
can-11500	84	1	cancer	cancer	NOUN
can-11500	84	2	cell	cell	NOUN
can-11500	84	3	cultivation	cultivation	NOUN
can-11500	84	4	the	the	DET
can-11500	84	5	mda	mda	PROPN
can-11500	84	6	-	-	PUNCT
can-11500	84	7	mb-231	mb-231	PROPN
can-11500	84	8	cancer	cancer	NOUN
can-11500	84	9	cell	cell	NOUN
can-11500	84	10	line	line	NOUN
can-11500	84	11	was	be	AUX
can-11500	84	12	cultured	cultured	ADJ
can-11500	84	13	in	in	ADP
can-11500	84	14	75	75	NUM
can-11500	84	15	-	-	PUNCT
can-11500	84	16	cm2	cm2	NOUN
can-11500	84	17	flasks	flask	NOUN
can-11500	84	18	using	use	VERB
can-11500	84	19	rpmi1640	rpmi1640	NOUN
can-11500	84	20	medium	medium	NOUN
can-11500	84	21	supplemented	supplement	VERB
can-11500	84	22	with	with	ADP
can-11500	84	23	10	10	NUM
can-11500	84	24	%	%	NOUN
can-11500	84	25	(	(	PUNCT
can-11500	84	26	v	v	NOUN
can-11500	84	27	/	/	SYM
can-11500	84	28	v	v	NOUN
can-11500	84	29	)	)	PUNCT
can-11500	84	30	fetal	fetal	ADJ
can-11500	84	31	bovine	bovine	NOUN
can-11500	84	32	serum	serum	NOUN
can-11500	84	33	and	and	CCONJ
can-11500	84	34	1	1	NUM
can-11500	84	35	%	%	NOUN
can-11500	84	36	(	(	PUNCT
can-11500	84	37	v	v	NOUN
can-11500	84	38	/	/	SYM
can-11500	84	39	v	v	NOUN
can-11500	84	40	)	)	PUNCT
can-11500	84	41	gentamicin	gentamicin	NOUN
can-11500	84	42	.	.	PUNCT
can-11500	85	1	the	the	DET
can-11500	85	2	cells	cell	NOUN
can-11500	85	3	were	be	AUX
can-11500	85	4	maintained	maintain	VERB
can-11500	85	5	in	in	ADP
can-11500	85	6	a	a	DET
can-11500	85	7	5	5	NUM
can-11500	85	8	%	%	NOUN
can-11500	85	9	co2	co2	NOUN
can-11500	85	10	incubator	incubator	NOUN
can-11500	85	11	at	at	ADP
can-11500	85	12	37	37	NUM
can-11500	85	13	°	°	NOUN
can-11500	85	14	c	c	NOUN
can-11500	85	15	.	.	PUNCT
can-11500	86	1	2.4	2.4	NUM
can-11500	86	2	.	.	PUNCT
can-11500	86	3	cytotoxicity	cytotoxicity	NOUN
can-11500	86	4	analysis	analysis	NOUN
can-11500	86	5	in	in	ADP
can-11500	86	6	2d	2d	NUM
can-11500	86	7	cell	cell	NOUN
can-11500	86	8	cultures	culture	VERB
can-11500	86	9	the	the	DET
can-11500	86	10	cytotoxicity	cytotoxicity	NOUN
can-11500	86	11	of	of	ADP
can-11500	86	12	dexamethasone	dexamethasone	NOUN
can-11500	86	13	was	be	AUX
can-11500	86	14	assessed	assess	VERB
can-11500	86	15	in	in	ADP
can-11500	86	16	2d	2d	NUM
can-11500	86	17	cell	cell	NOUN
can-11500	86	18	cultures	culture	NOUN
can-11500	86	19	using	use	VERB
can-11500	86	20	an	an	DET
can-11500	86	21	xtt	xtt	NOUN
can-11500	86	22	(	(	PUNCT
can-11500	86	23	2,3	2,3	NUM
can-11500	86	24	-	-	PUNCT
can-11500	86	25	bis-(2	bis-(2	NOUN
can-11500	86	26	-	-	PUNCT
can-11500	86	27	methoxy-4	methoxy-4	PROPN
can-11500	86	28	-	-	PUNCT
can-11500	86	29	nitro-5	nitro-5	NUM
can-11500	86	30	-	-	PUNCT
can-11500	86	31	sulfophenyl)-2h	sulfophenyl)-2h	NOUN
can-11500	86	32	-	-	PUNCT
can-11500	86	33	tetrazolium-5	tetrazolium-5	NOUN
can-11500	86	34	-	-	PUNCT
can-11500	86	35	carboxanilide)based	carboxanilide)base	VERB
can-11500	86	36	cytotoxicity	cytotoxicity	NOUN
can-11500	86	37	assay	assay	PROPN
can-11500	86	38	kit	kit	NOUN
can-11500	86	39	.	.	PUNCT
can-11500	87	1	viable	viable	ADJ
can-11500	87	2	cells	cell	NOUN
can-11500	87	3	convert	convert	VERB
can-11500	87	4	the	the	DET
can-11500	87	5	tetrazolium	tetrazolium	NOUN
can-11500	87	6	salt	salt	NOUN
can-11500	87	7	xtt	xtt	PROPN
can-11500	87	8	into	into	ADP
can-11500	87	9	a	a	DET
can-11500	87	10	colored	colored	ADJ
can-11500	87	11	formazan	formazan	ADJ
can-11500	87	12	dye	dye	NOUN
can-11500	87	13	through	through	ADP
can-11500	87	14	mitochondrial	mitochondrial	ADJ
can-11500	87	15	enzymes	enzyme	NOUN
can-11500	87	16	.	.	PUNCT
can-11500	88	1	the	the	DET
can-11500	88	2	amount	amount	NOUN
can-11500	88	3	of	of	ADP
can-11500	88	4	viable	viable	ADJ
can-11500	88	5	cells	cell	NOUN
can-11500	88	6	was	be	AUX
can-11500	88	7	determined	determine	VERB
can-11500	88	8	by	by	ADP
can-11500	88	9	colorimetric	colorimetric	ADJ
can-11500	88	10	measurement	measurement	NOUN
can-11500	88	11	of	of	ADP
can-11500	88	12	this	this	DET
can-11500	88	13	dye	dye	NOUN
can-11500	88	14	.	.	PUNCT
can-11500	89	1	cells	cell	NOUN
can-11500	89	2	were	be	AUX
can-11500	89	3	seeded	seed	VERB
can-11500	89	4	in	in	ADP
can-11500	89	5	96	96	NUM
can-11500	89	6	-	-	PUNCT
can-11500	89	7	well	well	NOUN
can-11500	89	8	plates	plate	NOUN
can-11500	89	9	at	at	ADP
can-11500	89	10	a	a	DET
can-11500	89	11	density	density	NOUN
can-11500	89	12	of	of	ADP
can-11500	89	13	5,000	5,000	NUM
can-11500	89	14	cells	cell	NOUN
can-11500	89	15	per	per	ADP
can-11500	89	16	well	well	ADV
can-11500	89	17	.	.	PUNCT
can-11500	90	1	one	one	NUM
can-11500	90	2	column	column	NOUN
can-11500	90	3	of	of	ADP
can-11500	90	4	the	the	DET
can-11500	90	5	plate	plate	NOUN
can-11500	90	6	was	be	AUX
can-11500	90	7	reserved	reserve	VERB
can-11500	90	8	as	as	ADP
can-11500	90	9	a	a	DET
can-11500	90	10	medium	medium	NOUN
can-11500	90	11	control	control	NOUN
can-11500	90	12	,	,	PUNCT
can-11500	90	13	and	and	CCONJ
can-11500	90	14	no	no	DET
can-11500	90	15	cells	cell	NOUN
can-11500	90	16	were	be	AUX
can-11500	90	17	added	add	VERB
can-11500	90	18	to	to	ADP
can-11500	90	19	these	these	DET
can-11500	90	20	wells	well	NOUN
can-11500	90	21	.	.	PUNCT
can-11500	91	1	after	after	ADP
can-11500	91	2	seeding	seed	VERB
can-11500	91	3	,	,	PUNCT
can-11500	91	4	the	the	DET
can-11500	91	5	cells	cell	NOUN
can-11500	91	6	were	be	AUX
can-11500	91	7	characterization	characterization	NOUN
can-11500	91	8	and	and	CCONJ
can-11500	91	9	application	application	NOUN
can-11500	91	10	of	of	ADP
can-11500	91	11	nanomaterials	nanomaterial	NOUN
can-11500	91	12	2025	2025	NUM
can-11500	91	13	,	,	PUNCT
can-11500	91	14	8(3	8(3	NUM
can-11500	91	15	)	)	PUNCT
can-11500	91	16	,	,	PUNCT
can-11500	91	17	11500	11500	NUM
can-11500	91	18	.	.	PUNCT
can-11500	92	1	5	5	NUM
can-11500	92	2	treated	treat	VERB
can-11500	92	3	with	with	ADP
can-11500	92	4	serial	serial	ADJ
can-11500	92	5	dilutions	dilution	NOUN
can-11500	92	6	of	of	ADP
can-11500	92	7	the	the	DET
can-11500	92	8	drug	drug	NOUN
can-11500	92	9	and	and	CCONJ
can-11500	92	10	incubated	incubate	VERB
can-11500	92	11	for	for	ADP
can-11500	92	12	24	24	NUM
can-11500	92	13	to	to	PART
can-11500	92	14	96	96	NUM
can-11500	92	15	h.	h.	NOUN
can-11500	92	16	activated	activate	VERB
can-11500	92	17	xtt	xtt	NOUN
can-11500	92	18	solution	solution	NOUN
can-11500	92	19	was	be	AUX
can-11500	92	20	then	then	ADV
can-11500	92	21	added	add	VERB
can-11500	92	22	to	to	ADP
can-11500	92	23	each	each	PRON
can-11500	92	24	well	well	ADV
can-11500	92	25	,	,	PUNCT
can-11500	92	26	and	and	CCONJ
can-11500	92	27	the	the	DET
can-11500	92	28	plates	plate	NOUN
can-11500	92	29	were	be	AUX
can-11500	92	30	incubated	incubate	VERB
can-11500	92	31	at	at	ADP
can-11500	92	32	37	37	NUM
can-11500	92	33	°	°	NOUN
can-11500	92	34	c	c	NOUN
can-11500	92	35	for	for	ADP
can-11500	92	36	2	2	NUM
can-11500	92	37	to	to	PART
can-11500	92	38	5	5	NUM
can-11500	92	39	h.	h.	NOUN
can-11500	92	40	the	the	DET
can-11500	92	41	formazan	formazan	ADJ
can-11500	92	42	dye	dye	NOUN
can-11500	92	43	in	in	ADP
can-11500	92	44	each	each	DET
can-11500	92	45	well	well	ADV
can-11500	92	46	was	be	AUX
can-11500	92	47	quantified	quantify	VERB
can-11500	92	48	using	use	VERB
can-11500	92	49	a	a	DET
can-11500	92	50	microplate	microplate	NOUN
can-11500	92	51	reader	reader	NOUN
can-11500	92	52	.	.	PUNCT
can-11500	93	1	cell	cell	NOUN
can-11500	93	2	growth	growth	NOUN
can-11500	93	3	in	in	ADP
can-11500	93	4	wells	well	NOUN
can-11500	93	5	without	without	ADP
can-11500	93	6	drug	drug	NOUN
can-11500	93	7	-	-	PUNCT
can-11500	93	8	loaded	load	VERB
can-11500	93	9	mnps	mnps	NOUN
can-11500	93	10	was	be	AUX
can-11500	93	11	assumed	assume	VERB
can-11500	93	12	to	to	PART
can-11500	93	13	be	be	AUX
can-11500	93	14	100	100	NUM
can-11500	93	15	%	%	NOUN
can-11500	93	16	,	,	PUNCT
can-11500	93	17	and	and	CCONJ
can-11500	93	18	the	the	DET
can-11500	93	19	growth	growth	NOUN
can-11500	93	20	in	in	ADP
can-11500	93	21	treated	treat	VERB
can-11500	93	22	wells	well	NOUN
can-11500	93	23	was	be	AUX
can-11500	93	24	calculated	calculate	VERB
can-11500	93	25	relative	relative	ADJ
can-11500	93	26	to	to	ADP
can-11500	93	27	this	this	DET
can-11500	93	28	control	control	NOUN
can-11500	93	29	.	.	PUNCT
can-11500	94	1	the	the	DET
can-11500	94	2	ic50	ic50	PROPN
can-11500	94	3	(	(	PUNCT
can-11500	94	4	concentration	concentration	NOUN
can-11500	94	5	required	require	VERB
can-11500	94	6	to	to	PART
can-11500	94	7	kill	kill	VERB
can-11500	94	8	50	50	NUM
can-11500	94	9	%	%	NOUN
can-11500	94	10	of	of	ADP
can-11500	94	11	the	the	DET
can-11500	94	12	cells	cell	NOUN
can-11500	94	13	)	)	PUNCT
can-11500	94	14	was	be	AUX
can-11500	94	15	determined	determine	VERB
can-11500	94	16	.	.	PUNCT
can-11500	95	1	each	each	DET
can-11500	95	2	experiment	experiment	NOUN
can-11500	95	3	was	be	AUX
can-11500	95	4	performed	perform	VERB
can-11500	95	5	in	in	ADP
can-11500	95	6	triplicate	triplicate	NOUN
can-11500	95	7	.	.	PUNCT
can-11500	96	1	2.5	2.5	NUM
can-11500	96	2	.	.	PUNCT
can-11500	97	1	migration	migration	NOUN
can-11500	97	2	assay	assay	VERB
can-11500	97	3	the	the	DET
can-11500	97	4	migration	migration	NOUN
can-11500	97	5	assay	assay	NOUN
can-11500	97	6	was	be	AUX
can-11500	97	7	conducted	conduct	VERB
can-11500	97	8	using	use	VERB
can-11500	97	9	the	the	DET
can-11500	97	10	method	method	NOUN
can-11500	97	11	outlined	outline	VERB
can-11500	97	12	by	by	ADP
can-11500	97	13	liang	liang	PROPN
can-11500	97	14	et	et	PROPN
can-11500	97	15	al	al	PROPN
can-11500	97	16	.	.	PUNCT
can-11500	98	1	[	[	X
can-11500	98	2	21	21	NUM
can-11500	98	3	]	]	X
can-11500	98	4	cells	cell	NOUN
can-11500	98	5	were	be	AUX
can-11500	98	6	seeded	seed	VERB
can-11500	98	7	at	at	ADP
can-11500	98	8	a	a	DET
can-11500	98	9	density	density	NOUN
can-11500	98	10	of	of	ADP
can-11500	98	11	1.5	1.5	NUM
can-11500	98	12	×	×	NOUN
can-11500	98	13	105	105	NUM
can-11500	98	14	cells	cell	NOUN
can-11500	98	15	per	per	ADP
can-11500	98	16	well	well	ADV
can-11500	98	17	in	in	ADP
can-11500	98	18	six	six	NUM
can-11500	98	19	-	-	PUNCT
can-11500	98	20	well	well	NOUN
can-11500	98	21	plates	plate	NOUN
can-11500	98	22	,	,	PUNCT
can-11500	98	23	with	with	ADP
can-11500	98	24	three	three	NUM
can-11500	98	25	wells	well	NOUN
can-11500	98	26	serving	serve	VERB
can-11500	98	27	as	as	ADP
can-11500	98	28	controls	control	NOUN
can-11500	98	29	and	and	CCONJ
can-11500	98	30	three	three	NUM
can-11500	98	31	wells	well	NOUN
can-11500	98	32	treated	treat	VERB
can-11500	98	33	with	with	ADP
can-11500	98	34	the	the	DET
can-11500	98	35	drug	drug	NOUN
can-11500	98	36	.	.	PUNCT
can-11500	99	1	the	the	DET
can-11500	99	2	plates	plate	NOUN
can-11500	99	3	were	be	AUX
can-11500	99	4	incubated	incubate	VERB
can-11500	99	5	for	for	ADP
can-11500	99	6	24	24	NUM
can-11500	99	7	h.	h.	NOUN
can-11500	99	8	once	once	SCONJ
can-11500	99	9	the	the	DET
can-11500	99	10	well	well	ADJ
can-11500	99	11	surface	surface	NOUN
can-11500	99	12	was	be	AUX
can-11500	99	13	80	80	NUM
can-11500	99	14	%	%	NOUN
can-11500	99	15	confluent	confluent	ADJ
can-11500	99	16	,	,	PUNCT
can-11500	99	17	a	a	DET
can-11500	99	18	straight	straight	ADJ
can-11500	99	19	scratch	scratch	NOUN
can-11500	99	20	was	be	AUX
can-11500	99	21	made	make	VERB
can-11500	99	22	through	through	ADP
can-11500	99	23	the	the	DET
can-11500	99	24	cell	cell	NOUN
can-11500	99	25	monolayer	monolayer	NOUN
can-11500	99	26	using	use	VERB
can-11500	99	27	a	a	DET
can-11500	99	28	pipette	pipette	NOUN
can-11500	99	29	tip	tip	NOUN
can-11500	99	30	.	.	PUNCT
can-11500	100	1	microscopic	microscopic	ADJ
can-11500	100	2	images	image	NOUN
can-11500	100	3	were	be	AUX
can-11500	100	4	taken	take	VERB
can-11500	100	5	immediately	immediately	ADV
can-11500	100	6	after	after	ADP
can-11500	100	7	creating	create	VERB
can-11500	100	8	the	the	DET
can-11500	100	9	scratch	scratch	NOUN
can-11500	100	10	(	(	PUNCT
can-11500	100	11	0	0	NUM
can-11500	100	12	h	h	NOUN
can-11500	100	13	)	)	PUNCT
can-11500	100	14	and	and	CCONJ
can-11500	100	15	at	at	ADP
can-11500	100	16	6	6	NUM
can-11500	100	17	-	-	PUNCT
can-11500	100	18	h	h	NOUN
can-11500	100	19	intervals	interval	NOUN
can-11500	100	20	until	until	ADP
can-11500	100	21	wound	wound	NOUN
can-11500	100	22	closure	closure	NOUN
can-11500	100	23	.	.	PUNCT
can-11500	101	1	the	the	DET
can-11500	101	2	images	image	NOUN
can-11500	101	3	were	be	AUX
can-11500	101	4	analyzed	analyze	VERB
can-11500	101	5	using	use	VERB
can-11500	101	6	the	the	DET
can-11500	101	7	imagej	imagej	ADJ
can-11500	101	8	software	software	NOUN
can-11500	101	9	(	(	PUNCT
can-11500	101	10	national	national	ADJ
can-11500	101	11	institutes	institutes	PROPN
can-11500	101	12	of	of	ADP
can-11500	101	13	health	health	PROPN
can-11500	101	14	,	,	PUNCT
can-11500	101	15	us	we	PRON
can-11500	101	16	)	)	PUNCT
can-11500	101	17	to	to	PART
can-11500	101	18	evaluate	evaluate	VERB
can-11500	101	19	cell	cell	NOUN
can-11500	101	20	migration	migration	NOUN
can-11500	101	21	.	.	PUNCT
can-11500	102	1	2.6	2.6	NUM
can-11500	102	2	.	.	PUNCT
can-11500	103	1	cellular	cellular	ADJ
can-11500	103	2	internalization	internalization	NOUN
can-11500	103	3	of	of	ADP
can-11500	103	4	nanoparticles	nanoparticle	NOUN
can-11500	103	5	to	to	PART
can-11500	103	6	determine	determine	VERB
can-11500	103	7	the	the	DET
can-11500	103	8	cellular	cellular	ADJ
can-11500	103	9	uptake	uptake	NOUN
can-11500	103	10	of	of	ADP
can-11500	103	11	nanoparticles	nanoparticle	NOUN
can-11500	103	12	,	,	PUNCT
can-11500	103	13	both	both	CCONJ
can-11500	103	14	neutral	neutral	ADJ
can-11500	103	15	and	and	CCONJ
can-11500	103	16	charged	charge	VERB
can-11500	103	17	nanoparticles	nanoparticle	NOUN
can-11500	103	18	were	be	AUX
can-11500	103	19	treated	treat	VERB
can-11500	103	20	with	with	ADP
can-11500	103	21	cells	cell	NOUN
can-11500	103	22	.	.	PUNCT
can-11500	104	1	subsequently	subsequently	ADV
can-11500	104	2	,	,	PUNCT
can-11500	104	3	the	the	DET
can-11500	104	4	internalization	internalization	NOUN
can-11500	104	5	status	status	NOUN
can-11500	104	6	of	of	ADP
can-11500	104	7	the	the	DET
can-11500	104	8	nanoparticles	nanoparticle	NOUN
can-11500	104	9	into	into	ADP
can-11500	104	10	the	the	DET
can-11500	104	11	cells	cell	NOUN
can-11500	104	12	was	be	AUX
can-11500	104	13	examined	examine	VERB
can-11500	104	14	under	under	ADP
can-11500	104	15	a	a	DET
can-11500	104	16	microscope	microscope	NOUN
can-11500	104	17	(	(	PUNCT
can-11500	104	18	bab	bab	PROPN
can-11500	104	19	-	-	PUNCT
can-11500	104	20	ters	ter	NOUN
can-11500	104	21	,	,	PUNCT
can-11500	104	22	bab	bab	PROPN
can-11500	104	23	,	,	PUNCT
can-11500	104	24	turkey	turkey	PROPN
can-11500	104	25	)	)	PUNCT
can-11500	104	26	at	at	ADP
can-11500	104	27	1	1	NUM
can-11500	104	28	,	,	PUNCT
can-11500	104	29	2	2	NUM
can-11500	104	30	,	,	PUNCT
can-11500	104	31	4	4	NUM
can-11500	104	32	,	,	PUNCT
can-11500	104	33	6	6	NUM
can-11500	104	34	,	,	PUNCT
can-11500	104	35	8	8	NUM
can-11500	104	36	,	,	PUNCT
can-11500	104	37	and	and	CCONJ
can-11500	104	38	12	12	NUM
can-11500	104	39	-	-	PUNCT
can-11500	104	40	h	h	NOUN
can-11500	104	41	intervals	interval	NOUN
can-11500	104	42	.	.	PUNCT
can-11500	105	1	3	3	X
can-11500	105	2	.	.	NOUN
can-11500	105	3	results	result	NOUN
can-11500	105	4	and	and	CCONJ
can-11500	105	5	discussion	discussion	VERB
can-11500	105	6	the	the	DET
can-11500	105	7	system	system	NOUN
can-11500	105	8	consists	consist	VERB
can-11500	105	9	of	of	ADP
can-11500	105	10	fe3o4	fe3o4	NOUN
can-11500	105	11	mnps	mnps	NOUN
can-11500	105	12	at	at	ADP
can-11500	105	13	its	its	PRON
can-11500	105	14	core	core	NOUN
can-11500	105	15	,	,	PUNCT
can-11500	105	16	enveloped	envelop	VERB
can-11500	105	17	by	by	ADP
can-11500	105	18	chitosan	chitosan	ADJ
can-11500	105	19	polymers	polymer	NOUN
can-11500	105	20	that	that	PRON
can-11500	105	21	serve	serve	VERB
can-11500	105	22	as	as	ADP
can-11500	105	23	drug	drug	NOUN
can-11500	105	24	carriers	carrier	NOUN
can-11500	105	25	on	on	ADP
can-11500	105	26	the	the	DET
can-11500	105	27	nanoparticle	nanoparticle	NOUN
can-11500	105	28	surface	surface	NOUN
can-11500	105	29	.	.	PUNCT
can-11500	106	1	as	as	SCONJ
can-11500	106	2	depicted	depict	VERB
can-11500	106	3	in	in	ADP
can-11500	106	4	figure	figure	NOUN
can-11500	106	5	3	3	NUM
can-11500	106	6	,	,	PUNCT
can-11500	106	7	dexamethasone	dexamethasone	NOUN
can-11500	106	8	molecules	molecule	NOUN
can-11500	106	9	(	(	PUNCT
can-11500	106	10	marked	mark	VERB
can-11500	106	11	by	by	ADP
can-11500	106	12	blue	blue	ADJ
can-11500	106	13	circles	circle	NOUN
can-11500	106	14	)	)	PUNCT
can-11500	106	15	were	be	AUX
can-11500	106	16	bound	bind	VERB
can-11500	106	17	to	to	ADP
can-11500	106	18	the	the	DET
can-11500	106	19	polymer	polymer	NOUN
can-11500	106	20	via	via	ADP
can-11500	106	21	covalent	covalent	NOUN
can-11500	106	22	or	or	CCONJ
can-11500	106	23	electrostatic	electrostatic	ADJ
can-11500	106	24	interactions	interaction	NOUN
can-11500	106	25	.	.	PUNCT
can-11500	107	1	this	this	DET
can-11500	107	2	structure	structure	NOUN
can-11500	107	3	was	be	AUX
can-11500	107	4	designed	design	VERB
can-11500	107	5	to	to	PART
can-11500	107	6	facilitate	facilitate	VERB
can-11500	107	7	controlled	control	VERB
can-11500	107	8	drug	drug	NOUN
can-11500	107	9	release	release	NOUN
can-11500	107	10	,	,	PUNCT
can-11500	107	11	enhance	enhance	VERB
can-11500	107	12	biocompatibility	biocompatibility	NOUN
can-11500	107	13	,	,	PUNCT
can-11500	107	14	and	and	CCONJ
can-11500	107	15	support	support	VERB
can-11500	107	16	targeted	target	VERB
can-11500	107	17	therapy	therapy	NOUN
can-11500	107	18	.	.	PUNCT
can-11500	108	1	to	to	PART
can-11500	108	2	verify	verify	VERB
can-11500	108	3	the	the	DET
can-11500	108	4	successful	successful	ADJ
can-11500	108	5	loading	loading	NOUN
can-11500	108	6	of	of	ADP
can-11500	108	7	dexamethasone	dexamethasone	NOUN
can-11500	108	8	onto	onto	ADP
can-11500	108	9	the	the	DET
can-11500	108	10	nanoparticles	nanoparticle	NOUN
can-11500	108	11	,	,	PUNCT
can-11500	108	12	ftir	ftir	NOUN
can-11500	108	13	and	and	CCONJ
can-11500	108	14	sem	sem	NOUN
can-11500	108	15	analyses	analysis	NOUN
can-11500	108	16	were	be	AUX
can-11500	108	17	conducted	conduct	VERB
can-11500	108	18	.	.	PUNCT
can-11500	109	1	analysis	analysis	NOUN
can-11500	109	2	of	of	ADP
can-11500	109	3	the	the	DET
can-11500	109	4	sem	sem	NOUN
can-11500	109	5	images	image	NOUN
can-11500	109	6	revealed	reveal	VERB
can-11500	109	7	distinct	distinct	ADJ
can-11500	109	8	morphological	morphological	ADJ
can-11500	109	9	features	feature	NOUN
can-11500	109	10	.	.	PUNCT
can-11500	110	1	in	in	ADP
can-11500	110	2	figure	figure	NOUN
can-11500	110	3	4	4	NUM
can-11500	110	4	,	,	PUNCT
can-11500	110	5	the	the	DET
can-11500	110	6	surface	surface	NOUN
can-11500	110	7	displayed	display	VERB
can-11500	110	8	a	a	DET
can-11500	110	9	rough	rough	ADJ
can-11500	110	10	and	and	CCONJ
can-11500	110	11	irregular	irregular	ADJ
can-11500	110	12	texture	texture	NOUN
can-11500	110	13	,	,	PUNCT
can-11500	110	14	a	a	DET
can-11500	110	15	characteristic	characteristic	NOUN
can-11500	110	16	commonly	commonly	ADV
can-11500	110	17	associated	associate	VERB
can-11500	110	18	with	with	ADP
can-11500	110	19	chitosan	chitosan	NOUN
can-11500	110	20	-	-	PUNCT
can-11500	110	21	coated	coat	VERB
can-11500	110	22	nanoparticles	nanoparticle	NOUN
can-11500	110	23	.	.	PUNCT
can-11500	111	1	this	this	DET
can-11500	111	2	irregularity	irregularity	NOUN
can-11500	111	3	arises	arise	VERB
can-11500	111	4	from	from	ADP
can-11500	111	5	the	the	DET
can-11500	111	6	uneven	uneven	ADJ
can-11500	111	7	coating	coating	NOUN
can-11500	111	8	of	of	ADP
can-11500	111	9	the	the	DET
can-11500	111	10	chitosan	chitosan	ADJ
can-11500	111	11	polymer	polymer	NOUN
can-11500	111	12	,	,	PUNCT
can-11500	111	13	which	which	PRON
can-11500	111	14	creates	create	VERB
can-11500	111	15	a	a	DET
can-11500	111	16	porous	porous	ADJ
can-11500	111	17	and	and	CCONJ
can-11500	111	18	granular	granular	ADJ
can-11500	111	19	structure	structure	NOUN
can-11500	111	20	.	.	PUNCT
can-11500	112	1	such	such	DET
can-11500	112	2	a	a	DET
can-11500	112	3	structure	structure	NOUN
can-11500	112	4	is	be	AUX
can-11500	112	5	likely	likely	ADJ
can-11500	112	6	to	to	PART
can-11500	112	7	enhance	enhance	VERB
can-11500	112	8	drug	drug	NOUN
can-11500	112	9	loading	loading	NOUN
can-11500	112	10	capacity	capacity	NOUN
can-11500	112	11	,	,	PUNCT
can-11500	112	12	thereby	thereby	ADV
can-11500	112	13	improving	improve	VERB
can-11500	112	14	bioavailability	bioavailability	NOUN
can-11500	112	15	.	.	PUNCT
can-11500	113	1	the	the	DET
can-11500	113	2	sem	sem	PROPN
can-11500	113	3	images	image	NOUN
can-11500	113	4	confirmed	confirm	VERB
can-11500	113	5	the	the	DET
can-11500	113	6	successful	successful	ADJ
can-11500	113	7	synthesis	synthesis	NOUN
can-11500	113	8	of	of	ADP
can-11500	113	9	chitosancoated	chitosancoate	VERB
can-11500	113	10	fe3o4	fe3o4	PROPN
can-11500	113	11	mnps	mnps	NOUN
can-11500	113	12	.	.	PUNCT
can-11500	114	1	in	in	ADP
can-11500	114	2	figure	figure	NOUN
can-11500	114	3	5	5	NUM
can-11500	114	4	,	,	PUNCT
can-11500	114	5	the	the	DET
can-11500	114	6	loading	loading	NOUN
can-11500	114	7	of	of	ADP
can-11500	114	8	dexamethasone	dexamethasone	NOUN
can-11500	114	9	was	be	AUX
can-11500	114	10	observed	observe	VERB
can-11500	114	11	to	to	PART
can-11500	114	12	increase	increase	VERB
can-11500	114	13	the	the	DET
can-11500	114	14	density	density	NOUN
can-11500	114	15	of	of	ADP
can-11500	114	16	the	the	DET
can-11500	114	17	nanoparticles	nanoparticle	NOUN
can-11500	114	18	and	and	CCONJ
can-11500	114	19	form	form	VERB
can-11500	114	20	an	an	DET
can-11500	114	21	adhesive	adhesive	ADJ
can-11500	114	22	structure	structure	NOUN
can-11500	114	23	.	.	PUNCT
can-11500	115	1	the	the	DET
can-11500	115	2	presence	presence	NOUN
can-11500	115	3	of	of	ADP
can-11500	115	4	13.7	13.7	NUM
can-11500	115	5	%	%	NOUN
can-11500	115	6	carbon	carbon	NOUN
can-11500	115	7	content	content	NOUN
can-11500	115	8	further	far	ADV
can-11500	115	9	supported	support	VERB
can-11500	115	10	the	the	DET
can-11500	115	11	successful	successful	ADJ
can-11500	115	12	coating	coating	NOUN
can-11500	115	13	of	of	ADP
can-11500	115	14	chitosan	chitosan	NOUN
can-11500	115	15	and	and	CCONJ
can-11500	115	16	the	the	DET
can-11500	115	17	loading	loading	NOUN
can-11500	115	18	of	of	ADP
can-11500	115	19	dexamethasone	dexamethasone	NOUN
can-11500	115	20	.	.	PUNCT
can-11500	116	1	these	these	DET
can-11500	116	2	findings	finding	NOUN
can-11500	116	3	collectively	collectively	ADV
can-11500	116	4	demonstrate	demonstrate	VERB
can-11500	116	5	that	that	SCONJ
can-11500	116	6	fe3o4	fe3o4	NOUN
can-11500	116	7	mnps	mnps	NOUN
can-11500	116	8	were	be	AUX
can-11500	116	9	effectively	effectively	ADV
can-11500	116	10	coated	coat	VERB
can-11500	116	11	with	with	ADP
can-11500	116	12	chitosan	chitosan	NOUN
can-11500	116	13	and	and	CCONJ
can-11500	116	14	subsequently	subsequently	ADV
can-11500	116	15	loaded	load	VERB
can-11500	116	16	with	with	ADP
can-11500	116	17	dexamethasone	dexamethasone	NOUN
can-11500	116	18	.	.	PUNCT
can-11500	117	1	characterization	characterization	NOUN
can-11500	117	2	and	and	CCONJ
can-11500	117	3	application	application	NOUN
can-11500	117	4	of	of	ADP
can-11500	117	5	nanomaterials	nanomaterial	NOUN
can-11500	117	6	2025	2025	NUM
can-11500	117	7	,	,	PUNCT
can-11500	117	8	8(3	8(3	NUM
can-11500	117	9	)	)	PUNCT
can-11500	117	10	,	,	PUNCT
can-11500	117	11	11500	11500	NUM
can-11500	117	12	.	.	PUNCT
can-11500	118	1	6	6	NUM
can-11500	118	2	(	(	PUNCT
can-11500	118	3	a	a	NOUN
can-11500	118	4	)	)	PUNCT
can-11500	118	5	(	(	PUNCT
can-11500	118	6	b	b	X
can-11500	118	7	)	)	PUNCT
can-11500	118	8	figure	figure	NOUN
can-11500	118	9	3	3	NUM
can-11500	118	10	.	.	PUNCT
can-11500	118	11	fourier	fourier	NOUN
can-11500	118	12	transform	transform	VERB
can-11500	118	13	infrared	infrared	ADJ
can-11500	118	14	spectroscopy	spectroscopy	VERB
can-11500	118	15	analysis	analysis	NOUN
can-11500	118	16	results	result	NOUN
can-11500	118	17	.	.	PUNCT
can-11500	119	1	(	(	PUNCT
can-11500	119	2	a	a	X
can-11500	119	3	)	)	PUNCT
can-11500	119	4	pure	pure	ADJ
can-11500	119	5	dexamethasone	dexamethasone	NOUN
can-11500	119	6	.	.	PUNCT
can-11500	120	1	(	(	PUNCT
can-11500	120	2	b	b	X
can-11500	120	3	)	)	PUNCT
can-11500	120	4	dexamethasoneloaded	dexamethasoneloade	VERB
can-11500	120	5	nanoparticles	nanoparticle	NOUN
can-11500	120	6	.	.	PUNCT
can-11500	121	1	characterization	characterization	NOUN
can-11500	121	2	and	and	CCONJ
can-11500	121	3	application	application	NOUN
can-11500	121	4	of	of	ADP
can-11500	121	5	nanomaterials	nanomaterial	NOUN
can-11500	121	6	2025	2025	NUM
can-11500	121	7	,	,	PUNCT
can-11500	121	8	8(3	8(3	NUM
can-11500	121	9	)	)	PUNCT
can-11500	121	10	,	,	PUNCT
can-11500	121	11	11500	11500	NUM
can-11500	121	12	.	.	PUNCT
can-11500	122	1	7	7	NUM
can-11500	122	2	figure	figure	NOUN
can-11500	122	3	4	4	NUM
can-11500	122	4	.	.	PUNCT
can-11500	122	5	scanning	scan	VERB
can-11500	122	6	electron	electron	NOUN
can-11500	122	7	microscopy	microscopy	NOUN
can-11500	122	8	analysis	analysis	NOUN
can-11500	122	9	results	result	NOUN
can-11500	122	10	of	of	ADP
can-11500	122	11	the	the	DET
can-11500	122	12	chitosan	chitosan	NOUN
can-11500	122	13	-	-	PUNCT
can-11500	122	14	coated	coated	ADJ
can-11500	122	15	magnetic	magnetic	ADJ
can-11500	122	16	nanoparticles	nanoparticle	NOUN
can-11500	122	17	.	.	PUNCT
can-11500	123	1	scale	scale	NOUN
can-11500	123	2	bar	bar	NOUN
can-11500	123	3	:	:	PUNCT
can-11500	123	4	50	50	NUM
can-11500	123	5	µm	µm	NOUN
can-11500	123	6	;	;	PUNCT
can-11500	123	7	magnification	magnification	NOUN
can-11500	123	8	:	:	PUNCT
can-11500	123	9	1200×.	1200×.	NOUN
can-11500	123	10	figure	figure	VERB
can-11500	123	11	5	5	NUM
can-11500	123	12	.	.	PUNCT
can-11500	123	13	scanning	scan	VERB
can-11500	123	14	electron	electron	NOUN
can-11500	123	15	microscopy	microscopy	NOUN
can-11500	123	16	analysis	analysis	NOUN
can-11500	123	17	results	result	NOUN
can-11500	123	18	of	of	ADP
can-11500	123	19	the	the	DET
can-11500	123	20	dexamethasone	dexamethasone	NOUN
can-11500	123	21	-	-	PUNCT
can-11500	123	22	loaded	load	VERB
can-11500	123	23	chitosan	chitosan	NOUN
can-11500	123	24	-	-	PUNCT
can-11500	123	25	coated	coated	ADJ
can-11500	123	26	magnetic	magnetic	ADJ
can-11500	123	27	nanoparticles	nanoparticle	NOUN
can-11500	123	28	.	.	PUNCT
can-11500	124	1	scale	scale	NOUN
can-11500	124	2	bar	bar	NOUN
can-11500	124	3	:	:	PUNCT
can-11500	124	4	3	3	NUM
can-11500	124	5	µm	µm	NOUN
can-11500	124	6	;	;	PUNCT
can-11500	124	7	magnification	magnification	NOUN
can-11500	124	8	:	:	PUNCT
can-11500	124	9	10×.	10×.	NUM
can-11500	124	10	figure	figure	NOUN
can-11500	124	11	6	6	NUM
can-11500	124	12	displays	display	VERB
can-11500	124	13	the	the	DET
can-11500	124	14	in	in	ADV
can-11500	124	15	vitro	vitro	X
can-11500	124	16	release	release	NOUN
can-11500	124	17	profiles	profile	NOUN
can-11500	124	18	of	of	ADP
can-11500	124	19	dexmethasone	dexmethasone	NOUN
can-11500	124	20	from	from	ADP
can-11500	124	21	mnps	mnps	PROPN
can-11500	124	22	in	in	ADP
can-11500	124	23	pbs	pbs	PROPN
can-11500	124	24	solution	solution	NOUN
can-11500	124	25	.	.	PUNCT
can-11500	125	1	the	the	DET
can-11500	125	2	dexamethasone	dexamethasone	NOUN
can-11500	125	3	-	-	PUNCT
can-11500	125	4	loaded	load	VERB
can-11500	125	5	mnps	mnps	PROPN
can-11500	125	6	exhibited	exhibit	VERB
can-11500	125	7	an	an	DET
can-11500	125	8	initial	initial	ADJ
can-11500	125	9	burst	burst	ADJ
can-11500	125	10	release	release	NOUN
can-11500	125	11	of	of	ADP
can-11500	125	12	56	56	NUM
can-11500	125	13	%	%	NOUN
can-11500	125	14	within	within	ADP
can-11500	125	15	the	the	DET
can-11500	125	16	first	first	ADJ
can-11500	125	17	72	72	NUM
can-11500	125	18	h.	h.	NOUN
can-11500	125	19	then	then	ADV
can-11500	125	20	,	,	PUNCT
can-11500	125	21	the	the	DET
can-11500	125	22	drug	drug	NOUN
can-11500	125	23	reached	reach	VERB
can-11500	125	24	a	a	DET
can-11500	125	25	stable	stable	ADJ
can-11500	125	26	state	state	NOUN
can-11500	125	27	.	.	PUNCT
can-11500	126	1	characterization	characterization	NOUN
can-11500	126	2	and	and	CCONJ
can-11500	126	3	application	application	NOUN
can-11500	126	4	of	of	ADP
can-11500	126	5	nanomaterials	nanomaterial	NOUN
can-11500	126	6	2025	2025	NUM
can-11500	126	7	,	,	PUNCT
can-11500	126	8	8(3	8(3	NUM
can-11500	126	9	)	)	PUNCT
can-11500	126	10	,	,	PUNCT
can-11500	126	11	11500	11500	NUM
can-11500	126	12	.	.	PUNCT
can-11500	127	1	8	8	NUM
can-11500	127	2	figure	figure	NOUN
can-11500	127	3	6	6	NUM
can-11500	127	4	.	.	PUNCT
can-11500	128	1	the	the	DET
can-11500	128	2	release	release	NOUN
can-11500	128	3	of	of	ADP
can-11500	128	4	dexamethasone	dexamethasone	NOUN
can-11500	128	5	from	from	ADP
can-11500	128	6	magnetic	magnetic	ADJ
can-11500	128	7	nanoparticles	nanoparticle	NOUN
can-11500	128	8	across	across	ADP
can-11500	128	9	various	various	ADJ
can-11500	128	10	time	time	NOUN
can-11500	128	11	points	point	NOUN
can-11500	128	12	.	.	PUNCT
can-11500	129	1	figure	figure	VERB
can-11500	129	2	7	7	NUM
can-11500	129	3	.	.	PUNCT
can-11500	129	4	image	image	NOUN
can-11500	129	5	of	of	ADP
can-11500	129	6	the	the	DET
can-11500	129	7	control	control	NOUN
can-11500	129	8	mda	mda	PROPN
can-11500	129	9	-	-	PUNCT
can-11500	129	10	mb-231	mb-231	PROPN
can-11500	129	11	cell	cell	NOUN
can-11500	129	12	line	line	NOUN
can-11500	129	13	.	.	PUNCT
can-11500	130	1	scale	scale	NOUN
can-11500	130	2	bar	bar	NOUN
can-11500	130	3	:	:	PUNCT
can-11500	130	4	100	100	NUM
can-11500	130	5	µm	µm	NOUN
can-11500	130	6	;	;	PUNCT
can-11500	130	7	magnification	magnification	NOUN
can-11500	130	8	:	:	PUNCT
can-11500	130	9	10×.	10×.	NUM
can-11500	131	1	it	it	PRON
can-11500	131	2	was	be	AUX
can-11500	131	3	observed	observe	VERB
can-11500	131	4	that	that	SCONJ
can-11500	131	5	chitosan	chitosan	NOUN
can-11500	131	6	-	-	PUNCT
can-11500	131	7	coated	coat	VERB
can-11500	131	8	mnps	mnps	NOUN
can-11500	131	9	were	be	AUX
can-11500	131	10	internalized	internalize	VERB
can-11500	131	11	by	by	ADP
can-11500	131	12	mda	mda	PROPN
can-11500	131	13	-	-	PUNCT
can-11500	131	14	mb-231	mb-231	PROPN
can-11500	131	15	cells	cell	NOUN
can-11500	131	16	.	.	PUNCT
can-11500	132	1	these	these	DET
can-11500	132	2	nanoparticles	nanoparticle	NOUN
can-11500	132	3	were	be	AUX
can-11500	132	4	expected	expect	VERB
can-11500	132	5	to	to	PART
can-11500	132	6	be	be	AUX
can-11500	132	7	utilized	utilize	VERB
can-11500	132	8	for	for	ADP
can-11500	132	9	controlled	control	VERB
can-11500	132	10	drug	drug	NOUN
can-11500	132	11	release	release	NOUN
can-11500	132	12	.	.	PUNCT
can-11500	133	1	the	the	DET
can-11500	133	2	findings	finding	NOUN
can-11500	133	3	revealed	reveal	VERB
can-11500	133	4	a	a	DET
can-11500	133	5	disruption	disruption	NOUN
can-11500	133	6	in	in	ADP
can-11500	133	7	cellular	cellular	ADJ
can-11500	133	8	structural	structural	ADJ
can-11500	133	9	integrity	integrity	NOUN
can-11500	133	10	and	and	CCONJ
can-11500	133	11	a	a	DET
can-11500	133	12	decrease	decrease	NOUN
can-11500	133	13	in	in	ADP
can-11500	133	14	cell	cell	NOUN
can-11500	133	15	density	density	NOUN
can-11500	133	16	compared	compare	VERB
can-11500	133	17	to	to	ADP
can-11500	133	18	the	the	DET
can-11500	133	19	control	control	NOUN
can-11500	133	20	group	group	NOUN
can-11500	133	21	(	(	PUNCT
can-11500	133	22	figures	figure	NOUN
can-11500	133	23	7–9	7–9	NUM
can-11500	133	24	)	)	PUNCT
can-11500	133	25	.	.	PUNCT
can-11500	134	1	dexamethasone	dexamethasone	NOUN
can-11500	134	2	-	-	PUNCT
can-11500	134	3	loaded	load	VERB
can-11500	134	4	nanoparticles	nanoparticle	NOUN
can-11500	134	5	were	be	AUX
can-11500	134	6	shown	show	VERB
can-11500	134	7	to	to	PART
can-11500	134	8	enhance	enhance	VERB
can-11500	134	9	the	the	DET
can-11500	134	10	localized	localized	ADJ
can-11500	134	11	effect	effect	NOUN
can-11500	134	12	of	of	ADP
can-11500	134	13	dexamethasone	dexamethasone	NOUN
can-11500	134	14	while	while	SCONJ
can-11500	134	15	minimizing	minimize	VERB
can-11500	134	16	peripheral	peripheral	ADJ
can-11500	134	17	toxicity	toxicity	NOUN
can-11500	134	18	.	.	PUNCT
can-11500	135	1	in	in	ADP
can-11500	135	2	the	the	DET
can-11500	135	3	red	red	ADJ
can-11500	135	4	-	-	PUNCT
can-11500	135	5	marked	mark	VERB
can-11500	135	6	areas	area	NOUN
can-11500	135	7	in	in	ADP
can-11500	135	8	figure	figure	NOUN
can-11500	135	9	8	8	NUM
can-11500	135	10	,	,	PUNCT
can-11500	135	11	dexamethasoneloaded	dexamethasoneloade	VERB
can-11500	135	12	nanoparticles	nanoparticle	NOUN
can-11500	135	13	were	be	AUX
can-11500	135	14	observed	observe	VERB
can-11500	135	15	to	to	PART
can-11500	135	16	be	be	AUX
can-11500	135	17	localized	localize	VERB
can-11500	135	18	either	either	CCONJ
can-11500	135	19	along	along	ADP
can-11500	135	20	the	the	DET
can-11500	135	21	cell	cell	NOUN
can-11500	135	22	membrane	membrane	NOUN
can-11500	135	23	or	or	CCONJ
can-11500	135	24	dispersed	disperse	VERB
can-11500	135	25	within	within	ADP
can-11500	135	26	the	the	DET
can-11500	135	27	cytoplasm	cytoplasm	NOUN
can-11500	135	28	.	.	PUNCT
can-11500	136	1	characterization	characterization	NOUN
can-11500	136	2	and	and	CCONJ
can-11500	136	3	application	application	NOUN
can-11500	136	4	of	of	ADP
can-11500	136	5	nanomaterials	nanomaterial	NOUN
can-11500	136	6	2025	2025	NUM
can-11500	136	7	,	,	PUNCT
can-11500	136	8	8(3	8(3	NUM
can-11500	136	9	)	)	PUNCT
can-11500	136	10	,	,	PUNCT
can-11500	136	11	11500	11500	NUM
can-11500	136	12	.	.	PUNCT
can-11500	137	1	9	9	NUM
can-11500	137	2	figure	figure	NOUN
can-11500	137	3	8	8	NUM
can-11500	137	4	.	.	PUNCT
can-11500	137	5	image	image	NOUN
can-11500	137	6	of	of	ADP
can-11500	137	7	dexamethasone	dexamethasone	NOUN
can-11500	137	8	-	-	PUNCT
can-11500	137	9	loaded	load	VERB
can-11500	137	10	chitosan	chitosan	NOUN
can-11500	137	11	-	-	PUNCT
can-11500	137	12	coated	coat	VERB
can-11500	137	13	magnetic	magnetic	ADJ
can-11500	137	14	nanoparticles	nanoparticle	NOUN
can-11500	137	15	in	in	ADP
can-11500	137	16	and	and	CCONJ
can-11500	137	17	around	around	ADP
can-11500	137	18	mda	mda	PROPN
can-11500	137	19	-	-	PUNCT
can-11500	137	20	mb-231	mb-231	PROPN
can-11500	137	21	cells	cell	NOUN
can-11500	137	22	post	post	ADJ
can-11500	137	23	-	-	NOUN
can-11500	137	24	transfection	transfection	NOUN
can-11500	137	25	.	.	PUNCT
can-11500	138	1	scale	scale	NOUN
can-11500	138	2	bar	bar	NOUN
can-11500	138	3	:	:	PUNCT
can-11500	138	4	100	100	NUM
can-11500	138	5	µm	µm	NOUN
can-11500	138	6	;	;	PUNCT
can-11500	138	7	magnification	magnification	NOUN
can-11500	138	8	:	:	PUNCT
can-11500	138	9	100×.	100×.	NUM
can-11500	138	10	figure	figure	NOUN
can-11500	138	11	9	9	NUM
can-11500	138	12	.	.	PUNCT
can-11500	138	13	cell	cell	NOUN
can-11500	138	14	internalization	internalization	NOUN
can-11500	138	15	analyses	analysis	NOUN
can-11500	138	16	.	.	PUNCT
can-11500	139	1	(	(	PUNCT
can-11500	139	2	a	a	X
can-11500	139	3	)	)	PUNCT
can-11500	139	4	microscopic	microscopic	ADJ
can-11500	139	5	image	image	NOUN
can-11500	139	6	showing	show	VERB
can-11500	139	7	cell	cell	NOUN
can-11500	139	8	death	death	NOUN
can-11500	139	9	following	follow	VERB
can-11500	139	10	nanoparticle	nanoparticle	NOUN
can-11500	139	11	entry	entry	NOUN
can-11500	139	12	.	.	PUNCT
can-11500	140	1	scale	scale	NOUN
can-11500	140	2	bar	bar	NOUN
can-11500	140	3	:	:	PUNCT
can-11500	140	4	100	100	NUM
can-11500	140	5	µm	µm	NOUN
can-11500	140	6	;	;	PUNCT
can-11500	140	7	magnification	magnification	NOUN
can-11500	140	8	:	:	PUNCT
can-11500	140	9	10×.	10×.	NUM
can-11500	140	10	(	(	PUNCT
can-11500	140	11	b	b	NOUN
can-11500	140	12	)	)	PUNCT
can-11500	140	13	time	time	NOUN
can-11500	140	14	-	-	PUNCT
can-11500	140	15	dependent	dependent	ADJ
can-11500	140	16	increase	increase	NOUN
can-11500	140	17	in	in	ADP
can-11500	140	18	nanoparticle	nanoparticle	NOUN
can-11500	140	19	internalization	internalization	NOUN
can-11500	140	20	in	in	ADP
can-11500	140	21	cells	cell	NOUN
can-11500	140	22	.	.	PUNCT
can-11500	141	1	(	(	PUNCT
can-11500	141	2	c	c	X
can-11500	141	3	)	)	PUNCT
can-11500	141	4	3d	3d	NUM
can-11500	141	5	surface	surface	NOUN
can-11500	141	6	(	(	PUNCT
can-11500	141	7	surface	surface	NOUN
can-11500	141	8	/	/	SYM
can-11500	141	9	density	density	NOUN
can-11500	141	10	)	)	PUNCT
can-11500	141	11	mapping(x	mapping(x	NOUN
can-11500	141	12	:	:	PUNCT
can-11500	141	13	pixel	pixel	PROPN
can-11500	141	14	,	,	PUNCT
can-11500	141	15	y	y	NOUN
can-11500	141	16	:	:	PUNCT
can-11500	141	17	pixel	pixel	PROPN
can-11500	141	18	,	,	PUNCT
can-11500	141	19	z	z	NOUN
can-11500	141	20	:	:	PUNCT
can-11500	141	21	intensity	intensity	NOUN
can-11500	141	22	)	)	PUNCT
can-11500	141	23	characterization	characterization	NOUN
can-11500	141	24	and	and	CCONJ
can-11500	141	25	application	application	NOUN
can-11500	141	26	of	of	ADP
can-11500	141	27	nanomaterials	nanomaterial	NOUN
can-11500	141	28	2025	2025	NUM
can-11500	141	29	,	,	PUNCT
can-11500	141	30	8(3	8(3	NUM
can-11500	141	31	)	)	PUNCT
can-11500	141	32	,	,	PUNCT
can-11500	141	33	11500	11500	NUM
can-11500	141	34	.	.	PUNCT
can-11500	142	1	10	10	NUM
can-11500	142	2	previous	previous	ADJ
can-11500	142	3	studies	study	NOUN
can-11500	142	4	have	have	AUX
can-11500	142	5	demonstrated	demonstrate	VERB
can-11500	142	6	that	that	SCONJ
can-11500	142	7	chitosan	chitosan	ADJ
can-11500	142	8	nanoparticles	nanoparticle	NOUN
can-11500	142	9	exhibit	exhibit	VERB
can-11500	142	10	varying	vary	VERB
can-11500	142	11	transfection	transfection	NOUN
can-11500	142	12	efficiencies	efficiency	NOUN
can-11500	142	13	depending	depend	VERB
can-11500	142	14	on	on	ADP
can-11500	142	15	their	their	PRON
can-11500	142	16	formulation	formulation	NOUN
can-11500	142	17	and	and	CCONJ
can-11500	142	18	the	the	DET
can-11500	142	19	cell	cell	NOUN
can-11500	142	20	type	type	NOUN
can-11500	142	21	.	.	PUNCT
can-11500	143	1	for	for	ADP
can-11500	143	2	example	example	NOUN
can-11500	143	3	,	,	PUNCT
can-11500	143	4	chitosan	chitosan	ADJ
can-11500	143	5	–	–	PUNCT
can-11500	143	6	dna	dna	PROPN
can-11500	143	7	nanoparticles	nanoparticle	NOUN
can-11500	143	8	have	have	AUX
can-11500	143	9	displayed	display	VERB
can-11500	143	10	cell	cell	NOUN
can-11500	143	11	type	type	NOUN
can-11500	143	12	-	-	PUNCT
can-11500	143	13	dependent	dependent	ADJ
can-11500	143	14	transfection	transfection	NOUN
can-11500	143	15	efficiency	efficiency	NOUN
can-11500	143	16	,	,	PUNCT
can-11500	143	17	with	with	ADP
can-11500	143	18	higher	high	ADJ
can-11500	143	19	efficiency	efficiency	NOUN
can-11500	143	20	observed	observe	VERB
can-11500	143	21	in	in	ADP
can-11500	143	22	hek293	hek293	PROPN
can-11500	143	23	cells	cell	NOUN
can-11500	143	24	compared	compare	VERB
can-11500	143	25	to	to	ADP
can-11500	143	26	other	other	ADJ
can-11500	143	27	cell	cell	NOUN
can-11500	143	28	types	type	NOUN
can-11500	143	29	,	,	PUNCT
can-11500	143	30	such	such	ADJ
can-11500	143	31	as	as	ADP
can-11500	143	32	mg63	mg63	PROPN
can-11500	143	33	and	and	CCONJ
can-11500	143	34	mesenchymal	mesenchymal	NOUN
can-11500	143	35	stem	stem	NOUN
can-11500	143	36	cells	cell	NOUN
can-11500	143	37	[	[	X
can-11500	143	38	22,23	22,23	NOUN
can-11500	143	39	]	]	PUNCT
can-11500	143	40	.	.	PUNCT
can-11500	144	1	the	the	DET
can-11500	144	2	use	use	NOUN
can-11500	144	3	of	of	ADP
can-11500	144	4	lipochitoplexes	lipochitoplexe	NOUN
can-11500	144	5	—	—	PUNCT
can-11500	144	6	liposome	liposome	NOUN
can-11500	144	7	-	-	PUNCT
can-11500	144	8	encapsulated	encapsulate	VERB
can-11500	144	9	chitosan	chitosan	NOUN
can-11500	144	10	nanoparticles	nanoparticle	NOUN
can-11500	144	11	—	—	PUNCT
can-11500	144	12	has	have	AUX
can-11500	144	13	been	be	AUX
can-11500	144	14	shown	show	VERB
can-11500	144	15	to	to	PART
can-11500	144	16	increase	increase	VERB
can-11500	144	17	transfection	transfection	NOUN
can-11500	144	18	efficiency	efficiency	NOUN
can-11500	144	19	at	at	ADP
can-11500	144	20	least	least	ADJ
can-11500	144	21	twofold	twofold	ADV
can-11500	144	22	under	under	ADP
can-11500	144	23	physiological	physiological	ADJ
can-11500	144	24	conditions	condition	NOUN
can-11500	144	25	[	[	X
can-11500	144	26	24	24	NUM
can-11500	144	27	]	]	PUNCT
can-11500	144	28	.	.	PUNCT
can-11500	145	1	in	in	ADP
can-11500	145	2	the	the	DET
can-11500	145	3	mda	mda	PROPN
can-11500	145	4	-	-	PUNCT
can-11500	145	5	mb-231	mb-231	PROPN
can-11500	145	6	cell	cell	NOUN
can-11500	145	7	line	line	NOUN
can-11500	145	8	,	,	PUNCT
can-11500	145	9	as	as	SCONJ
can-11500	145	10	illustrated	illustrate	VERB
can-11500	145	11	in	in	ADP
can-11500	145	12	figure	figure	NOUN
can-11500	145	13	9	9	NUM
can-11500	145	14	,	,	PUNCT
can-11500	145	15	the	the	DET
can-11500	145	16	transfer	transfer	NOUN
can-11500	145	17	of	of	ADP
can-11500	145	18	nanoparticles	nanoparticle	NOUN
can-11500	145	19	to	to	ADP
can-11500	145	20	the	the	DET
can-11500	145	21	cell	cell	NOUN
can-11500	145	22	membrane	membrane	NOUN
can-11500	145	23	and	and	CCONJ
can-11500	145	24	interior	interior	NOUN
can-11500	145	25	was	be	AUX
can-11500	145	26	confirmed	confirm	VERB
can-11500	145	27	.	.	PUNCT
can-11500	146	1	cytotoxicity	cytotoxicity	NOUN
can-11500	146	2	analysis	analysis	NOUN
can-11500	146	3	was	be	AUX
can-11500	146	4	conducted	conduct	VERB
can-11500	146	5	using	use	VERB
can-11500	146	6	the	the	DET
can-11500	146	7	xtt	xtt	PROPN
can-11500	146	8	assay	assay	PROPN
can-11500	146	9	kit	kit	PROPN
can-11500	146	10	.	.	PUNCT
can-11500	147	1	the	the	DET
can-11500	147	2	xtt	xtt	PROPN
can-11500	147	3	assay	assay	PROPN
can-11500	147	4	operates	operate	VERB
can-11500	147	5	on	on	ADP
can-11500	147	6	the	the	DET
can-11500	147	7	principle	principle	NOUN
can-11500	147	8	that	that	SCONJ
can-11500	147	9	the	the	DET
can-11500	147	10	yellow	yellow	ADJ
can-11500	147	11	tetrazolium	tetrazolium	NOUN
can-11500	147	12	salt	salt	NOUN
can-11500	147	13	is	be	AUX
can-11500	147	14	cleaved	cleave	VERB
can-11500	147	15	by	by	ADP
can-11500	147	16	the	the	DET
can-11500	147	17	metabolic	metabolic	NOUN
can-11500	147	18	activity	activity	NOUN
can-11500	147	19	of	of	ADP
can-11500	147	20	living	living	NOUN
can-11500	147	21	cells	cell	NOUN
can-11500	147	22	,	,	PUNCT
can-11500	147	23	producing	produce	VERB
can-11500	147	24	an	an	DET
can-11500	147	25	orange	orange	ADJ
can-11500	147	26	color	color	NOUN
can-11500	147	27	change	change	NOUN
can-11500	147	28	.	.	PUNCT
can-11500	148	1	chitosan	chitosan	NOUN
can-11500	148	2	-	-	PUNCT
can-11500	148	3	coated	coat	VERB
can-11500	148	4	mnps	mnps	NOUN
can-11500	148	5	,	,	PUNCT
can-11500	148	6	dexamethasone	dexamethasone	NOUN
can-11500	148	7	alone	alone	ADV
can-11500	148	8	,	,	PUNCT
can-11500	148	9	and	and	CCONJ
can-11500	148	10	dexamethasone	dexamethasone	NOUN
can-11500	148	11	-	-	PUNCT
can-11500	148	12	loaded	load	VERB
can-11500	148	13	mnps	mnps	NOUN
can-11500	148	14	were	be	AUX
can-11500	148	15	administered	administer	VERB
can-11500	148	16	in	in	ADP
can-11500	148	17	diluted	dilute	VERB
can-11500	148	18	form	form	NOUN
can-11500	148	19	.	.	PUNCT
can-11500	149	1	after	after	ADP
can-11500	149	2	72	72	NUM
can-11500	149	3	h	h	NOUN
can-11500	149	4	,	,	PUNCT
can-11500	149	5	readings	reading	NOUN
can-11500	149	6	were	be	AUX
can-11500	149	7	taken	take	VERB
can-11500	149	8	using	use	VERB
can-11500	149	9	the	the	DET
can-11500	149	10	elisa	elisa	NOUN
can-11500	149	11	reader	reader	NOUN
can-11500	149	12	(	(	PUNCT
can-11500	149	13	elx808	elx808	PROPN
can-11500	149	14	,	,	PUNCT
can-11500	149	15	biotek	biotek	NOUN
can-11500	149	16	,	,	PUNCT
can-11500	149	17	us	we	PRON
can-11500	149	18	)	)	PUNCT
can-11500	149	19	,	,	PUNCT
can-11500	149	20	and	and	CCONJ
can-11500	149	21	the	the	DET
can-11500	149	22	results	result	NOUN
can-11500	149	23	were	be	AUX
can-11500	149	24	analyzed	analyze	VERB
can-11500	149	25	to	to	PART
can-11500	149	26	determine	determine	VERB
can-11500	149	27	the	the	DET
can-11500	149	28	ic50	ic50	PROPN
can-11500	149	29	doses	dose	NOUN
can-11500	149	30	.	.	PUNCT
can-11500	150	1	the	the	DET
can-11500	150	2	xtt	xtt	PROPN
can-11500	150	3	cytotoxicity	cytotoxicity	NOUN
can-11500	150	4	analysis	analysis	NOUN
can-11500	150	5	revealed	reveal	VERB
can-11500	150	6	that	that	SCONJ
can-11500	150	7	chitosan	chitosan	NOUN
can-11500	150	8	-	-	PUNCT
can-11500	150	9	coated	coat	VERB
can-11500	150	10	mnps	mnps	PROPN
can-11500	150	11	exhibited	exhibit	VERB
can-11500	150	12	no	no	DET
can-11500	150	13	toxic	toxic	ADJ
can-11500	150	14	effects	effect	NOUN
can-11500	150	15	on	on	ADP
can-11500	150	16	cell	cell	NOUN
can-11500	150	17	viability	viability	NOUN
can-11500	150	18	.	.	PUNCT
can-11500	151	1	in	in	ADP
can-11500	151	2	contrast	contrast	NOUN
can-11500	151	3	,	,	PUNCT
can-11500	151	4	dexamethasone	dexamethasone	NOUN
can-11500	151	5	alone	alone	ADV
can-11500	151	6	was	be	AUX
can-11500	151	7	found	find	VERB
can-11500	151	8	to	to	PART
can-11500	151	9	reduce	reduce	VERB
can-11500	151	10	cell	cell	NOUN
can-11500	151	11	proliferation	proliferation	NOUN
can-11500	151	12	by	by	ADP
can-11500	151	13	approximately	approximately	ADV
can-11500	151	14	60	60	NUM
can-11500	151	15	%	%	NOUN
can-11500	151	16	.	.	PUNCT
can-11500	152	1	importantly	importantly	ADV
can-11500	152	2	,	,	PUNCT
can-11500	152	3	when	when	SCONJ
can-11500	152	4	dexamethasone	dexamethasone	NOUN
can-11500	152	5	was	be	AUX
can-11500	152	6	loaded	load	VERB
can-11500	152	7	onto	onto	ADP
can-11500	152	8	the	the	DET
can-11500	152	9	nanoparticles	nanoparticle	NOUN
can-11500	152	10	,	,	PUNCT
can-11500	152	11	its	its	PRON
can-11500	152	12	effectiveness	effectiveness	NOUN
can-11500	152	13	increased	increase	VERB
can-11500	152	14	,	,	PUNCT
can-11500	152	15	potentially	potentially	ADV
can-11500	152	16	due	due	ADP
can-11500	152	17	to	to	ADP
can-11500	152	18	the	the	DET
can-11500	152	19	controlled	control	VERB
can-11500	152	20	release	release	NOUN
can-11500	152	21	mechanism	mechanism	NOUN
can-11500	152	22	that	that	PRON
can-11500	152	23	more	more	ADV
can-11500	152	24	efficiently	efficiently	ADV
can-11500	152	25	inhibits	inhibit	VERB
can-11500	152	26	cell	cell	NOUN
can-11500	152	27	proliferation	proliferation	NOUN
can-11500	152	28	.	.	PUNCT
can-11500	153	1	these	these	DET
can-11500	153	2	findings	finding	NOUN
can-11500	153	3	suggest	suggest	VERB
can-11500	153	4	that	that	SCONJ
can-11500	153	5	chitosan	chitosan	NOUN
can-11500	153	6	-	-	PUNCT
can-11500	153	7	coated	coat	VERB
can-11500	153	8	mnps	mnps	NOUN
can-11500	153	9	are	be	AUX
can-11500	153	10	non	non	ADJ
can-11500	153	11	-	-	ADJ
can-11500	153	12	toxic	toxic	ADJ
can-11500	153	13	and	and	CCONJ
can-11500	153	14	,	,	PUNCT
can-11500	153	15	when	when	SCONJ
can-11500	153	16	combined	combine	VERB
can-11500	153	17	with	with	ADP
can-11500	153	18	dexamethasone	dexamethasone	NOUN
can-11500	153	19	,	,	PUNCT
can-11500	153	20	can	can	AUX
can-11500	153	21	act	act	VERB
can-11500	153	22	as	as	ADP
can-11500	153	23	a	a	DET
can-11500	153	24	more	more	ADV
can-11500	153	25	potent	potent	ADJ
can-11500	153	26	therapeutic	therapeutic	ADJ
can-11500	153	27	agent	agent	NOUN
can-11500	153	28	for	for	ADP
can-11500	153	29	targeting	target	VERB
can-11500	153	30	cancer	cancer	NOUN
can-11500	153	31	cells	cell	NOUN
can-11500	153	32	compared	compare	VERB
can-11500	153	33	to	to	ADP
can-11500	153	34	free	free	ADJ
can-11500	153	35	dexamethasone	dexamethasone	NOUN
can-11500	153	36	(	(	PUNCT
can-11500	153	37	figure	figure	NOUN
can-11500	153	38	10	10	NUM
can-11500	153	39	)	)	PUNCT
can-11500	153	40	.	.	PUNCT
can-11500	154	1	the	the	DET
can-11500	154	2	free	free	ADJ
can-11500	154	3	nanoparticles	nanoparticle	NOUN
can-11500	154	4	,	,	PUNCT
can-11500	154	5	free	free	ADJ
can-11500	154	6	drug	drug	NOUN
can-11500	154	7	,	,	PUNCT
can-11500	154	8	and	and	CCONJ
can-11500	154	9	drug	drug	NOUN
can-11500	154	10	-	-	PUNCT
can-11500	154	11	loaded	load	VERB
can-11500	154	12	nanoparticles	nanoparticle	NOUN
can-11500	154	13	were	be	AUX
can-11500	154	14	applied	apply	VERB
can-11500	154	15	to	to	ADP
can-11500	154	16	the	the	DET
can-11500	154	17	cells	cell	NOUN
can-11500	154	18	,	,	PUNCT
can-11500	154	19	and	and	CCONJ
can-11500	154	20	cytotoxicity	cytotoxicity	NOUN
can-11500	154	21	analysis	analysis	NOUN
can-11500	154	22	was	be	AUX
can-11500	154	23	performed	perform	VERB
can-11500	154	24	.	.	PUNCT
can-11500	155	1	according	accord	VERB
can-11500	155	2	to	to	ADP
can-11500	155	3	the	the	DET
can-11500	155	4	obtained	obtain	VERB
can-11500	155	5	results	result	NOUN
can-11500	155	6	,	,	PUNCT
can-11500	155	7	empty	empty	ADJ
can-11500	155	8	nanoparticles	nanoparticle	NOUN
can-11500	155	9	did	do	AUX
can-11500	155	10	not	not	PART
can-11500	155	11	show	show	VERB
can-11500	155	12	any	any	DET
can-11500	155	13	toxic	toxic	ADJ
can-11500	155	14	effect	effect	NOUN
can-11500	155	15	.	.	PUNCT
can-11500	156	1	while	while	SCONJ
can-11500	156	2	the	the	DET
can-11500	156	3	ic50	ic50	PROPN
can-11500	156	4	value	value	NOUN
can-11500	156	5	of	of	ADP
can-11500	156	6	the	the	DET
can-11500	156	7	free	free	ADJ
can-11500	156	8	drug	drug	NOUN
can-11500	156	9	was	be	AUX
can-11500	156	10	123	123	NUM
can-11500	156	11	µg	µg	NOUN
can-11500	156	12	/	/	SYM
can-11500	156	13	ml	ml	NOUN
can-11500	156	14	,	,	PUNCT
can-11500	156	15	the	the	DET
can-11500	156	16	ic50	ic50	PROPN
can-11500	156	17	value	value	NOUN
can-11500	156	18	of	of	ADP
can-11500	156	19	the	the	DET
can-11500	156	20	drug	drug	NOUN
can-11500	156	21	-	-	PUNCT
can-11500	156	22	loaded	load	VERB
can-11500	156	23	nanoparticles	nanoparticle	NOUN
can-11500	156	24	was	be	AUX
can-11500	156	25	63	63	NUM
can-11500	156	26	µg	µg	NOUN
can-11500	156	27	/	/	SYM
can-11500	156	28	ml	ml	NOUN
can-11500	156	29	.	.	NOUN
can-11500	156	30	characterization	characterization	NOUN
can-11500	156	31	and	and	CCONJ
can-11500	156	32	application	application	NOUN
can-11500	156	33	of	of	ADP
can-11500	156	34	nanomaterials	nanomaterial	NOUN
can-11500	156	35	2025	2025	NUM
can-11500	156	36	,	,	PUNCT
can-11500	156	37	8(3	8(3	NUM
can-11500	156	38	)	)	PUNCT
can-11500	156	39	,	,	PUNCT
can-11500	156	40	11500	11500	NUM
can-11500	156	41	.	.	PUNCT
can-11500	157	1	11	11	NUM
can-11500	157	2	figure	figure	NOUN
can-11500	157	3	10	10	NUM
can-11500	157	4	.	.	PUNCT
can-11500	157	5	cytotoxicity	cytotoxicity	NOUN
can-11500	157	6	analysis	analysis	NOUN
can-11500	157	7	of	of	ADP
can-11500	157	8	control	control	NOUN
can-11500	157	9	,	,	PUNCT
can-11500	157	10	free	free	ADJ
can-11500	157	11	nanoparticles	nanoparticle	NOUN
can-11500	157	12	,	,	PUNCT
can-11500	157	13	dexamethasone	dexamethasone	NOUN
can-11500	157	14	,	,	PUNCT
can-11500	157	15	and	and	CCONJ
can-11500	157	16	dexamethasone	dexamethasone	NOUN
can-11500	157	17	-	-	PUNCT
can-11500	157	18	loaded	load	VERB
can-11500	157	19	nanoparticles	nanoparticle	NOUN
can-11500	157	20	.	.	PUNCT
can-11500	158	1	note	note	NOUN
can-11500	158	2	:	:	PUNCT
can-11500	158	3	*	*	PUNCT
can-11500	158	4	p<0.05	p<0.05	NOUN
can-11500	158	5	,	,	PUNCT
can-11500	158	6	*	*	PUNCT
can-11500	158	7	*	*	PUNCT
can-11500	158	8	p<0.01	p<0.01	PROPN
can-11500	158	9	.	.	PUNCT
can-11500	159	1	the	the	DET
can-11500	159	2	migration	migration	NOUN
can-11500	159	3	assay	assay	NOUN
can-11500	159	4	showed	show	VERB
can-11500	159	5	that	that	SCONJ
can-11500	159	6	dexamethasone	dexamethasone	NOUN
can-11500	159	7	-	-	PUNCT
can-11500	159	8	loaded	load	VERB
can-11500	159	9	mnp	mnp	PROPN
can-11500	159	10	treatment	treatment	NOUN
can-11500	159	11	significantly	significantly	ADV
can-11500	159	12	suppressed	suppress	VERB
can-11500	159	13	cell	cell	NOUN
can-11500	159	14	migration	migration	NOUN
can-11500	159	15	(	(	PUNCT
can-11500	159	16	p<0.05	p<0.05	NOUN
can-11500	159	17	;	;	PUNCT
can-11500	159	18	figure	figure	NOUN
can-11500	159	19	11	11	NUM
can-11500	159	20	)	)	PUNCT
can-11500	159	21	.	.	PUNCT
can-11500	160	1	figure	figure	VERB
can-11500	160	2	11	11	NUM
can-11500	160	3	.	.	PUNCT
can-11500	161	1	the	the	DET
can-11500	161	2	results	result	NOUN
can-11500	161	3	of	of	ADP
can-11500	161	4	the	the	DET
can-11500	161	5	migration	migration	NOUN
can-11500	161	6	assay	assay	NOUN
can-11500	161	7	.	.	PUNCT
can-11500	162	1	note	note	NOUN
can-11500	162	2	:	:	PUNCT
can-11500	162	3	*	*	PUNCT
can-11500	162	4	p<0.05	p<0.05	NOUN
can-11500	162	5	.	.	PUNCT
can-11500	163	1	abbreviation	abbreviation	NOUN
can-11500	163	2	:	:	PUNCT
can-11500	163	3	dex	dex	NOUN
can-11500	163	4	-	-	PUNCT
can-11500	163	5	mnps	mnps	NOUN
can-11500	163	6	:	:	PUNCT
can-11500	163	7	dexamethasone	dexamethasone	NOUN
can-11500	163	8	-	-	PUNCT
can-11500	163	9	loaded	load	VERB
can-11500	163	10	magnetic	magnetic	ADJ
can-11500	163	11	nanoparticles	nanoparticle	NOUN
can-11500	163	12	.	.	PUNCT
can-11500	164	1	characterization	characterization	NOUN
can-11500	164	2	and	and	CCONJ
can-11500	164	3	application	application	NOUN
can-11500	164	4	of	of	ADP
can-11500	164	5	nanomaterials	nanomaterial	NOUN
can-11500	164	6	2025	2025	NUM
can-11500	164	7	,	,	PUNCT
can-11500	164	8	8(3	8(3	NUM
can-11500	164	9	)	)	PUNCT
can-11500	164	10	,	,	PUNCT
can-11500	164	11	11500	11500	NUM
can-11500	164	12	.	.	PUNCT
can-11500	165	1	12	12	NUM
can-11500	165	2	dexamethasone	dexamethasone	NOUN
can-11500	165	3	is	be	AUX
can-11500	165	4	known	know	VERB
can-11500	165	5	to	to	PART
can-11500	165	6	influence	influence	VERB
can-11500	165	7	the	the	DET
can-11500	165	8	tumor	tumor	NOUN
can-11500	165	9	microenvironment	microenvironment	NOUN
can-11500	165	10	by	by	ADP
can-11500	165	11	regulating	regulate	VERB
can-11500	165	12	blood	blood	NOUN
can-11500	165	13	vessels	vessel	NOUN
can-11500	165	14	and	and	CCONJ
can-11500	165	15	the	the	DET
can-11500	165	16	extracellular	extracellular	ADJ
can-11500	165	17	matrix	matrix	NOUN
can-11500	165	18	.	.	PUNCT
can-11500	166	1	these	these	DET
can-11500	166	2	regulations	regulation	NOUN
can-11500	166	3	reduce	reduce	VERB
can-11500	166	4	interstitial	interstitial	ADJ
can-11500	166	5	fluid	fluid	NOUN
can-11500	166	6	pressure	pressure	NOUN
can-11500	166	7	,	,	PUNCT
can-11500	166	8	tissue	tissue	NOUN
can-11500	166	9	stiffness	stiffness	NOUN
can-11500	166	10	,	,	PUNCT
can-11500	166	11	and	and	CCONJ
can-11500	166	12	solid	solid	ADJ
can-11500	166	13	stress	stress	NOUN
can-11500	166	14	,	,	PUNCT
can-11500	166	15	thereby	thereby	ADV
can-11500	166	16	enhancing	enhance	VERB
can-11500	166	17	the	the	DET
can-11500	166	18	penetration	penetration	NOUN
can-11500	166	19	of	of	ADP
can-11500	166	20	nanocarriers	nanocarrier	NOUN
can-11500	166	21	into	into	ADP
can-11500	166	22	tumors	tumor	NOUN
can-11500	166	23	.	.	PUNCT
can-11500	167	1	this	this	DET
can-11500	167	2	characteristic	characteristic	NOUN
can-11500	167	3	indicates	indicate	VERB
can-11500	167	4	that	that	SCONJ
can-11500	167	5	dexamethasone	dexamethasone	NOUN
can-11500	167	6	could	could	AUX
can-11500	167	7	improve	improve	VERB
can-11500	167	8	the	the	DET
can-11500	167	9	effectiveness	effectiveness	NOUN
can-11500	167	10	of	of	ADP
can-11500	167	11	metastatic	metastatic	ADJ
can-11500	167	12	breast	breast	NOUN
can-11500	167	13	cancer	cancer	NOUN
can-11500	167	14	treatment	treatment	NOUN
can-11500	167	15	[	[	X
can-11500	167	16	25	25	NUM
can-11500	167	17	]	]	PUNCT
can-11500	167	18	.	.	PUNCT
can-11500	168	1	however	however	ADV
can-11500	168	2	,	,	PUNCT
can-11500	168	3	its	its	PRON
can-11500	168	4	use	use	NOUN
can-11500	168	5	in	in	ADP
can-11500	168	6	brain	brain	NOUN
can-11500	168	7	tumors	tumor	NOUN
can-11500	168	8	,	,	PUNCT
can-11500	168	9	such	such	ADJ
can-11500	168	10	as	as	ADP
can-11500	168	11	glioblastoma	glioblastoma	NOUN
can-11500	168	12	,	,	PUNCT
can-11500	168	13	has	have	AUX
can-11500	168	14	been	be	AUX
can-11500	168	15	linked	link	VERB
can-11500	168	16	to	to	ADP
can-11500	168	17	poor	poor	ADJ
can-11500	168	18	outcomes	outcome	NOUN
can-11500	168	19	,	,	PUNCT
can-11500	168	20	as	as	SCONJ
can-11500	168	21	high	high	ADJ
can-11500	168	22	doses	dose	NOUN
can-11500	168	23	may	may	AUX
can-11500	168	24	cause	cause	VERB
can-11500	168	25	more	more	ADJ
can-11500	168	26	side	side	NOUN
can-11500	168	27	effects	effect	NOUN
can-11500	168	28	without	without	ADP
can-11500	168	29	improving	improve	VERB
can-11500	168	30	clinical	clinical	ADJ
can-11500	168	31	results	result	NOUN
can-11500	168	32	[	[	X
can-11500	168	33	26,27	26,27	NUM
can-11500	168	34	]	]	PUNCT
can-11500	168	35	.	.	PUNCT
can-11500	169	1	furthermore	furthermore	ADV
can-11500	169	2	,	,	PUNCT
can-11500	169	3	dexamethasone	dexamethasone	NOUN
can-11500	169	4	has	have	AUX
can-11500	169	5	been	be	AUX
can-11500	169	6	shown	show	VERB
can-11500	169	7	to	to	PART
can-11500	169	8	promote	promote	VERB
can-11500	169	9	metastatic	metastatic	ADJ
can-11500	169	10	behavior	behavior	NOUN
can-11500	169	11	in	in	ADP
can-11500	169	12	certain	certain	ADJ
can-11500	169	13	breast	breast	NOUN
can-11500	169	14	cancer	cancer	NOUN
can-11500	169	15	cell	cell	NOUN
can-11500	169	16	lines	line	NOUN
can-11500	169	17	,	,	PUNCT
can-11500	169	18	particularly	particularly	ADV
can-11500	169	19	estrogen	estrogen	NOUN
can-11500	169	20	receptor	receptor	NOUN
can-11500	169	21	-	-	PUNCT
can-11500	169	22	negative	negative	ADJ
can-11500	169	23	cells	cell	NOUN
can-11500	169	24	,	,	PUNCT
can-11500	169	25	by	by	ADP
can-11500	169	26	increasing	increase	VERB
can-11500	169	27	cell	cell	NOUN
can-11500	169	28	count	count	NOUN
can-11500	169	29	,	,	PUNCT
can-11500	169	30	invasiveness	invasiveness	ADJ
can-11500	169	31	,	,	PUNCT
can-11500	169	32	and	and	CCONJ
can-11500	169	33	migration	migration	NOUN
can-11500	169	34	[	[	X
can-11500	169	35	28	28	NUM
can-11500	169	36	]	]	PUNCT
can-11500	169	37	.	.	PUNCT
can-11500	170	1	it	it	PRON
can-11500	170	2	has	have	AUX
can-11500	170	3	also	also	ADV
can-11500	170	4	been	be	AUX
can-11500	170	5	found	find	VERB
can-11500	170	6	to	to	PART
can-11500	170	7	promote	promote	VERB
can-11500	170	8	lung	lung	NOUN
can-11500	170	9	metastasis	metastasis	NOUN
can-11500	170	10	[	[	X
can-11500	170	11	29,30	29,30	NUM
can-11500	170	12	]	]	PUNCT
can-11500	170	13	.	.	PUNCT
can-11500	171	1	in	in	ADP
can-11500	171	2	this	this	DET
can-11500	171	3	study	study	NOUN
can-11500	171	4	,	,	PUNCT
can-11500	171	5	dexamethasone	dexamethasone	NOUN
can-11500	171	6	was	be	AUX
can-11500	171	7	successfully	successfully	ADV
can-11500	171	8	attached	attach	VERB
can-11500	171	9	to	to	ADP
can-11500	171	10	chitosan	chitosan	NOUN
can-11500	171	11	-	-	PUNCT
can-11500	171	12	coated	coat	VERB
can-11500	171	13	mnps	mnps	NOUN
can-11500	171	14	,	,	PUNCT
can-11500	171	15	and	and	CCONJ
can-11500	171	16	the	the	DET
can-11500	171	17	mnps	mnps	PROPN
can-11500	171	18	demonstrated	demonstrate	VERB
can-11500	171	19	significant	significant	ADJ
can-11500	171	20	cytotoxic	cytotoxic	ADJ
can-11500	171	21	effects	effect	NOUN
can-11500	171	22	on	on	ADP
can-11500	171	23	breast	breast	NOUN
can-11500	171	24	cancer	cancer	NOUN
can-11500	171	25	cells	cell	NOUN
can-11500	171	26	(	(	PUNCT
can-11500	171	27	figure	figure	NOUN
can-11500	171	28	9	9	NUM
can-11500	171	29	)	)	PUNCT
can-11500	171	30	.	.	PUNCT
can-11500	172	1	these	these	DET
can-11500	172	2	results	result	NOUN
can-11500	172	3	highlight	highlight	VERB
can-11500	172	4	the	the	DET
can-11500	172	5	effectiveness	effectiveness	NOUN
can-11500	172	6	of	of	ADP
can-11500	172	7	mnps	mnps	PROPN
can-11500	172	8	as	as	ADP
can-11500	172	9	a	a	DET
can-11500	172	10	delivery	delivery	NOUN
can-11500	172	11	system	system	NOUN
can-11500	172	12	and	and	CCONJ
can-11500	172	13	their	their	PRON
can-11500	172	14	potential	potential	NOUN
can-11500	172	15	to	to	PART
can-11500	172	16	amplify	amplify	VERB
can-11500	172	17	the	the	DET
can-11500	172	18	biological	biological	ADJ
can-11500	172	19	impact	impact	NOUN
can-11500	172	20	of	of	ADP
can-11500	172	21	dexamethasone	dexamethasone	NOUN
can-11500	172	22	on	on	ADP
can-11500	172	23	target	target	NOUN
can-11500	172	24	cells	cell	NOUN
can-11500	172	25	.	.	PUNCT
can-11500	173	1	the	the	DET
can-11500	173	2	findings	finding	NOUN
can-11500	173	3	suggest	suggest	VERB
can-11500	173	4	that	that	SCONJ
can-11500	173	5	further	further	ADJ
can-11500	173	6	optimization	optimization	NOUN
can-11500	173	7	of	of	ADP
can-11500	173	8	the	the	DET
can-11500	173	9	surface	surface	NOUN
can-11500	173	10	modification	modification	NOUN
can-11500	173	11	and	and	CCONJ
can-11500	173	12	drug	drug	NOUN
can-11500	173	13	-	-	PUNCT
can-11500	173	14	loading	loading	NOUN
can-11500	173	15	capacity	capacity	NOUN
can-11500	173	16	of	of	ADP
can-11500	173	17	mnps	mnps	PROPN
can-11500	173	18	is	be	AUX
can-11500	173	19	possible	possible	ADJ
can-11500	173	20	.	.	PUNCT
can-11500	174	1	the	the	DET
can-11500	174	2	chitosan	chitosan	NOUN
can-11500	174	3	coating	coating	NOUN
can-11500	174	4	created	create	VERB
can-11500	174	5	a	a	DET
can-11500	174	6	biocompatible	biocompatible	ADJ
can-11500	174	7	environment	environment	NOUN
can-11500	174	8	for	for	ADP
can-11500	174	9	controlled	control	VERB
can-11500	174	10	drug	drug	NOUN
can-11500	174	11	release	release	NOUN
can-11500	174	12	,	,	PUNCT
can-11500	174	13	enabling	enable	VERB
can-11500	174	14	efficient	efficient	ADJ
can-11500	174	15	delivery	delivery	NOUN
can-11500	174	16	of	of	ADP
can-11500	174	17	dexamethasone	dexamethasone	NOUN
can-11500	174	18	to	to	PART
can-11500	174	19	target	target	VERB
can-11500	174	20	cells	cell	NOUN
can-11500	174	21	(	(	PUNCT
can-11500	174	22	figure	figure	NOUN
can-11500	174	23	7	7	NUM
can-11500	174	24	)	)	PUNCT
can-11500	174	25	.	.	PUNCT
can-11500	175	1	moreover	moreover	ADV
can-11500	175	2	,	,	PUNCT
can-11500	175	3	the	the	DET
can-11500	175	4	magnetic	magnetic	ADJ
can-11500	175	5	properties	property	NOUN
can-11500	175	6	of	of	ADP
can-11500	175	7	the	the	DET
can-11500	175	8	nanoparticles	nanoparticle	NOUN
can-11500	175	9	provide	provide	VERB
can-11500	175	10	a	a	DET
can-11500	175	11	promising	promising	ADJ
can-11500	175	12	method	method	NOUN
can-11500	175	13	for	for	ADP
can-11500	175	14	targeted	target	VERB
can-11500	175	15	drug	drug	NOUN
can-11500	175	16	delivery	delivery	NOUN
can-11500	175	17	using	use	VERB
can-11500	175	18	external	external	ADJ
can-11500	175	19	magnetic	magnetic	ADJ
can-11500	175	20	fields	field	NOUN
can-11500	175	21	.	.	PUNCT
can-11500	176	1	however	however	ADV
can-11500	176	2	,	,	PUNCT
can-11500	176	3	this	this	DET
can-11500	176	4	study	study	NOUN
can-11500	176	5	is	be	AUX
can-11500	176	6	preliminary	preliminary	ADJ
can-11500	176	7	,	,	PUNCT
can-11500	176	8	and	and	CCONJ
can-11500	176	9	additional	additional	ADJ
can-11500	176	10	validation	validation	NOUN
can-11500	176	11	of	of	ADP
can-11500	176	12	the	the	DET
can-11500	176	13	data	data	NOUN
can-11500	176	14	is	be	AUX
can-11500	176	15	necessary	necessary	ADJ
can-11500	176	16	.	.	PUNCT
can-11500	177	1	key	key	ADJ
can-11500	177	2	factors	factor	NOUN
can-11500	177	3	such	such	ADJ
can-11500	177	4	as	as	ADP
can-11500	177	5	drug	drug	NOUN
can-11500	177	6	-	-	PUNCT
can-11500	177	7	loading	loading	NOUN
can-11500	177	8	capacity	capacity	NOUN
can-11500	177	9	,	,	PUNCT
can-11500	177	10	release	release	NOUN
can-11500	177	11	kinetics	kinetic	NOUN
can-11500	177	12	,	,	PUNCT
can-11500	177	13	bioavailability	bioavailability	NOUN
can-11500	177	14	,	,	PUNCT
can-11500	177	15	and	and	CCONJ
can-11500	177	16	targeting	target	VERB
can-11500	177	17	efficiency	efficiency	NOUN
can-11500	177	18	need	need	VERB
can-11500	177	19	to	to	PART
can-11500	177	20	be	be	AUX
can-11500	177	21	thoroughly	thoroughly	ADV
can-11500	177	22	examined	examine	VERB
can-11500	177	23	.	.	PUNCT
can-11500	178	1	in	in	ADP
can-11500	178	2	vivo	vivo	ADJ
can-11500	178	3	studies	study	NOUN
can-11500	178	4	are	be	AUX
can-11500	178	5	also	also	ADV
can-11500	178	6	essential	essential	ADJ
can-11500	178	7	to	to	PART
can-11500	178	8	draw	draw	VERB
can-11500	178	9	more	more	ADV
can-11500	178	10	definitive	definitive	ADJ
can-11500	178	11	conclusions	conclusion	NOUN
can-11500	178	12	about	about	ADP
can-11500	178	13	the	the	DET
can-11500	178	14	safety	safety	NOUN
can-11500	178	15	and	and	CCONJ
can-11500	178	16	efficacy	efficacy	NOUN
can-11500	178	17	of	of	ADP
can-11500	178	18	this	this	DET
can-11500	178	19	system	system	NOUN
can-11500	178	20	.	.	PUNCT
can-11500	179	1	future	future	ADJ
can-11500	179	2	research	research	NOUN
can-11500	179	3	should	should	AUX
can-11500	179	4	focus	focus	VERB
can-11500	179	5	on	on	ADP
can-11500	179	6	assessing	assess	VERB
can-11500	179	7	the	the	DET
can-11500	179	8	biological	biological	ADJ
can-11500	179	9	safety	safety	NOUN
can-11500	179	10	and	and	CCONJ
can-11500	179	11	pharmacokinetic	pharmacokinetic	ADJ
can-11500	179	12	properties	property	NOUN
can-11500	179	13	of	of	ADP
can-11500	179	14	the	the	DET
can-11500	179	15	system	system	NOUN
can-11500	179	16	,	,	PUNCT
can-11500	179	17	as	as	ADV
can-11500	179	18	well	well	ADV
can-11500	179	19	as	as	ADP
can-11500	179	20	testing	test	VERB
can-11500	179	21	its	its	PRON
can-11500	179	22	effectiveness	effectiveness	NOUN
can-11500	179	23	across	across	ADP
can-11500	179	24	various	various	ADJ
can-11500	179	25	cancer	cancer	NOUN
can-11500	179	26	types	type	NOUN
can-11500	179	27	and	and	CCONJ
can-11500	179	28	larger	large	ADJ
can-11500	179	29	cell	cell	NOUN
can-11500	179	30	populations	population	NOUN
can-11500	179	31	.	.	PUNCT
can-11500	180	1	such	such	ADJ
can-11500	180	2	data	datum	NOUN
can-11500	180	3	are	be	AUX
can-11500	180	4	crucial	crucial	ADJ
can-11500	180	5	for	for	ADP
can-11500	180	6	evaluating	evaluate	VERB
can-11500	180	7	the	the	DET
can-11500	180	8	clinical	clinical	ADJ
can-11500	180	9	potential	potential	NOUN
can-11500	180	10	of	of	ADP
can-11500	180	11	nanoparticle	nanoparticle	NOUN
can-11500	180	12	-	-	PUNCT
can-11500	180	13	based	base	VERB
can-11500	180	14	drug	drug	NOUN
can-11500	180	15	delivery	delivery	NOUN
can-11500	180	16	systems	system	NOUN
can-11500	180	17	.	.	PUNCT
can-11500	181	1	4	4	X
can-11500	181	2	.	.	X
can-11500	181	3	conclusion	conclusion	NOUN
can-11500	181	4	in	in	ADP
can-11500	181	5	conclusion	conclusion	NOUN
can-11500	181	6	,	,	PUNCT
can-11500	181	7	the	the	DET
can-11500	181	8	dexamethasone	dexamethasone	NOUN
can-11500	181	9	-	-	PUNCT
can-11500	181	10	loaded	load	VERB
can-11500	181	11	mnp	mnp	NOUN
can-11500	181	12	system	system	NOUN
can-11500	181	13	developed	develop	VERB
can-11500	181	14	in	in	ADP
can-11500	181	15	this	this	DET
can-11500	181	16	study	study	NOUN
can-11500	181	17	represents	represent	VERB
can-11500	181	18	an	an	DET
can-11500	181	19	innovative	innovative	ADJ
can-11500	181	20	approach	approach	NOUN
can-11500	181	21	to	to	ADP
can-11500	181	22	drug	drug	NOUN
can-11500	181	23	delivery	delivery	NOUN
can-11500	181	24	and	and	CCONJ
can-11500	181	25	targeting	targeting	NOUN
can-11500	181	26	,	,	PUNCT
can-11500	181	27	with	with	ADP
can-11500	181	28	the	the	DET
can-11500	181	29	potential	potential	NOUN
can-11500	181	30	to	to	PART
can-11500	181	31	become	become	VERB
can-11500	181	32	a	a	DET
can-11500	181	33	patentable	patentable	ADJ
can-11500	181	34	technology	technology	NOUN
can-11500	181	35	in	in	ADP
can-11500	181	36	the	the	DET
can-11500	181	37	future	future	NOUN
can-11500	181	38	.	.	PUNCT
can-11500	182	1	author	author	NOUN
can-11500	182	2	contributions	contribution	NOUN
can-11500	182	3	:	:	PUNCT
can-11500	182	4	conceptualization	conceptualization	NOUN
can-11500	182	5	,	,	PUNCT
can-11500	182	6	dsp	dsp	NOUN
can-11500	182	7	,	,	PUNCT
can-11500	182	8	da	da	PROPN
can-11500	182	9	,	,	PUNCT
can-11500	182	10	dad	dad	NOUN
can-11500	182	11	,	,	PUNCT
can-11500	182	12	ea	ea	X
can-11500	182	13	,	,	PUNCT
can-11500	182	14	fb	fb	INTJ
can-11500	182	15	,	,	PUNCT
can-11500	182	16	gy	gy	NOUN
can-11500	182	17	,	,	PUNCT
can-11500	182	18	heb	heb	NOUN
can-11500	182	19	,	,	PUNCT
can-11500	182	20	mao	mao	PROPN
can-11500	182	21	,	,	PUNCT
can-11500	182	22	mb	mb	PROPN
can-11500	182	23	,	,	PUNCT
can-11500	182	24	mfy	mfy	PROPN
can-11500	182	25	,	,	PUNCT
can-11500	182	26	sb	sb	PROPN
can-11500	182	27	,	,	PUNCT
can-11500	182	28	snb	snb	PROPN
can-11500	182	29	,	,	PUNCT
can-11500	182	30	fbc	fbc	PROPN
can-11500	182	31	,	,	PUNCT
can-11500	182	32	sya	sya	PROPN
can-11500	182	33	;	;	PUNCT
can-11500	182	34	formal	formal	ADJ
can-11500	182	35	analysis	analysis	NOUN
can-11500	182	36	,	,	PUNCT
can-11500	182	37	sya	sya	PROPN
can-11500	182	38	;	;	PUNCT
can-11500	182	39	investigation	investigation	NOUN
can-11500	182	40	,	,	PUNCT
can-11500	182	41	dsp	dsp	PROPN
can-11500	182	42	,	,	PUNCT
can-11500	182	43	da	da	PROPN
can-11500	182	44	,	,	PUNCT
can-11500	182	45	dad	dad	NOUN
can-11500	182	46	,	,	PUNCT
can-11500	182	47	ea	ea	X
can-11500	182	48	,	,	PUNCT
can-11500	182	49	fb	fb	INTJ
can-11500	182	50	,	,	PUNCT
can-11500	182	51	gy	gy	NOUN
can-11500	182	52	,	,	PUNCT
can-11500	182	53	heb	heb	NOUN
can-11500	182	54	,	,	PUNCT
can-11500	182	55	mao	mao	PROPN
can-11500	182	56	,	,	PUNCT
can-11500	182	57	mb	mb	PROPN
can-11500	182	58	,	,	PUNCT
can-11500	182	59	mfy	mfy	PROPN
can-11500	182	60	,	,	PUNCT
can-11500	182	61	sb	sb	PROPN
can-11500	182	62	,	,	PUNCT
can-11500	182	63	snb	snb	PROPN
can-11500	182	64	,	,	PUNCT
can-11500	182	65	fbc	fbc	PROPN
can-11500	182	66	,	,	PUNCT
can-11500	182	67	sya	sya	PROPN
can-11500	182	68	;	;	PUNCT
can-11500	182	69	methodology	methodology	PROPN
can-11500	182	70	,	,	PUNCT
can-11500	182	71	sya	sya	PROPN
can-11500	182	72	;	;	PUNCT
can-11500	182	73	visualization	visualization	NOUN
can-11500	182	74	,	,	PUNCT
can-11500	182	75	fbc	fbc	PROPN
can-11500	182	76	;	;	PUNCT
can-11500	182	77	writing	write	VERB
can-11500	182	78	–	–	PUNCT
can-11500	182	79	original	original	ADJ
can-11500	182	80	draft	draft	NOUN
can-11500	182	81	,	,	PUNCT
can-11500	182	82	sya	sya	PROPN
can-11500	182	83	;	;	PUNCT
can-11500	182	84	writing	writing	NOUN
can-11500	182	85	–	–	PUNCT
can-11500	182	86	review	review	NOUN
can-11500	182	87	and	and	CCONJ
can-11500	182	88	editing	editing	NOUN
can-11500	182	89	,	,	PUNCT
can-11500	182	90	fbc	fbc	PROPN
can-11500	182	91	,	,	PUNCT
can-11500	182	92	sya	sya	PROPN
can-11500	182	93	.	.	PUNCT
can-11500	183	1	all	all	DET
can-11500	183	2	authors	author	NOUN
can-11500	183	3	have	have	AUX
can-11500	183	4	read	read	VERB
can-11500	183	5	and	and	CCONJ
can-11500	183	6	agreed	agree	VERB
can-11500	183	7	to	to	ADP
can-11500	183	8	the	the	DET
can-11500	183	9	published	publish	VERB
can-11500	183	10	version	version	NOUN
can-11500	183	11	of	of	ADP
can-11500	183	12	the	the	DET
can-11500	183	13	manuscript	manuscript	NOUN
can-11500	183	14	.	.	PUNCT
can-11500	184	1	conflict	conflict	NOUN
can-11500	184	2	of	of	ADP
can-11500	184	3	interest	interest	NOUN
can-11500	184	4	:	:	PUNCT
can-11500	184	5	the	the	DET
can-11500	184	6	authors	author	NOUN
can-11500	184	7	declare	declare	VERB
can-11500	184	8	no	no	DET
can-11500	184	9	conflict	conflict	NOUN
can-11500	184	10	of	of	ADP
can-11500	184	11	interest	interest	NOUN
can-11500	184	12	.	.	PUNCT
can-11500	185	1	data	datum	NOUN
can-11500	185	2	availability	availability	NOUN
can-11500	185	3	statement	statement	NOUN
can-11500	185	4	:	:	PUNCT
can-11500	185	5	the	the	DET
can-11500	185	6	data	datum	NOUN
can-11500	185	7	that	that	PRON
can-11500	185	8	support	support	VERB
can-11500	185	9	the	the	DET
can-11500	185	10	findings	finding	NOUN
can-11500	185	11	of	of	ADP
can-11500	185	12	this	this	DET
can-11500	185	13	study	study	NOUN
can-11500	185	14	are	be	AUX
can-11500	185	15	available	available	ADJ
can-11500	185	16	from	from	ADP
can-11500	185	17	the	the	DET
can-11500	185	18	corresponding	corresponding	ADJ
can-11500	185	19	author	author	NOUN
can-11500	185	20	upon	upon	SCONJ
can-11500	185	21	reasonable	reasonable	ADJ
can-11500	185	22	request	request	NOUN
can-11500	185	23	.	.	PUNCT
can-11500	186	1	characterization	characterization	NOUN
can-11500	186	2	and	and	CCONJ
can-11500	186	3	application	application	NOUN
can-11500	186	4	of	of	ADP
can-11500	186	5	nanomaterials	nanomaterial	NOUN
can-11500	186	6	2025	2025	NUM
can-11500	186	7	,	,	PUNCT
can-11500	186	8	8(3	8(3	NUM
can-11500	186	9	)	)	PUNCT
can-11500	186	10	,	,	PUNCT
can-11500	186	11	11500	11500	NUM
can-11500	186	12	.	.	PUNCT
can-11500	187	1	13	13	NUM
can-11500	187	2	references	reference	NOUN
can-11500	187	3	1	1	NUM
can-11500	187	4	.	.	NOUN
can-11500	187	5	harbeck	harbeck	PROPN
can-11500	187	6	n	n	SYM
can-11500	187	7	,	,	PUNCT
can-11500	187	8	penault	penault	ADJ
can-11500	187	9	-	-	PUNCT
can-11500	187	10	llorca	llorca	NOUN
can-11500	187	11	f	f	NOUN
can-11500	187	12	,	,	PUNCT
can-11500	187	13	cortes	corte	VERB
can-11500	187	14	j	j	PROPN
can-11500	187	15	,	,	PUNCT
can-11500	187	16	et	et	PROPN
can-11500	187	17	al	al	PROPN
can-11500	187	18	.	.	PUNCT
can-11500	187	19	breast	breast	NOUN
can-11500	187	20	cancer	cancer	NOUN
can-11500	187	21	.	.	PUNCT
can-11500	188	1	nature	nature	NOUN
can-11500	188	2	reviews	review	NOUN
can-11500	188	3	disease	disease	NOUN
can-11500	188	4	primers	primer	NOUN
can-11500	188	5	.	.	PUNCT
can-11500	189	1	2019	2019	NUM
can-11500	189	2	;	;	PUNCT
can-11500	189	3	5(1	5(1	NUM
can-11500	189	4	)	)	PUNCT
can-11500	189	5	.	.	PUNCT
can-11500	190	1	doi	doi	NOUN
can-11500	190	2	:	:	PUNCT
can-11500	190	3	10.1038	10.1038	NUM
can-11500	190	4	/	/	SYM
can-11500	190	5	s41572019	s41572019	PROPN
can-11500	190	6	-	-	PUNCT
can-11500	190	7	0111	0111	NUM
can-11500	190	8	-	-	SYM
can-11500	190	9	2	2	NUM
can-11500	190	10	2	2	NUM
can-11500	190	11	.	.	NOUN
can-11500	190	12	harbeck	harbeck	PROPN
can-11500	190	13	n	n	PROPN
can-11500	190	14	,	,	PUNCT
can-11500	190	15	gnant	gnant	PROPN
can-11500	190	16	m.	m.	NOUN
can-11500	190	17	breast	breast	NOUN
can-11500	190	18	cancer	cancer	NOUN
can-11500	190	19	.	.	PUNCT
can-11500	191	1	lancet	lancet	PROPN
can-11500	191	2	.	.	PUNCT
can-11500	192	1	2017;389(10074):1134	2017;389(10074):1134	NUM
can-11500	192	2	-	-	SYM
can-11500	192	3	1150	1150	NUM
can-11500	192	4	.	.	PUNCT
can-11500	193	1	doi:10.1016	doi:10.1016	PROPN
can-11500	193	2	/	/	SYM
can-11500	193	3	s0140	s0140	PROPN
can-11500	193	4	-	-	PUNCT
can-11500	193	5	6736(16)31891	6736(16)31891	NUM
can-11500	193	6	-	-	SYM
can-11500	193	7	8	8	NUM
can-11500	193	8	3	3	NUM
can-11500	193	9	.	.	PUNCT
can-11500	194	1	hong	hong	PROPN
can-11500	194	2	r	r	PROPN
can-11500	194	3	,	,	PUNCT
can-11500	194	4	xu	xu	PROPN
can-11500	194	5	b.	b.	PROPN
can-11500	194	6	breast	breast	PROPN
can-11500	194	7	cancer	cancer	NOUN
can-11500	194	8	:	:	PUNCT
can-11500	194	9	an	an	DET
can-11500	194	10	up‐to‐date	up‐to‐date	ADJ
can-11500	194	11	review	review	NOUN
can-11500	194	12	and	and	CCONJ
can-11500	194	13	future	future	ADJ
can-11500	194	14	perspectives	perspective	NOUN
can-11500	194	15	.	.	PUNCT
can-11500	195	1	cancer	cancer	NOUN
can-11500	195	2	communications	communication	NOUN
can-11500	195	3	.	.	PUNCT
can-11500	196	1	2022	2022	NUM
can-11500	196	2	;	;	PUNCT
can-11500	196	3	42(10	42(10	NUM
can-11500	196	4	):	):	PUNCT
can-11500	196	5	913936	913936	NUM
can-11500	196	6	.	.	PUNCT
can-11500	197	1	doi	doi	NOUN
can-11500	197	2	:	:	PUNCT
can-11500	197	3	10.1002	10.1002	NUM
can-11500	197	4	/	/	SYM
can-11500	197	5	cac2.12358	cac2.12358	PRON
can-11500	197	6	4	4	NUM
can-11500	197	7	.	.	PUNCT
can-11500	198	1	feng	feng	PROPN
can-11500	198	2	y	y	PROPN
can-11500	198	3	,	,	PUNCT
can-11500	198	4	spezia	spezia	VERB
can-11500	198	5	m	m	PROPN
can-11500	198	6	,	,	PUNCT
can-11500	198	7	huang	huang	PROPN
can-11500	198	8	s	s	PROPN
can-11500	198	9	,	,	PUNCT
can-11500	198	10	et	et	PROPN
can-11500	198	11	al	al	PROPN
can-11500	198	12	.	.	PUNCT
can-11500	198	13	breast	breast	NOUN
can-11500	198	14	cancer	cancer	NOUN
can-11500	198	15	development	development	NOUN
can-11500	198	16	and	and	CCONJ
can-11500	198	17	progression	progression	NOUN
can-11500	198	18	:	:	PUNCT
can-11500	198	19	risk	risk	NOUN
can-11500	198	20	factors	factor	NOUN
can-11500	198	21	,	,	PUNCT
can-11500	198	22	cancer	cancer	NOUN
can-11500	198	23	stem	stem	NOUN
can-11500	198	24	cells	cell	NOUN
can-11500	198	25	,	,	PUNCT
can-11500	198	26	signaling	signal	VERB
can-11500	198	27	pathways	pathway	NOUN
can-11500	198	28	,	,	PUNCT
can-11500	198	29	genomics	genomic	NOUN
can-11500	198	30	,	,	PUNCT
can-11500	198	31	and	and	CCONJ
can-11500	198	32	molecular	molecular	ADJ
can-11500	198	33	pathogenesis	pathogenesis	NOUN
can-11500	198	34	.	.	PUNCT
can-11500	199	1	genes	gene	NOUN
can-11500	199	2	&	&	CCONJ
can-11500	199	3	diseases	disease	NOUN
can-11500	199	4	.	.	PUNCT
can-11500	199	5	2018	2018	NUM
can-11500	199	6	;	;	PUNCT
can-11500	199	7	5(2	5(2	NUM
can-11500	199	8	):	):	PUNCT
can-11500	199	9	77	77	NUM
can-11500	199	10	-	-	SYM
can-11500	199	11	106	106	NUM
can-11500	199	12	.	.	PUNCT
can-11500	200	1	doi	doi	NOUN
can-11500	200	2	:	:	PUNCT
can-11500	200	3	10.1016	10.1016	NUM
can-11500	200	4	/	/	SYM
can-11500	200	5	j.gendis.2018.05.001	j.gendis.2018.05.001	PROPN
can-11500	200	6	5	5	NUM
can-11500	200	7	.	.	PUNCT
can-11500	201	1	loibl	loibl	PROPN
can-11500	201	2	s	s	PROPN
can-11500	201	3	,	,	PUNCT
can-11500	201	4	poortmans	poortman	NOUN
can-11500	201	5	p	p	X
can-11500	201	6	,	,	PUNCT
can-11500	201	7	morrow	morrow	PROPN
can-11500	201	8	m	m	PROPN
can-11500	201	9	,	,	PUNCT
can-11500	201	10	denkert	denkert	PROPN
can-11500	201	11	c	c	NOUN
can-11500	201	12	,	,	PUNCT
can-11500	201	13	curigliano	curigliano	PROPN
can-11500	201	14	g.	g.	PROPN
can-11500	201	15	breast	breast	NOUN
can-11500	201	16	cancer	cancer	NOUN
can-11500	201	17	.	.	PUNCT
can-11500	202	1	lancet	lancet	PROPN
can-11500	202	2	.	.	PUNCT
can-11500	203	1	2021;397(10286):1750	2021;397(10286):1750	NUM
can-11500	203	2	-	-	PUNCT
can-11500	203	3	1769	1769	NUM
can-11500	203	4	.	.	PUNCT
can-11500	204	1	doi:10.1016	doi:10.1016	PROPN
can-11500	204	2	/	/	SYM
can-11500	204	3	s0140	s0140	PROPN
can-11500	204	4	-	-	PUNCT
can-11500	204	5	6736(20)32381	6736(20)32381	NUM
can-11500	204	6	-	-	PUNCT
can-11500	204	7	3	3	NUM
can-11500	204	8	6	6	NUM
can-11500	204	9	.	.	PUNCT
can-11500	205	1	akram	akram	PROPN
can-11500	205	2	m	m	PROPN
can-11500	205	3	,	,	PUNCT
can-11500	205	4	iqbal	iqbal	PROPN
can-11500	205	5	m	m	PROPN
can-11500	205	6	,	,	PUNCT
can-11500	205	7	daniyal	daniyal	PROPN
can-11500	205	8	m	m	PROPN
can-11500	205	9	,	,	PUNCT
can-11500	205	10	et	et	PROPN
can-11500	205	11	al	al	PROPN
can-11500	205	12	.	.	PUNCT
can-11500	205	13	awareness	awareness	NOUN
can-11500	205	14	and	and	CCONJ
can-11500	205	15	current	current	ADJ
can-11500	205	16	knowledge	knowledge	NOUN
can-11500	205	17	of	of	ADP
can-11500	205	18	breast	breast	NOUN
can-11500	205	19	cancer	cancer	NOUN
can-11500	205	20	.	.	PUNCT
can-11500	206	1	biological	biological	ADJ
can-11500	206	2	research	research	NOUN
can-11500	206	3	.	.	PUNCT
can-11500	207	1	2017	2017	NUM
can-11500	207	2	;	;	PUNCT
can-11500	207	3	50(1	50(1	NUM
can-11500	207	4	)	)	PUNCT
can-11500	207	5	.	.	PUNCT
can-11500	208	1	doi	doi	NOUN
can-11500	208	2	:	:	PUNCT
can-11500	208	3	10.1186	10.1186	NUM
can-11500	208	4	/	/	SYM
can-11500	208	5	s40659	s40659	PROPN
can-11500	208	6	-	-	PUNCT
can-11500	208	7	017	017	NUM
can-11500	208	8	-	-	PUNCT
can-11500	208	9	0140	0140	NUM
can-11500	208	10	-	-	SYM
can-11500	208	11	9	9	NUM
can-11500	208	12	7	7	NUM
can-11500	208	13	.	.	PUNCT
can-11500	208	14	mcdonald	mcdonald	PROPN
can-11500	208	15	es	es	PROPN
can-11500	208	16	,	,	PUNCT
can-11500	208	17	clark	clark	NOUN
can-11500	208	18	as	as	ADP
can-11500	208	19	,	,	PUNCT
can-11500	208	20	tchou	tchou	PROPN
can-11500	208	21	j	j	PROPN
can-11500	208	22	,	,	PUNCT
can-11500	208	23	et	et	PROPN
can-11500	208	24	al	al	PROPN
can-11500	208	25	.	.	PROPN
can-11500	209	1	clinical	clinical	ADJ
can-11500	209	2	diagnosis	diagnosis	NOUN
can-11500	209	3	and	and	CCONJ
can-11500	209	4	management	management	NOUN
can-11500	209	5	of	of	ADP
can-11500	209	6	breast	breast	NOUN
can-11500	209	7	cancer	cancer	NOUN
can-11500	209	8	.	.	PUNCT
can-11500	210	1	journal	journal	NOUN
can-11500	210	2	of	of	ADP
can-11500	210	3	nuclear	nuclear	ADJ
can-11500	210	4	medicine	medicine	NOUN
can-11500	210	5	.	.	PUNCT
can-11500	211	1	2016	2016	NUM
can-11500	211	2	;	;	PUNCT
can-11500	211	3	57(supplement	57(supplement	NUM
can-11500	211	4	1	1	NUM
can-11500	211	5	):	):	PUNCT
can-11500	211	6	9s-16s	9s-16s	X
can-11500	211	7	.	.	PUNCT
can-11500	211	8	doi	doi	NOUN
can-11500	211	9	:	:	PUNCT
can-11500	211	10	10.2967	10.2967	NUM
can-11500	211	11	/	/	SYM
can-11500	211	12	jnumed.115.157834	jnumed.115.157834	NOUN
can-11500	211	13	8	8	NUM
can-11500	211	14	.	.	PUNCT
can-11500	212	1	huang	huang	PROPN
can-11500	212	2	z	z	PROPN
can-11500	212	3	,	,	PUNCT
can-11500	212	4	yu	yu	PROPN
can-11500	212	5	p	p	PROPN
can-11500	212	6	,	,	PUNCT
can-11500	212	7	tang	tang	NOUN
can-11500	212	8	j.	j.	PROPN
can-11500	212	9	characterization	characterization	NOUN
can-11500	212	10	of	of	ADP
can-11500	212	11	triple	triple	ADJ
can-11500	212	12	-	-	PUNCT
can-11500	212	13	negative	negative	ADJ
can-11500	212	14	breast	breast	NOUN
can-11500	212	15	cancer	cancer	NOUN
can-11500	212	16	mda	mda	PROPN
can-11500	212	17	-	-	PUNCT
can-11500	212	18	mb-231	mb-231	PROPN
can-11500	212	19	cell	cell	NOUN
can-11500	212	20	spheroid	spheroid	NOUN
can-11500	212	21	model	model	NOUN
can-11500	212	22	oncotargets	oncotarget	NOUN
can-11500	212	23	and	and	CCONJ
can-11500	212	24	therapy	therapy	NOUN
can-11500	212	25	.	.	PUNCT
can-11500	213	1	2020	2020	NUM
can-11500	213	2	;	;	PUNCT
can-11500	213	3	13	13	NUM
can-11500	213	4	:	:	SYM
can-11500	213	5	5395	5395	NUM
can-11500	213	6	-	-	SYM
can-11500	213	7	5405	5405	NUM
can-11500	213	8	.	.	PUNCT
can-11500	214	1	doi	doi	NOUN
can-11500	214	2	:	:	PUNCT
can-11500	214	3	10.2147	10.2147	NUM
can-11500	214	4	/	/	SYM
can-11500	214	5	ott.s249756	ott.s249756	NOUN
can-11500	214	6	9	9	NUM
can-11500	214	7	.	.	PUNCT
can-11500	215	1	smolarz	smolarz	PROPN
can-11500	215	2	b	b	PROPN
can-11500	215	3	,	,	PUNCT
can-11500	215	4	nowak	nowak	PROPN
can-11500	215	5	az	az	PROPN
can-11500	215	6	,	,	PUNCT
can-11500	215	7	romanowicz	romanowicz	PROPN
can-11500	215	8	h.	h.	PROPN
can-11500	215	9	breast	breast	NOUN
can-11500	215	10	cancer	cancer	NOUN
can-11500	215	11	—	—	PUNCT
can-11500	215	12	epidemiology	epidemiology	NOUN
can-11500	215	13	,	,	PUNCT
can-11500	215	14	classification	classification	NOUN
can-11500	215	15	,	,	PUNCT
can-11500	215	16	pathogenesis	pathogenesis	NOUN
can-11500	215	17	and	and	CCONJ
can-11500	215	18	treatment	treatment	NOUN
can-11500	215	19	(	(	PUNCT
can-11500	215	20	review	review	NOUN
can-11500	215	21	of	of	ADP
can-11500	215	22	literature	literature	NOUN
can-11500	215	23	)	)	PUNCT
can-11500	215	24	.	.	PUNCT
can-11500	216	1	cancers	cancer	NOUN
can-11500	216	2	.	.	PUNCT
can-11500	217	1	2022	2022	NUM
can-11500	217	2	;	;	PUNCT
can-11500	217	3	14(10	14(10	NUM
can-11500	217	4	):	):	PUNCT
can-11500	217	5	2569	2569	NUM
can-11500	217	6	.	.	PUNCT
can-11500	218	1	doi	doi	NOUN
can-11500	218	2	:	:	PUNCT
can-11500	218	3	10.3390	10.3390	NUM
can-11500	218	4	/	/	SYM
can-11500	218	5	cancers14102569	cancers14102569	PROPN
can-11500	218	6	10	10	NUM
can-11500	218	7	.	.	PUNCT
can-11500	219	1	recent	recent	ADJ
can-11500	219	2	advances	advance	NOUN
can-11500	219	3	in	in	ADP
can-11500	219	4	nanoparticle	nanoparticle	NOUN
can-11500	219	5	-	-	PUNCT
can-11500	219	6	based	base	VERB
can-11500	219	7	cancer	cancer	NOUN
can-11500	219	8	drug	drug	NOUN
can-11500	219	9	and	and	CCONJ
can-11500	219	10	gene	gene	NOUN
can-11500	219	11	delivery	delivery	NOUN
can-11500	219	12	.	.	PUNCT
can-11500	220	1	advances	advance	NOUN
can-11500	220	2	in	in	ADP
can-11500	220	3	cancer	cancer	NOUN
can-11500	220	4	research	research	NOUN
can-11500	220	5	.	.	PUNCT
can-11500	221	1	published	publish	VERB
can-11500	221	2	online	online	ADJ
can-11500	221	3	2018	2018	NUM
can-11500	221	4	:	:	PUNCT
can-11500	221	5	115	115	NUM
can-11500	221	6	-	-	SYM
can-11500	221	7	170	170	NUM
can-11500	221	8	.	.	PUNCT
can-11500	222	1	doi	doi	NOUN
can-11500	222	2	:	:	PUNCT
can-11500	222	3	10.1016	10.1016	NUM
can-11500	222	4	/	/	SYM
can-11500	222	5	bs.acr.2017.11.003	bs.acr.2017.11.003	PROPN
can-11500	222	6	11	11	NUM
can-11500	222	7	.	.	PUNCT
can-11500	223	1	golombek	golombek	NOUN
can-11500	223	2	sk	sk	PROPN
can-11500	223	3	,	,	PUNCT
can-11500	223	4	may	may	AUX
can-11500	223	5	jn	jn	PROPN
can-11500	223	6	,	,	PUNCT
can-11500	223	7	theek	theek	NOUN
can-11500	223	8	b	b	PROPN
can-11500	223	9	,	,	PUNCT
can-11500	223	10	et	et	PROPN
can-11500	223	11	al	al	PROPN
can-11500	223	12	.	.	PROPN
can-11500	224	1	tumor	tumor	PROPN
can-11500	224	2	targeting	target	VERB
can-11500	224	3	via	via	ADP
can-11500	224	4	epr	epr	ADJ
can-11500	224	5	:	:	PUNCT
can-11500	224	6	strategies	strategy	NOUN
can-11500	224	7	to	to	PART
can-11500	224	8	enhance	enhance	VERB
can-11500	224	9	patient	patient	ADJ
can-11500	224	10	responses	response	NOUN
can-11500	224	11	.	.	PUNCT
can-11500	225	1	advanced	advanced	ADJ
can-11500	225	2	drug	drug	NOUN
can-11500	225	3	delivery	delivery	NOUN
can-11500	225	4	reviews	review	NOUN
can-11500	225	5	.	.	PUNCT
can-11500	226	1	2018	2018	NUM
can-11500	226	2	;	;	PUNCT
can-11500	226	3	130	130	NUM
can-11500	226	4	:	:	SYM
can-11500	226	5	17	17	NUM
can-11500	226	6	-	-	SYM
can-11500	226	7	38	38	NUM
can-11500	226	8	.	.	PUNCT
can-11500	227	1	doi	doi	NOUN
can-11500	227	2	:	:	PUNCT
can-11500	227	3	10.1016	10.1016	NUM
can-11500	227	4	/	/	SYM
can-11500	227	5	j.addr.2018.07.007	j.addr.2018.07.007	PROPN
can-11500	227	6	12	12	NUM
can-11500	227	7	.	.	PUNCT
can-11500	228	1	gavas	gavas	PROPN
can-11500	228	2	s	s	PROPN
can-11500	228	3	,	,	PUNCT
can-11500	228	4	quazi	quazi	PROPN
can-11500	228	5	s	s	PART
can-11500	228	6	,	,	PUNCT
can-11500	228	7	karpiński	karpiński	PROPN
can-11500	228	8	tm	tm	PROPN
can-11500	228	9	.	.	PROPN
can-11500	228	10	nanoparticles	nanoparticle	NOUN
can-11500	228	11	for	for	ADP
can-11500	228	12	cancer	cancer	NOUN
can-11500	228	13	therapy	therapy	NOUN
can-11500	228	14	:	:	PUNCT
can-11500	228	15	current	current	ADJ
can-11500	228	16	progress	progress	NOUN
can-11500	228	17	and	and	CCONJ
can-11500	228	18	challenges	challenge	NOUN
can-11500	228	19	.	.	PUNCT
can-11500	229	1	nanoscale	nanoscale	NOUN
can-11500	229	2	research	research	NOUN
can-11500	229	3	letters	letter	NOUN
can-11500	229	4	.	.	PUNCT
can-11500	230	1	2021	2021	NUM
can-11500	230	2	;	;	PUNCT
can-11500	230	3	16(1	16(1	NUM
can-11500	230	4	)	)	PUNCT
can-11500	230	5	.	.	PUNCT
can-11500	231	1	doi	doi	NOUN
can-11500	231	2	:	:	PUNCT
can-11500	231	3	10.1186	10.1186	NUM
can-11500	231	4	/	/	SYM
can-11500	231	5	s11671	s11671	NOUN
can-11500	231	6	-	-	PUNCT
can-11500	231	7	021	021	NUM
can-11500	231	8	-	-	PUNCT
can-11500	231	9	03628	03628	NUM
can-11500	231	10	-	-	SYM
can-11500	231	11	6	6	NUM
can-11500	231	12	13	13	NUM
can-11500	231	13	.	.	PUNCT
can-11500	232	1	yao	yao	PROPN
can-11500	232	2	y	y	PROPN
can-11500	232	3	,	,	PUNCT
can-11500	232	4	zhou	zhou	PROPN
can-11500	232	5	y	y	PROPN
can-11500	232	6	,	,	PUNCT
can-11500	232	7	liu	liu	PROPN
can-11500	232	8	l	l	PROPN
can-11500	232	9	,	,	PUNCT
can-11500	232	10	et	et	PROPN
can-11500	232	11	al	al	PROPN
can-11500	232	12	.	.	PROPN
can-11500	232	13	nanoparticle	nanoparticle	NOUN
can-11500	232	14	-	-	PUNCT
can-11500	232	15	based	base	VERB
can-11500	232	16	drug	drug	NOUN
can-11500	232	17	delivery	delivery	NOUN
can-11500	232	18	in	in	ADP
can-11500	232	19	cancer	cancer	NOUN
can-11500	232	20	therapy	therapy	NOUN
can-11500	232	21	and	and	CCONJ
can-11500	232	22	its	its	PRON
can-11500	232	23	role	role	NOUN
can-11500	232	24	in	in	ADP
can-11500	232	25	overcoming	overcome	VERB
can-11500	232	26	drug	drug	NOUN
can-11500	232	27	resistance	resistance	NOUN
can-11500	232	28	.	.	PUNCT
can-11500	233	1	frontiers	frontier	NOUN
can-11500	233	2	in	in	ADP
can-11500	233	3	molecular	molecular	ADJ
can-11500	233	4	biosciences	bioscience	NOUN
can-11500	233	5	.	.	PUNCT
can-11500	233	6	2020	2020	NUM
can-11500	233	7	;	;	PUNCT
can-11500	233	8	7	7	X
can-11500	233	9	.	.	X
can-11500	233	10	doi	doi	NOUN
can-11500	233	11	:	:	PUNCT
can-11500	233	12	10.3389	10.3389	NUM
can-11500	233	13	/	/	SYM
can-11500	233	14	fmolb.2020.00193	fmolb.2020.00193	PRON
can-11500	233	15	14	14	NUM
can-11500	233	16	.	.	PUNCT
can-11500	234	1	zhu	zhu	PROPN
can-11500	234	2	l	l	PROPN
can-11500	234	3	,	,	PUNCT
can-11500	234	4	ma	ma	PROPN
can-11500	234	5	j	j	PROPN
can-11500	234	6	,	,	PUNCT
can-11500	234	7	jia	jia	PROPN
can-11500	234	8	n	n	CCONJ
can-11500	234	9	,	,	PUNCT
can-11500	234	10	et	et	PROPN
can-11500	234	11	al	al	PROPN
can-11500	234	12	.	.	PUNCT
can-11500	235	1	chitosan	chitosan	NOUN
can-11500	235	2	-	-	PUNCT
can-11500	235	3	coated	coat	VERB
can-11500	235	4	magnetic	magnetic	ADJ
can-11500	235	5	nanoparticles	nanoparticle	NOUN
can-11500	235	6	as	as	ADP
can-11500	235	7	carriers	carrier	NOUN
can-11500	235	8	of	of	ADP
can-11500	235	9	5	5	NUM
can-11500	235	10	-	-	PUNCT
can-11500	235	11	fluorouracil	fluorouracil	NOUN
can-11500	235	12	:	:	PUNCT
can-11500	235	13	preparation	preparation	NOUN
can-11500	235	14	,	,	PUNCT
can-11500	235	15	characterization	characterization	NOUN
can-11500	235	16	and	and	CCONJ
can-11500	235	17	cytotoxicity	cytotoxicity	NOUN
can-11500	235	18	studies	study	NOUN
can-11500	235	19	.	.	PUNCT
can-11500	236	1	colloids	colloid	NOUN
can-11500	236	2	and	and	CCONJ
can-11500	236	3	surfaces	surface	NOUN
can-11500	236	4	b	b	X
can-11500	236	5	:	:	PUNCT
can-11500	236	6	biointerfaces	biointerface	NOUN
can-11500	236	7	.	.	PUNCT
can-11500	236	8	2009	2009	NUM
can-11500	236	9	;	;	PUNCT
can-11500	236	10	68(1	68(1	NOUN
can-11500	236	11	):	):	PUNCT
can-11500	236	12	1	1	NUM
can-11500	236	13	-	-	SYM
can-11500	236	14	6	6	NUM
can-11500	236	15	.	.	PUNCT
can-11500	236	16	doi	doi	NOUN
can-11500	236	17	:	:	PUNCT
can-11500	236	18	10.1016	10.1016	NUM
can-11500	236	19	/	/	SYM
can-11500	236	20	j.colsurfb.2008.07.020	j.colsurfb.2008.07.020	PROPN
can-11500	236	21	15	15	NUM
can-11500	236	22	.	.	PUNCT
can-11500	237	1	parsian	parsian	PROPN
can-11500	237	2	m	m	PROPN
can-11500	237	3	,	,	PUNCT
can-11500	237	4	unsoy	unsoy	ADJ
can-11500	237	5	g	g	NOUN
can-11500	237	6	,	,	PUNCT
can-11500	237	7	mutlu	mutlu	PROPN
can-11500	237	8	p	p	PRON
can-11500	237	9	,	,	PUNCT
can-11500	237	10	et	et	PROPN
can-11500	237	11	al	al	PROPN
can-11500	237	12	.	.	PROPN
can-11500	237	13	loading	loading	NOUN
can-11500	237	14	of	of	ADP
can-11500	237	15	gemcitabine	gemcitabine	NOUN
can-11500	237	16	on	on	ADP
can-11500	237	17	chitosan	chitosan	ADJ
can-11500	237	18	magnetic	magnetic	ADJ
can-11500	237	19	nanoparticles	nanoparticle	NOUN
can-11500	237	20	increases	increase	VERB
can-11500	237	21	the	the	DET
can-11500	237	22	anti	anti	ADJ
can-11500	237	23	-	-	ADJ
can-11500	237	24	cancer	cancer	ADJ
can-11500	237	25	efficacy	efficacy	NOUN
can-11500	237	26	of	of	ADP
can-11500	237	27	the	the	DET
can-11500	237	28	drug	drug	NOUN
can-11500	237	29	.	.	PUNCT
can-11500	238	1	european	european	PROPN
can-11500	238	2	journal	journal	PROPN
can-11500	238	3	of	of	ADP
can-11500	238	4	pharmacology	pharmacology	NOUN
can-11500	238	5	.	.	PUNCT
can-11500	239	1	2016	2016	NUM
can-11500	239	2	;	;	PUNCT
can-11500	239	3	784	784	NUM
can-11500	239	4	:	:	PUNCT
can-11500	239	5	121	121	NUM
can-11500	239	6	-	-	SYM
can-11500	239	7	128	128	NUM
can-11500	239	8	.	.	PUNCT
can-11500	240	1	doi	doi	NOUN
can-11500	240	2	:	:	PUNCT
can-11500	240	3	10.1016	10.1016	NUM
can-11500	240	4	/	/	SYM
can-11500	240	5	j.ejphar.2016.05.016	j.ejphar.2016.05.016	PROPN
can-11500	240	6	16	16	NUM
can-11500	240	7	.	.	PUNCT
can-11500	241	1	oh	oh	INTJ
can-11500	241	2	y	y	PROPN
can-11500	241	3	,	,	PUNCT
can-11500	241	4	lee	lee	PROPN
can-11500	241	5	n	n	PROPN
can-11500	241	6	,	,	PUNCT
can-11500	241	7	kang	kang	PROPN
can-11500	241	8	hw	hw	PROPN
can-11500	241	9	,	,	PUNCT
can-11500	241	10	et	et	PROPN
can-11500	241	11	al	al	PROPN
can-11500	241	12	.	.	PROPN
can-11500	242	1	in	in	ADP
can-11500	242	2	vitrostudy	vitrostudy	NOUN
can-11500	242	3	on	on	ADP
can-11500	242	4	apoptotic	apoptotic	ADJ
can-11500	242	5	cell	cell	NOUN
can-11500	242	6	death	death	NOUN
can-11500	242	7	by	by	ADP
can-11500	242	8	effective	effective	ADJ
can-11500	242	9	magnetic	magnetic	ADJ
can-11500	242	10	hyperthermia	hyperthermia	NOUN
can-11500	242	11	with	with	ADP
can-11500	242	12	chitosan	chitosan	NOUN
can-11500	242	13	-	-	PUNCT
can-11500	242	14	coated	coat	VERB
can-11500	242	15	mnfe2o4	mnfe2o4	PROPN
can-11500	242	16	.	.	PUNCT
can-11500	242	17	nanotechnology	nanotechnology	PROPN
can-11500	242	18	.	.	PUNCT
can-11500	242	19	2016	2016	NUM
can-11500	242	20	;	;	PUNCT
can-11500	242	21	27(11	27(11	NUM
can-11500	242	22	):	):	PUNCT
can-11500	242	23	115101	115101	NUM
can-11500	242	24	.	.	PUNCT
can-11500	243	1	doi	doi	NOUN
can-11500	243	2	:	:	PUNCT
can-11500	243	3	10.1088/0957	10.1088/0957	NUM
can-11500	243	4	-	-	SYM
can-11500	243	5	4484/27/11/115101	4484/27/11/115101	NUM
can-11500	243	6	17	17	NUM
can-11500	243	7	.	.	PUNCT
can-11500	244	1	thorat	thorat	NOUN
can-11500	244	2	nd	nd	PROPN
can-11500	244	3	,	,	PUNCT
can-11500	244	4	otari	otari	PROPN
can-11500	244	5	sv	sv	PROPN
can-11500	244	6	,	,	PUNCT
can-11500	244	7	patil	patil	PROPN
can-11500	244	8	rm	rm	PROPN
can-11500	244	9	,	,	PUNCT
can-11500	244	10	et	et	PROPN
can-11500	244	11	al	al	PROPN
can-11500	244	12	.	.	PUNCT
can-11500	244	13	synthesis	synthesis	NOUN
can-11500	244	14	,	,	PUNCT
can-11500	244	15	characterization	characterization	NOUN
can-11500	244	16	and	and	CCONJ
can-11500	244	17	biocompatibility	biocompatibility	NOUN
can-11500	244	18	of	of	ADP
can-11500	244	19	chitosan	chitosan	NOUN
can-11500	244	20	functionalized	functionalize	VERB
can-11500	244	21	superparamagnetic	superparamagnetic	ADJ
can-11500	244	22	nanoparticles	nanoparticle	NOUN
can-11500	244	23	for	for	ADP
can-11500	244	24	heat	heat	NOUN
can-11500	244	25	activated	activate	VERB
can-11500	244	26	curing	curing	NOUN
can-11500	244	27	of	of	ADP
can-11500	244	28	cancer	cancer	NOUN
can-11500	244	29	cells	cell	NOUN
can-11500	244	30	.	.	PUNCT
can-11500	245	1	dalton	dalton	PROPN
can-11500	245	2	trans	trans	PROPN
can-11500	245	3	.	.	PROPN
can-11500	245	4	2014	2014	NUM
can-11500	245	5	;	;	PUNCT
can-11500	245	6	43(46	43(46	NOUN
can-11500	245	7	):	):	PUNCT
can-11500	245	8	17343	17343	NUM
can-11500	245	9	-	-	SYM
can-11500	245	10	17351	17351	NUM
can-11500	245	11	.	.	PUNCT
can-11500	246	1	doi	doi	NOUN
can-11500	246	2	:	:	PUNCT
can-11500	246	3	10.1039	10.1039	NUM
can-11500	246	4	/	/	SYM
can-11500	246	5	c4dt02293a	c4dt02293a	PROPN
can-11500	246	6	18	18	NUM
can-11500	246	7	.	.	PUNCT
can-11500	246	8	national	national	ADJ
can-11500	246	9	center	center	NOUN
can-11500	246	10	for	for	ADP
can-11500	246	11	biotechnology	biotechnology	NOUN
can-11500	246	12	information	information	NOUN
can-11500	246	13	(	(	PUNCT
can-11500	246	14	ncbi	ncbi	NOUN
can-11500	246	15	)	)	PUNCT
can-11500	246	16	.	.	PUNCT
can-11500	247	1	pubchem	pubchem	PROPN
can-11500	247	2	compound	compound	NOUN
can-11500	247	3	summary	summary	NOUN
can-11500	247	4	for	for	ADP
can-11500	247	5	cid	cid	NOUN
can-11500	247	6	5743	5743	NUM
can-11500	247	7	:	:	PUNCT
can-11500	248	1	dexamethasone	dexamethasone	NOUN
can-11500	248	2	.	.	PUNCT
can-11500	249	1	accessed	access	VERB
can-11500	249	2	january	january	PROPN
can-11500	249	3	24	24	NUM
can-11500	249	4	,	,	PUNCT
can-11500	249	5	2025	2025	NUM
can-11500	249	6	.	.	PUNCT
can-11500	250	1	https://pubchem.ncbi.nlm.nih.gov/compound/dexamethasone	https://pubchem.ncbi.nlm.nih.gov/compound/dexamethasone	PROPN
can-11500	250	2	19	19	NUM
can-11500	250	3	.	.	PUNCT
can-11500	250	4	dey	dey	PROPN
can-11500	250	5	kk	kk	PROPN
can-11500	250	6	,	,	PUNCT
can-11500	250	7	ghosh	ghosh	PROPN
can-11500	250	8	m.	m.	PROPN
can-11500	250	9	understanding	understand	VERB
can-11500	250	10	the	the	DET
can-11500	250	11	structure	structure	NOUN
can-11500	250	12	and	and	CCONJ
can-11500	250	13	dynamics	dynamic	NOUN
can-11500	250	14	of	of	ADP
can-11500	250	15	anti	anti	ADJ
can-11500	250	16	-	-	ADJ
can-11500	250	17	inflammatory	inflammatory	ADJ
can-11500	250	18	corticosteroid	corticosteroid	ADJ
can-11500	250	19	dexamethasone	dexamethasone	NOUN
can-11500	250	20	by	by	ADP
can-11500	250	21	solid	solid	ADJ
can-11500	250	22	state	state	NOUN
can-11500	250	23	nmr	nmr	NOUN
can-11500	250	24	spectroscopy	spectroscopy	NOUN
can-11500	250	25	.	.	PUNCT
can-11500	251	1	rsc	rsc	PROPN
can-11500	251	2	advances	advance	NOUN
can-11500	251	3	.	.	PUNCT
can-11500	252	1	2020	2020	NUM
can-11500	252	2	;	;	PUNCT
can-11500	252	3	10(61	10(61	NUM
can-11500	252	4	):	):	PUNCT
can-11500	252	5	37564	37564	NUM
can-11500	252	6	-	-	SYM
can-11500	252	7	37575	37575	NUM
can-11500	252	8	.	.	PUNCT
can-11500	253	1	doi	doi	NOUN
can-11500	253	2	:	:	PUNCT
can-11500	253	3	10.1039	10.1039	NUM
can-11500	253	4	/	/	SYM
can-11500	253	5	d0ra05474	d0ra05474	PROPN
can-11500	253	6	g	g	NOUN
can-11500	253	7	20	20	NUM
can-11500	253	8	.	.	PUNCT
can-11500	254	1	unsoy	unsoy	PROPN
can-11500	254	2	g	g	PROPN
can-11500	254	3	,	,	PUNCT
can-11500	254	4	yalcin	yalcin	PROPN
can-11500	254	5	s	s	PART
can-11500	254	6	,	,	PUNCT
can-11500	254	7	khodadust	khodadust	PROPN
can-11500	254	8	r	r	NOUN
can-11500	254	9	,	,	PUNCT
can-11500	254	10	et	et	PROPN
can-11500	254	11	al	al	PROPN
can-11500	254	12	.	.	PROPN
can-11500	254	13	synthesis	synthesis	NOUN
can-11500	254	14	optimization	optimization	NOUN
can-11500	254	15	and	and	CCONJ
can-11500	254	16	characterization	characterization	NOUN
can-11500	254	17	of	of	ADP
can-11500	254	18	chitosan	chitosan	NOUN
can-11500	254	19	-	-	PUNCT
can-11500	254	20	coated	coat	VERB
can-11500	254	21	iron	iron	NOUN
can-11500	254	22	oxide	oxide	NOUN
can-11500	254	23	nanoparticles	nanoparticle	NOUN
can-11500	254	24	produced	produce	VERB
can-11500	254	25	for	for	ADP
can-11500	254	26	biomedical	biomedical	ADJ
can-11500	254	27	applications	application	NOUN
can-11500	254	28	.	.	PUNCT
can-11500	255	1	journal	journal	PROPN
can-11500	255	2	of	of	ADP
can-11500	255	3	nanoparticle	nanoparticle	NOUN
can-11500	255	4	research	research	NOUN
can-11500	255	5	.	.	PUNCT
can-11500	256	1	2012	2012	NUM
can-11500	256	2	;	;	PUNCT
can-11500	256	3	14(11	14(11	NUM
can-11500	256	4	)	)	PUNCT
can-11500	256	5	.	.	PUNCT
can-11500	257	1	doi	doi	NOUN
can-11500	257	2	:	:	PUNCT
can-11500	257	3	10.1007	10.1007	NUM
can-11500	257	4	/	/	SYM
can-11500	257	5	s11051012	s11051012	NOUN
can-11500	257	6	-	-	PUNCT
can-11500	257	7	0964	0964	NUM
can-11500	257	8	-	-	SYM
can-11500	257	9	8	8	NUM
can-11500	257	10	21	21	NUM
can-11500	257	11	.	.	PUNCT
can-11500	258	1	liang	liang	PROPN
can-11500	258	2	cc	cc	PROPN
can-11500	258	3	,	,	PUNCT
can-11500	258	4	park	park	PROPN
can-11500	258	5	ay	ay	PROPN
can-11500	258	6	,	,	PUNCT
can-11500	258	7	guan	guan	PROPN
can-11500	258	8	jl	jl	PROPN
can-11500	258	9	.	.	PUNCT
can-11500	259	1	in	in	ADP
can-11500	259	2	vitro	vitro	X
can-11500	259	3	scratch	scratch	NOUN
can-11500	259	4	assay	assay	VERB
can-11500	259	5	:	:	PUNCT
can-11500	259	6	a	a	DET
can-11500	259	7	convenient	convenient	ADJ
can-11500	259	8	and	and	CCONJ
can-11500	259	9	inexpensive	inexpensive	ADJ
can-11500	259	10	method	method	NOUN
can-11500	259	11	for	for	ADP
can-11500	259	12	analysis	analysis	NOUN
can-11500	259	13	of	of	ADP
can-11500	259	14	cell	cell	NOUN
can-11500	259	15	migration	migration	NOUN
can-11500	259	16	in	in	ADP
can-11500	259	17	vitro	vitro	X
can-11500	259	18	.	.	PUNCT
can-11500	260	1	nature	nature	NOUN
can-11500	260	2	protocols	protocol	NOUN
can-11500	260	3	.	.	PUNCT
can-11500	261	1	2007	2007	NUM
can-11500	261	2	;	;	PUNCT
can-11500	261	3	2(2	2(2	NUM
can-11500	261	4	):	):	PUNCT
can-11500	261	5	329	329	NUM
can-11500	261	6	-	-	SYM
can-11500	261	7	333	333	NUM
can-11500	261	8	.	.	PUNCT
can-11500	262	1	doi	doi	NOUN
can-11500	262	2	:	:	PUNCT
can-11500	262	3	10.1038	10.1038	NUM
can-11500	262	4	/	/	SYM
can-11500	262	5	nprot.2007.30	nprot.2007.30	NOUN
can-11500	262	6	22	22	NUM
can-11500	262	7	.	.	PUNCT
can-11500	262	8	mao	mao	PROPN
can-11500	263	1	hq	hq	PROPN
can-11500	263	2	,	,	PUNCT
can-11500	263	3	roy	roy	PROPN
can-11500	263	4	k	k	PROPN
can-11500	263	5	,	,	PUNCT
can-11500	263	6	troung	troung	PROPN
can-11500	263	7	-	-	PUNCT
can-11500	263	8	le	le	X
can-11500	263	9	vl	vl	PROPN
can-11500	263	10	,	,	PUNCT
can-11500	263	11	et	et	PROPN
can-11500	263	12	al	al	PROPN
can-11500	263	13	.	.	PUNCT
can-11500	264	1	chitosan	chitosan	ADJ
can-11500	264	2	-	-	PUNCT
can-11500	264	3	dna	dna	PROPN
can-11500	264	4	nanoparticles	nanoparticle	NOUN
can-11500	264	5	as	as	ADP
can-11500	264	6	gene	gene	NOUN
can-11500	264	7	carriers	carrier	NOUN
can-11500	264	8	.	.	PUNCT
can-11500	265	1	j	j	PROPN
can-11500	265	2	control	control	PROPN
can-11500	265	3	release	release	PROPN
can-11500	265	4	.	.	PUNCT
can-11500	266	1	2001;70(3):399	2001;70(3):399	PROPN
can-11500	266	2	-	-	SYM
can-11500	266	3	421	421	NUM
can-11500	266	4	.	.	PUNCT
can-11500	266	5	doi:10.1016	doi:10.1016	PROPN
can-11500	266	6	/	/	SYM
can-11500	266	7	s0168	s0168	PROPN
can-11500	266	8	-	-	PUNCT
can-11500	266	9	3659(00)00361	3659(00)00361	NUM
can-11500	266	10	-	-	SYM
can-11500	266	11	8	8	NUM
can-11500	266	12	23	23	NUM
can-11500	266	13	.	.	PUNCT
can-11500	267	1	corsi	corsi	PROPN
can-11500	267	2	k	k	PROPN
can-11500	267	3	,	,	PUNCT
can-11500	267	4	chellat	chellat	PROPN
can-11500	267	5	f	f	PROPN
can-11500	267	6	,	,	PUNCT
can-11500	267	7	yahia	yahia	PROPN
can-11500	267	8	l	l	PROPN
can-11500	267	9	,	,	PUNCT
can-11500	267	10	fernandes	fernandes	PROPN
can-11500	267	11	jc	jc	PROPN
can-11500	267	12	.	.	PROPN
can-11500	268	1	mesenchymal	mesenchymal	ADJ
can-11500	268	2	stem	stem	NOUN
can-11500	268	3	cell	cell	NOUN
can-11500	268	4	transfection	transfection	NOUN
can-11500	268	5	using	use	VERB
can-11500	268	6	chitosan	chitosan	ADJ
can-11500	268	7	-	-	PUNCT
can-11500	268	8	dna	dna	NOUN
can-11500	268	9	nanoparticles	nanoparticle	NOUN
can-11500	268	10	.	.	PUNCT
can-11500	269	1	biomaterials	biomaterial	NOUN
can-11500	269	2	.	.	PUNCT
can-11500	270	1	2003;24(7):1255	2003;24(7):1255	NUM
can-11500	270	2	-	-	SYM
can-11500	270	3	1264	1264	NUM
can-11500	270	4	.	.	PUNCT
can-11500	271	1	doi:10.1016	doi:10.1016	PROPN
can-11500	271	2	/	/	SYM
can-11500	271	3	s0142	s0142	PROPN
can-11500	271	4	-	-	PUNCT
can-11500	271	5	9612(02)00507	9612(02)00507	NOUN
can-11500	271	6	-	-	PUNCT
can-11500	271	7	0	0	NUM
can-11500	271	8	characterization	characterization	NOUN
can-11500	271	9	and	and	CCONJ
can-11500	271	10	application	application	NOUN
can-11500	271	11	of	of	ADP
can-11500	271	12	nanomaterials	nanomaterial	NOUN
can-11500	271	13	2025	2025	NUM
can-11500	271	14	,	,	PUNCT
can-11500	271	15	8(3	8(3	NUM
can-11500	271	16	)	)	PUNCT
can-11500	271	17	,	,	PUNCT
can-11500	271	18	11500	11500	NUM
can-11500	271	19	.	.	PUNCT
can-11500	272	1	14	14	NUM
can-11500	272	2	24	24	NUM
can-11500	272	3	.	.	PUNCT
can-11500	273	1	baghdan	baghdan	PROPN
can-11500	273	2	e	e	PROPN
can-11500	273	3	,	,	PUNCT
can-11500	273	4	pinnapireddy	pinnapireddy	PROPN
can-11500	273	5	sr	sr	PROPN
can-11500	273	6	,	,	PUNCT
can-11500	273	7	strehlow	strehlow	PROPN
can-11500	273	8	b	b	PROPN
can-11500	273	9	,	,	PUNCT
can-11500	273	10	et	et	PROPN
can-11500	273	11	al	al	PROPN
can-11500	273	12	.	.	PROPN
can-11500	273	13	lipid	lipid	PROPN
can-11500	273	14	coated	coat	VERB
can-11500	273	15	chitosan	chitosan	ADJ
can-11500	273	16	-	-	PUNCT
can-11500	273	17	dna	dna	PROPN
can-11500	273	18	nanoparticles	nanoparticle	NOUN
can-11500	273	19	for	for	ADP
can-11500	273	20	enhanced	enhanced	ADJ
can-11500	273	21	gene	gene	NOUN
can-11500	273	22	delivery	delivery	NOUN
can-11500	273	23	.	.	PUNCT
can-11500	274	1	international	international	ADJ
can-11500	274	2	journal	journal	PROPN
can-11500	274	3	of	of	ADP
can-11500	274	4	pharmaceutics	pharmaceutic	NOUN
can-11500	274	5	.	.	PUNCT
can-11500	274	6	2018	2018	NUM
can-11500	274	7	;	;	PUNCT
can-11500	274	8	535(1	535(1	NUM
can-11500	274	9	-	-	SYM
can-11500	274	10	2	2	NUM
can-11500	274	11	):	):	PUNCT
can-11500	274	12	473	473	NUM
can-11500	274	13	-	-	SYM
can-11500	274	14	479	479	NUM
can-11500	274	15	.	.	PUNCT
can-11500	275	1	doi	doi	NOUN
can-11500	275	2	:	:	PUNCT
can-11500	275	3	10.1016	10.1016	NUM
can-11500	275	4	/	/	SYM
can-11500	275	5	j.ijpharm.2017.11.045	j.ijpharm.2017.11.045	PROPN
can-11500	275	6	25	25	NUM
can-11500	275	7	.	.	PUNCT
can-11500	276	1	martin	martin	PROPN
can-11500	276	2	jd	jd	PROPN
can-11500	276	3	,	,	PUNCT
can-11500	276	4	panagi	panagi	PROPN
can-11500	276	5	m	m	PROPN
can-11500	276	6	,	,	PUNCT
can-11500	276	7	wang	wang	PROPN
can-11500	276	8	c	c	PROPN
can-11500	276	9	,	,	PUNCT
can-11500	276	10	et	et	PROPN
can-11500	276	11	al	al	PROPN
can-11500	276	12	.	.	PUNCT
can-11500	277	1	dexamethasone	dexamethasone	NOUN
can-11500	277	2	increases	increase	VERB
can-11500	277	3	cisplatin	cisplatin	NOUN
can-11500	277	4	-	-	PUNCT
can-11500	277	5	loaded	load	VERB
can-11500	277	6	nanocarrier	nanocarrier	NOUN
can-11500	277	7	delivery	delivery	NOUN
can-11500	277	8	and	and	CCONJ
can-11500	277	9	efficacy	efficacy	NOUN
can-11500	277	10	in	in	ADP
can-11500	277	11	metastatic	metastatic	ADJ
can-11500	277	12	breast	breast	NOUN
can-11500	277	13	cancer	cancer	NOUN
can-11500	277	14	by	by	ADP
can-11500	277	15	normalizing	normalize	VERB
can-11500	277	16	the	the	DET
can-11500	277	17	tumor	tumor	NOUN
can-11500	277	18	microenvironment	microenvironment	NOUN
can-11500	277	19	.	.	PUNCT
can-11500	278	1	acs	acs	PROPN
can-11500	278	2	nano	nano	PROPN
can-11500	278	3	.	.	PUNCT
can-11500	279	1	2019	2019	NUM
can-11500	279	2	;	;	PUNCT
can-11500	279	3	13(6	13(6	NUM
can-11500	279	4	):	):	PUNCT
can-11500	279	5	6396	6396	NUM
can-11500	279	6	-	-	SYM
can-11500	279	7	6408	6408	NUM
can-11500	279	8	.	.	PUNCT
can-11500	280	1	doi	doi	NOUN
can-11500	280	2	:	:	PUNCT
can-11500	280	3	10.1021	10.1021	NUM
can-11500	280	4	/	/	SYM
can-11500	280	5	acsnano.8b07865	acsnano.8b07865	PROPN
can-11500	280	6	26	26	NUM
can-11500	280	7	.	.	PUNCT
can-11500	281	1	zhou	zhou	PROPN
can-11500	281	2	l	l	PROPN
can-11500	281	3	,	,	PUNCT
can-11500	281	4	shen	shen	PROPN
can-11500	281	5	y	y	PROPN
can-11500	281	6	,	,	PUNCT
can-11500	281	7	huang	huang	PROPN
can-11500	281	8	t	t	PROPN
can-11500	281	9	,	,	PUNCT
can-11500	281	10	et	et	PROPN
can-11500	281	11	al	al	PROPN
can-11500	281	12	.	.	PUNCT
can-11500	282	1	the	the	DET
can-11500	282	2	prognostic	prognostic	ADJ
can-11500	282	3	effect	effect	NOUN
can-11500	282	4	of	of	ADP
can-11500	282	5	dexamethasone	dexamethasone	NOUN
can-11500	282	6	on	on	ADP
can-11500	282	7	patients	patient	NOUN
can-11500	282	8	with	with	ADP
can-11500	282	9	glioblastoma	glioblastoma	NOUN
can-11500	282	10	:	:	PUNCT
can-11500	282	11	a	a	DET
can-11500	282	12	systematic	systematic	ADJ
can-11500	282	13	review	review	NOUN
can-11500	282	14	and	and	CCONJ
can-11500	282	15	meta	meta	ADJ
can-11500	282	16	-	-	PUNCT
can-11500	282	17	analysis	analysis	NOUN
can-11500	282	18	.	.	PUNCT
can-11500	283	1	frontiers	frontier	NOUN
can-11500	283	2	in	in	ADP
can-11500	283	3	pharmacology	pharmacology	NOUN
can-11500	283	4	.	.	PUNCT
can-11500	283	5	2021	2021	NUM
can-11500	283	6	;	;	PUNCT
can-11500	283	7	12	12	NUM
can-11500	283	8	.	.	PUNCT
can-11500	284	1	doi	doi	NOUN
can-11500	284	2	:	:	PUNCT
can-11500	284	3	10.3389	10.3389	NUM
can-11500	284	4	/	/	SYM
can-11500	284	5	fphar.2021.727707	fphar.2021.727707	NOUN
can-11500	284	6	27	27	NUM
can-11500	284	7	.	.	PUNCT
can-11500	285	1	jessurun	jessurun	PROPN
can-11500	285	2	cac	cac	PROPN
can-11500	285	3	,	,	PUNCT
can-11500	285	4	hulsbergen	hulsbergen	PROPN
can-11500	285	5	afc	afc	PROPN
can-11500	285	6	,	,	PUNCT
can-11500	285	7	cho	cho	PROPN
can-11500	285	8	ld	ld	PROPN
can-11500	285	9	,	,	PUNCT
can-11500	285	10	et	et	PROPN
can-11500	285	11	al	al	PROPN
can-11500	285	12	.	.	PROPN
can-11500	285	13	evidence	evidence	NOUN
can-11500	285	14	-	-	PUNCT
can-11500	285	15	based	base	VERB
can-11500	285	16	dexamethasone	dexamethasone	NOUN
can-11500	285	17	dosing	dose	VERB
can-11500	285	18	in	in	ADP
can-11500	285	19	malignant	malignant	ADJ
can-11500	285	20	brain	brain	NOUN
can-11500	285	21	tumors	tumor	NOUN
can-11500	285	22	:	:	PUNCT
can-11500	285	23	what	what	PRON
can-11500	285	24	do	do	AUX
can-11500	285	25	we	we	PRON
can-11500	285	26	really	really	ADV
can-11500	285	27	know	know	VERB
can-11500	285	28	?	?	PUNCT
can-11500	286	1	journal	journal	PROPN
can-11500	286	2	of	of	ADP
can-11500	286	3	neuro	neuro	NOUN
can-11500	286	4	-	-	PUNCT
can-11500	286	5	oncology	oncology	NOUN
can-11500	286	6	.	.	PUNCT
can-11500	287	1	2019	2019	NUM
can-11500	287	2	;	;	PUNCT
can-11500	287	3	144(2	144(2	NUM
can-11500	287	4	):	):	PUNCT
can-11500	287	5	249	249	NUM
can-11500	287	6	-	-	SYM
can-11500	287	7	264	264	NUM
can-11500	287	8	.	.	PUNCT
can-11500	288	1	doi	doi	NOUN
can-11500	288	2	:	:	PUNCT
can-11500	288	3	10.1007	10.1007	NUM
can-11500	288	4	/	/	SYM
can-11500	288	5	s11060	s11060	NOUN
can-11500	288	6	-	-	PUNCT
can-11500	288	7	019	019	NUM
can-11500	288	8	-	-	PUNCT
can-11500	288	9	03238	03238	NUM
can-11500	288	10	-	-	SYM
can-11500	288	11	4	4	NUM
can-11500	288	12	28	28	NUM
can-11500	288	13	.	.	PUNCT
can-11500	289	1	crozier	crozier	PROPN
can-11500	289	2	m	m	PROPN
can-11500	289	3	,	,	PUNCT
can-11500	289	4	tubman	tubman	PROPN
can-11500	289	5	j	j	PROPN
can-11500	289	6	,	,	PUNCT
can-11500	289	7	fifield	fifield	PROPN
can-11500	289	8	ba	ba	PROPN
can-11500	289	9	,	,	PUNCT
can-11500	289	10	et	et	PROPN
can-11500	289	11	al	al	PROPN
can-11500	289	12	.	.	PUNCT
can-11500	289	13	frequently	frequently	ADV
can-11500	289	14	used	use	VERB
can-11500	289	15	antiemetic	antiemetic	ADJ
can-11500	289	16	agent	agent	NOUN
can-11500	289	17	dexamethasone	dexamethasone	NOUN
can-11500	289	18	enhances	enhance	VERB
can-11500	289	19	the	the	DET
can-11500	289	20	metastatic	metastatic	ADJ
can-11500	289	21	behaviour	behaviour	NOUN
can-11500	289	22	of	of	ADP
can-11500	289	23	select	select	ADJ
can-11500	289	24	breast	breast	NOUN
can-11500	289	25	cancer	cancer	NOUN
can-11500	289	26	cells	cell	NOUN
can-11500	289	27	.	.	PUNCT
can-11500	290	1	seagroves	seagrove	NOUN
can-11500	290	2	t	t	PROPN
can-11500	290	3	,	,	PUNCT
can-11500	290	4	ed	ed	NOUN
can-11500	290	5	.	.	PUNCT
can-11500	291	1	plos	plos	PROPN
can-11500	291	2	one	one	NUM
can-11500	291	3	.	.	PUNCT
can-11500	291	4	2022	2022	NUM
can-11500	291	5	;	;	PUNCT
can-11500	291	6	17(9	17(9	NUM
can-11500	291	7	):	):	PUNCT
can-11500	291	8	e0274675	e0274675	PROPN
can-11500	291	9	.	.	PUNCT
can-11500	292	1	doi	doi	NOUN
can-11500	292	2	:	:	PUNCT
can-11500	292	3	10.1371	10.1371	NUM
can-11500	292	4	/	/	SYM
can-11500	292	5	journal.pone.0274675	journal.pone.0274675	PROPN
can-11500	292	6	29	29	NUM
can-11500	292	7	.	.	PUNCT
can-11500	293	1	zhang	zhang	PROPN
can-11500	293	2	x	x	PROPN
can-11500	293	3	,	,	PUNCT
can-11500	293	4	et	et	PROPN
can-11500	293	5	al	al	PROPN
can-11500	293	6	.	.	PROPN
can-11500	293	7	dexamethasone	dexamethasone	PROPN
can-11500	293	8	promotes	promote	VERB
can-11500	293	9	metastasis	metastasis	NOUN
can-11500	293	10	in	in	ADP
can-11500	293	11	er	er	ADJ
can-11500	293	12	-	-	PUNCT
can-11500	293	13	negative	negative	ADJ
can-11500	293	14	breast	breast	NOUN
can-11500	293	15	cancer	cancer	NOUN
can-11500	293	16	via	via	ADP
can-11500	293	17	emt	emt	PROPN
can-11500	293	18	.	.	PUNCT
can-11500	294	1	j	j	PROPN
can-11500	294	2	exp	exp	PROPN
can-11500	294	3	clin	clin	PROPN
can-11500	294	4	cancer	cancer	NOUN
can-11500	294	5	res	re	NOUN
can-11500	294	6	.	.	PUNCT
can-11500	295	1	2021;40(1):64	2021;40(1):64	PROPN
can-11500	295	2	.	.	PROPN
can-11500	295	3	doi:10.1186	doi:10.1186	PROPN
can-11500	295	4	/	/	SYM
can-11500	295	5	s13046	s13046	PROPN
can-11500	295	6	-	-	PUNCT
can-11500	295	7	021	021	NUM
can-11500	295	8	-	-	PUNCT
can-11500	295	9	01859	01859	NUM
can-11500	295	10	-	-	PUNCT
can-11500	295	11	1	1	NUM
can-11500	295	12	30	30	NUM
can-11500	295	13	.	.	PUNCT
can-11500	296	1	yalçın	yalçın	PROPN
can-11500	296	2	s	s	PROPN
can-11500	296	3	,	,	PUNCT
can-11500	296	4	erkan	erkan	PROPN
can-11500	296	5	m	m	PROPN
can-11500	296	6	,	,	PUNCT
can-11500	296	7	ünsoy	ünsoy	ADJ
can-11500	296	8	g	g	PROPN
can-11500	296	9	,	,	PUNCT
can-11500	296	10	et	et	PROPN
can-11500	296	11	al	al	PROPN
can-11500	296	12	.	.	PROPN
can-11500	296	13	effect	effect	NOUN
can-11500	296	14	of	of	ADP
can-11500	296	15	gemcitabine	gemcitabine	NOUN
can-11500	296	16	and	and	CCONJ
can-11500	296	17	retinoic	retinoic	PROPN
can-11500	296	18	acid	acid	PROPN
can-11500	296	19	loaded	load	VERB
can-11500	296	20	pamam	pamam	NOUN
can-11500	296	21	dendrimer	dendrimer	NOUN
can-11500	296	22	-	-	PUNCT
can-11500	296	23	coated	coat	VERB
can-11500	296	24	magnetic	magnetic	ADJ
can-11500	296	25	nanoparticles	nanoparticle	NOUN
can-11500	296	26	on	on	ADP
can-11500	296	27	pancreatic	pancreatic	ADJ
can-11500	296	28	cancer	cancer	NOUN
can-11500	296	29	and	and	CCONJ
can-11500	296	30	stellate	stellate	ADJ
can-11500	296	31	cell	cell	NOUN
can-11500	296	32	lines	line	NOUN
can-11500	296	33	.	.	PUNCT
can-11500	297	1	biomedicine	biomedicine	NOUN
can-11500	297	2	&	&	CCONJ
can-11500	297	3	pharmacotherapy	pharmacotherapy	NOUN
can-11500	297	4	.	.	PUNCT
can-11500	298	1	2014	2014	NUM
can-11500	298	2	;	;	PUNCT
can-11500	299	1	68(6	68(6	NOUN
can-11500	299	2	):	):	PUNCT
can-11500	299	3	737	737	NUM
can-11500	299	4	-	-	SYM
can-11500	299	5	743	743	NUM
can-11500	299	6	.	.	PUNCT
can-11500	300	1	doi	doi	NOUN
can-11500	300	2	:	:	PUNCT
can-11500	300	3	10.1016	10.1016	NUM
can-11500	300	4	/	/	SYM
can-11500	300	5	j.biopha.2014.07.003	j.biopha.2014.07.003	NOUN